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ABSTRACT OF DISSERTATION 
 
 
THE ROLE OF CO-INFECTION IN THE SPREAD OF HIV  
IN SUB-SAHARAN AFRICA 
 
The cause of the high HIV prevalence in sub-Saharan Africa is incompletely understood, 
with heterosexual penile-vaginal transmission proposed as the main mechanism. 
Heterosexual HIV transmission has a very low probability; further, a single estimation of 
heterosexual probability of HIV transmission fails to reproduce the variation associated 
with important biological cofactors. In particular, studies of HIV incidence suggest that 
co-infection with other infectious diseases influence the HIV transmission, and therefore 
might substantially vary the pattern of the spread of the infection. To assess the effect of 
co-infection on the spread of HIV, I developed and analyzed several mathematical and 
statistical models based on published data. The results show that despite the low 
probability of heterosexual transmission per sexual contact, the inclusion of individual 
variation generated by transient but repeated increases in HIV viral load associated with 
co-infections may provide a biological basis for the accelerated spread of HIV in sub-
Saharan Africa, and raises the possibility that that the natural history of HIV in sub-
Saharan Africa cannot be fully understood if individual variation in infectiousness is 
neglected. 
 Co-infection might be a key explanatory variable for the rapid spread of HIV 
infection in sub-Saharan Africa; in fact, co-infection may be a necessary factor, rather 
than merely being a contributing factor, in the successful spread and survival of HIV in 
populations where heterosexual vaginal-penile contact is the main mechanism of 
transmission. Consequently, broad population based control strategies to decrease 
infectivity and reduce the incidence of other sexual and parasitic infectious diseases 
might be effective strategies in diminishing the spread of HIV in sub-Saharan Africa. 
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Chapter 1 - Introduction 
 
Overview 
AIDS was first described in 1981 in homosexual men in North America (Gottlieb et al., 
1981) followed by the first report in patients from Central Africa in 1983 (Clumech et al., 
1983). Three years later, it was evident that HIV-1 had spread into populations of many 
countries from sub-Saharan Africa and had become an enormous public health problem 
(Quinn et al., 1986). Of the estimated 40 million HIV-seropositive patients in 2001, 70% 
were from sub-Saharan Africa, residence of less than 10% of the human population 
(UNAIDS/WHO). According to the global HIV/AIDS/STI working group 
(UNAIDS/WHO), an HIV epidemic is generalized if the prevalence in pregnant women 
consistently exceeds 1%. Using this definition, in 1999 the HIV epidemic was 
generalized in most of the countries of sub-Saharan Africa. By contrast, in Asia, the 
second most affected continent, only three countries had a generalized HIV epidemic 
(UNAIDS).  
 The causes of the uncontrollable expansion of the HIV epidemic in most countries 
from sub-Saharan Africa is incompletely understood (Curran et al., 1988; Hall et al., 
2008; Karon et al., 2001). Unlike the HIV epidemic in the US and Europe, which seems 
concentrated in specific high risk groups such as injection drug users and men who have 
sex with men (MSM) (Curran et al., 1988; Karon et al., 2001; Orroth et al., 2007), the 
epidemic in Africa is more widely distributed across the general population. The core risk 
group concept, the theory that a small group of people with large number of partners and 
repeated infections can maintain a reservoir of the infection within a population, does not 
fit in sub-Saharan Africa, where the infection has spread broadly beyond the putative risk 
groups (Hamilton et al., 2008).  
 Additionally, the hypothesis that heterosexual penile-vaginal transmission is the 
main mechanism of HIV transmission in sub-Saharan Africa (Gisselquist and Potterat, 
2002; Orroth et al., 2007; Vernazza et al., 1999; Waver et al., 2005) seems inconsistent 
with the low probability of heterosexual HIV transmission, estimated to be ~ 1/300 per 
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coital act in low-income countries (Boily et al., 2009; Gisselquist and Potterat, 2003). In 
particular, the assumption that the high incidence of HIV epidemic among African adults 
is almost exclusively due to sexual transmission actually requires much higher 
probabilities of heterosexual transmission in Africa than in the developed world (Boily et 
al., 2009). These contrasting differences observed among the HIV epidemics from 
different settings of the world raise a fundamental question: why does HIV prevalence 
vary so greatly in different locations? Answers to this question would help us to better 
understand the natural history of HIV and implement appropriate interventions. The 
identification of biological or behavioral factors that could explain the variation in 
prevalence of HIV infection may help us to design the more efficient public-health 
strategies to control the epidemic. 
 Epidemics caused by the transmission of infectious agents such as HIV are 
characterized by heterogeneities in the pathogen and host populations, and interactions 
between them profoundly affect the dynamic of the infection. There are several 
epidemiologically important sources of variation: disease independent host parameters 
such as sex, age and contact rates, and disease dependent host parameters such as 
susceptibility, transmission rate and duration of the infectiousness. Resulting from the 
possible influence of the population heterogeneity on the transmission efficiency of the 
virus, individual variation emerges as an important element for understanding the natural 
history of HIV. Regional factors may affect the spatial spread of the infection, while 
individual heterogeneities such as behavior may influence the pattern of the spread of the 
infection within populations. To understand the natural history of HIV, particularly in 
sub-Saharan Africa, and thus generate the most cost-efficient method to control the HIV 
epidemic, it becomes fundamental to identify the factors that generate the individual 
variation on the HIV infectivity in space and time.  
 
Background and motivation 
The causes for the extremely high HIV prevalence in sub-Sahara Africa is one of the 
biggest debates nowadays. Most attempts to explain the epidemic are based in behavioral 
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components of the population (i.e. number of sexual partners per year, partnership 
concurrency and commercial sex), yet they have not explained satisfactorily the dynamic 
of the HIV epidemic in sub-Saharan Africa. Unlike HIV in the US and Europe, which 
seems concentrated among injection drug users and men who have sex with men (Curran 
et al., 1988; Hall et al., 2008; Karon et al., 2001), the epidemic in Africa is evenly 
distributed into the general population, with heterosexual penile-vaginal contact proposed 
as the main mechanism of transmission (Gisselquis et al., 2002; Orroth et al., 2007; 
Vernazza et al., 1999; Waver et al., 2005).   
 The transmission efficiency of the virus and behavioral parameters such as the 
number of sexual partners per unit of time play a fundamental role in determining the 
course of the HIV epidemic. For sexually transmitted infections (STI), the contact rates 
are commonly used as a measure of the variation in infectiousness and susceptibility. 
With a high rate of partner change, sexual behaviors are assumed to determine how 
rapidly a STI can spread into the population. Thus host contact rates are used as a 
measure of individual infectiousness leading to the concept of high-risk (core groups) 
where most individuals experience low or no transmissions but a few are responsible for 
most of the transmissions (Bansal et al., 2007). This assumption, however, only captures 
the variability of the transmission generated by sexual behavior and therefore assumes 
constant infectivity of HIV across human populations. Based on this premise many 
studies have focused on the study of sexual behavior to understand the natural history of 
HIV. These studies have indicated that despite substantial regional variation in the 
prevalence of multiple partnerships, most people report having only one recent sexual 
partner. Particularly, surveys and standard measures available for African countries 
indicated that monogamy or serial monogamy is the dominant pattern (Ferguson et al., 
2004; Kapiga and Lugalla, 2002; Lagarde et al., 1996; Wellings et al., 2006).   
 Additionally, studies attempted to clarify the role of sexual behavior on the 
pattern of the HIV epidemic from different locations have found that sexual behavior did 
not appear to explain the observed differences in HIV prevalence (Ferry et al., 2001). 
These results support the possibility that highly infectious individuals are not only 
dependent on the contact rate but also may depend on other sources of host variation 
generated by biological cofactors. Hence, a fixed value for the infectivity of HIV may 
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ignore important differences associated with biological cofactors such as circumcision 
and the presence of co-infections with other STIs (Powers et al., 2008). 
 Studies have indicated that the infectivity of the virus is not constant but may vary 
with space and time, and demonstrated that the risk of HIV transmission could be 
strongly correlated with variations in blood viral burden (Corey et al., 2004; Pilcher et al., 
2004; Zetola and Klausner, 2007).  Furthermore, a wide range of infectious diseases, from 
STI to parasitic diseases, may affect the HIV viral load triggering an amplificatory effect 
in the risk of HIV transmission in co-infected  individuals (Corey et al., 2004; Freeman et 
al., 2007; Kublin et al., 2005; Zetola and Klausner, 2007). Thus, biological cofactors such 
as co-infections may then play an important role to understand the temporal and 
individual variation on the infectivity of HIV. 
 The aim of this study was to explore the limitations of the consideration that the 
existent heterogeneity on HIV infectivity could be explained merely by variations on 
sexual behavior. Additionally this study wants to show some evidence that disregarding 
the variation across individuals on the HIV infectivity generated by biological cofactors 
would fail to describe the natural history of HIV, especially in sub-Saharan Africa. 
Determining the degree of host heterogeneity in the transmission of the virus and the 
sources of this variation is especially important: it may help us to understand the 
contrasting differences on the pattern of the spread of the infection in different locations; 
consequently it would allow us to identify the characteristics of super-infectious 
individuals responsible for the majority of transmissions. 
 This study will be guided by the hypothesis that the inclusion of temporal and 
individual variation on the infectivity of HIV generated by transient but repeated 
increases in viral load affects the pattern of the spread of the infection at population level, 
and could potentially explain the differences on the HIV epidemic between populations. 
This research was conducted through mathematical and statistical analyses at three 
specific levels of sources of variation explored in the different chapters: (1) Chapter 2 
focused on population level variations generated by the structure of the sexual network 
and the prevalence of co-infection with other STIs, (2) Chapter 3 and 4 assessed the 
regional variations generated by the co-infection with environmental diseases such as 
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malaria, and (3) Chapter 5 and 6 explored the host variation generated by the immune 
response in presence of co-infections, and methodological issues regarding control 
interventions based on co-infections. The analyses of published data was focused on 
describing the possible causes of the differences on HIV prevalence between locations, 
and the implications of individual variations on the HIV infectivity on the spread of the 
disease at population level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Diego Fernando Cuadros 2011 
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Chapter 2 - Effect of variable transmission rate on the 
dynamics of HIV in sub-Saharan Africa 
 
Introduction 
The cause of the high HIV-1 prevalence in sub-Saharan Africa is incompletely 
understood (Curran et al., 1988; Hall et al., 2008; Karon et al., 2001). Unlike HIV in the 
US and Europe, which seems concentrated among injection drug users and men who have 
sex with men (Curran et al., 1988; Karon et al., 2001; Orroth et al., 2007), the epidemic in 
Africa is more widely distributed across the general population, with heterosexual penile-
vaginal transmission proposed as the main mechanism (Gisselquist and Potterat, 2002; 
Orroth et al., 2007; Vernazza et al., 1999; Waver et al., 2005).   
 Mathematical models are powerful tools in epidemiology: they can facilitate 
understanding of the interplay between the variables that determine the course of 
infection within an individual and the variables that control the pattern of infections 
within communities of people. But, mathematical modeling studies that attempt to 
reproduce the observed HIV epidemic curve in sub-Saharan Africa are often criticized for 
using per-contact and per-partnership heterosexual transmission efficiencies that are 
improbably high (Brewer et al., 2007; Deuchert, 2007).  For example in the calculation of 
per-partner rate of transmission, behavioral parameters such as number of sexual partners 
per year and number of sexual contacts per partner may be overestimated by assuming 
levels of promiscuity in African societies that are too high (Brewer et al., 2007).   
 Unlike more traditional epidemiological approaches that focus strictly either on 
individuals or on populations, sexual networks are based on the dynamics of the sexual 
links (connections between nodes = between individuals) and the topology of the linkage 
in a group (Doherty et al., 2005; May and Lloyd, 2001). Sexual networks have multiple 
advantages for characterizing individual heterogeneity of sexual behavior. This approach 
to understanding the spread of a sexually transmitted infection (STI) has focused 
attention on the properties of the frequency distribution of sexual partner number. In 
sexual networks, partner number is the node degree, the number of sexual links that each 
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node (individual) has to others (Hamilton et al., 2008). Thus, network studies mainly 
focus on the distribution of node degree, which can be characterized by the data 
(Handcock and Holland, 2004).  
 Network models also focus on other components of the network structure that 
cannot be described from the observation of individual nodes alone. The degree 
distribution is only one example of an aggregate statistics obtained by the study of the 
individual properties within the network. For the calculation of other statistics, such as 
the level of clustering, it would be necessary to observe larger fragments of the network 
(Proulx et al., 2005). Clustering measures focus on describing both the connections from 
focal nodes and the connections made by its neighbors. In particular, high levels of 
clustering may reduce the rate of spread of an infectious disease (Witten and Poulter, 
2007).  
  The typically high skew of sexual degree distributions has suggested that sexual 
networks may follow a power law (scale-free) distribution (Lilijeros et al., 2001; Ravasz 
and Babarasi, 2003). Power law distributions are characterized by many nodes with only 
one or few connections but also a few nodes with many more connections, generating a 
high contact variance. The high variance generated in large populations that follow the 
power law distributions implies that even very low transmission rates are consistent with 
disease spread (Anderson and May, 1991; May and Lloyd, 2001).  
 Most of the studies that have attempted to describe sexual behavior in Africa have 
found that the power law distribution does not adequately fit the data. Instead, fixed rate 
models such as the negative binomial model, which is a generalization of the Poisson 
model, appear to fit the degree distribution best (Hamilton et al., 2008; Handcock and 
Holland, 2004). In the negative binomial model, the propensities of individuals to form 
connections are estimated from a gamma distribution. This approach, with its lower 
variance in connectedness among nodes, raises the possibility that the infectivity of HIV 
may be an important determinant of the epidemic in sub-Saharan Africa (Anderson and 
May, 1991; Doherty et al., 2005).  
 Yet this conclusion is inconsistent with the low probability of heterosexual HIV 
transmission, estimated to be ~ 1/300 per coital act in low-income countries (Boily et al., 
2009; Gisselquist and Potterat, 2003). Moreover, studies that attempted to estimate the 
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probability of HIV transmission per sexual contact have found that the Bernoulli model 
accurately estimates the per-partner probability of HIV transmission but does not seem to 
correlate with the number of sex acts and thus fails to estimate the per sexual contact 
probability of transmission (Padian et al., 1990). It has been suggested that the constant 
transmission probability in the Bernoulli model may be the problem: variability of 
infectiousness among individuals and over time, such as may arise from important 
transmission cofactors, may be essential for a realistic representation of HIV transmission 
(Kaplan, 1990; Padian et al., 1990; Powers et al., 2008). 
 Despite the low probability of heterosexual penile-vaginal transmission per sexual 
contact, some studies have demonstrated that the risk of HIV transmission can be 
strongly correlated with variation in blood viral burden (Attia et al., 2009; Cohen et al., 
2007; Pilcher et al., 2007). The most relevant finding from these studies is that 
infectiousness can be directly correlated with the concentration of HIV-RNA in blood, 
which indicates shedding of the virus into genital track secretions.  
 In a pioneering study attempting to correlate the viral load and the transmission of 
the virus, Quinn and coworkers (Quinn et al., 2000) measured the HIV-RNA load in the 
blood of more than 15 000 subjects. They found that the virus was hardly ever 
transmitted by infected subjects with less than 1500 copies of HIV-RNA/ml, whereas 
individuals with more than 50 000 copies infected their sexual partners at a rate of 23 per 
100 person-years over 30 months.  
 A similar study conducted with discordant couples for HIV status in Uganda 
showed the existence of a strong correlation between HIV plasma viral load and HIV 
transmission rates (Wilson et al., 2008). The Uganda study indicated that a ten-fold 
increment in viral load could increase the risk of HIV transmission per sexual contact 
2.45-fold (95% CI 1.85-3.26). They pointed out that although blood and semen reside in 
separate biological compartments, blood viral burden can be correlated with viral burden 
in semen. 
 Growing evidence suggests the existence of additional biological factors that 
cause variations in the viral load. The viral set point is actually not constant and may be 
perturbed by reactivations of the immune system, such as those resulting from the 
invasion of other pathogens (Bentwich et al., 1995). Changes in the host immune 
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response may account for variations in the viral load that could make the host more 
infectious and increase the risk of transmission.  
 The average African host is usually exposed to numerous bacterial, viral and 
parasitic infections. Of special importance is the very high prevalence of STIs, 
particularly genital ulcerations caused by herpes simplex virus type 2 (HSV-2) (Bentwich 
et al., 1995). The existence of a synergistic relationship between HIV and HSV-2 has 
been strongly suggested by many observational and biological studies in which HSV-2 
has been implicated as a biological cofactor for the acquisition and transmission of HIV 
(Glynn et al., 2008; Weiss et al., 2001). 
 The rapid spread of HIV as a sexually transmitted disease is exceeded by that of 
HSV-2 (O'Farrell, 1999). The prevalence of HSV-2, which may be as high as 75% among 
women in parts of sub-Saharan Africa (WHO/UNAIDS/LSHTM), has reached a 
prevalence of up to 90% in HIV-positive persons (Weiss et al., 2001).   
 While bacterial STIs such as gonorrhea and syphilis, which also amplify the risk 
of HIV transmission (John-Arne et al., 2001), tend to be concentrated in high risk groups 
(Brunham  and Plummer, 1990), the biological characteristics of HSV-2 allow this virus 
to be sustainable at high levels in the general population, as  observed in sub-Saharan 
Africa (Corey et al., 2004). Consequently, as the HIV epidemic reaches the general 
population, the epidemiological overlap between HSV-2 and HIV is considerably larger 
than any other STI.  
 The ulcers caused by HSV-2 contain substantial numbers of CD4+ lymphocytes, 
the target cell for HIV, and therefore are likely to facilitate the acquisition of HIV in 
HIV-negative individuals (Celum et al., 2004). Additionally, the high levels of HIV-RNA 
in herpetic lesions from dually infected patients (Schacker et al., 1998) may be explained 
by studies in vitro demonstrating that HSV-2 increases HIV transcription, which supports 
the higher infectivity in co-infected individuals. Population-based studies have also 
demonstrated that HIV-RNA levels can increase during active HSV-2 infection (Mole et 
al., 1997), and suppression of HSV-2 with acyclovir was associated with a measurable 
decrease on the HIV-RNA levels (Schacker et al., 2002).  
 The enhanced HIV infectivity caused by HSV-2 co-infection has also been 
corroborated by population-based studies suggesting a relative risk of three-to five-fold 
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of HIV transmission from co-infected individuals compared to HSV-2 seronegative 
persons (Buve et al., 2001; Corey et al., 2004; Gray et al., 2001). These data, which 
indicate epidemiologic synergy between the two infectious diseases at the population 
level, suggest that HSV-2 may be playing a key role fueling the HIV epidemic in sub-
Saharan Africa (Abu-Raddad et al., 2008).  
 The activation of the immune system, however, is not only produced by STIs such 
as HSV-2, syphilis and gonorrhea. Parasitic infections such as helminth infections, 
leishmaniasis and malaria might produce a strong response from the immune system and 
consequently generate similar effects on the replication of the virus in HIV co-infected 
individuals (Bentwich et al., 1995; Korenromp et al., 2005; Kublin et al., 2005; Pisell et 
al., 2002; Reina et al., 2006). The geographical overlap observed between malaria and 
HIV infections has suggested a possible interaction influencing HIV transmission in 
some countries of sub-Saharan Africa. Malaria occurs throughout the tropical world, 
where it remains one of the most prevalent infectious diseases, with an estimated 300 
million cases per year (CDC).  
 The evidence of an interaction between malaria and HIV comes from various 
sources. Several in vitro studies have found that malaria antigens significantly enhanced 
HIV-1 replication (Kublin et al., 2005; Pisell et al., 2002; Reina et al., 2006; Xiao et al., 
1998). Additionally, population-based studies conducted with HIV-1 infected adults have 
indicated that the HIV-1 RNA concentration almost doubled between baseline (96 215 
copies per ml) and those co-infected with malaria (168 901 copies per ml). The authors 
concluded that HIV-positive individuals co-infected with malaria had a significantly 
increased viral load and possibly increased infection transmission (Kublin et al., 2005). 
 Based on the evidence previously mentioned, this study examines the limitations 
of the view that the level of the HIV epidemic in sub-Saharan Africa could be explained 
merely by a constant probability of transmission. We suspected that disregarding the 
variation across individuals in HIV infectivity would fail to replicate the HIV epidemic 
observed in a sexual network from sub-Saharan Africa. Instead, we predicted that 
individual and temporal variations in HIV transmission generated by biological factors 
such as co-infections with other infectious diseases could explain the severity of the HIV 
epidemic. 
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Methods 
With the aim of testing the effect of temporal and individual variation on HIV 
transmission generated by co-infection, we developed a dynamic sexual network model 
(Witten and Poulter, 2007). Modeling studies of sexual networks have focused primary 
on the node degree distribution (Bell et al., 2002; Doherty et al., 2005; Hamilton et al., 
2008; May and Lloyd, 2001). But the partnership acquisition process relevant to HIV 
infections is too complex to be adequately captured by a static degree distribution. Other 
nodal attributes such as gender, age and marital status are also of fundamental 
importance, as are the dynamics of the linkages themselves. To include these 
characteristics, we used Monte Carlo simulations to depict a dynamic sexual network 
with given nodal and structural characteristics, where links between nodes are formed 
and dissolved according to estimated parameters.  
 The model incorporates the dynamic of the behavioral components of the 
population, as well as the dynamics of HIV and the co-infection effect on the HIV 
transmission caused by other infectious diseases, including HSV-2, gonorrhea, syphilis 
and malaria, along with the spread of HIV infections caused by commercial sex. We used 
data from studies in Malawi when available as an example of a generalized HIV epidemic 
(Helleringer et al., 2007a; Helleringer et al., 2007b; University of Pennsylvania, 2003).  
Model structure 
A stochastic, individual-based sexual network model was created to simulate disease 
dynamics using the MATLAB® computing language version 7 (The MathWorks, 1994-
2008). The model was divided in two main modules: a behavioral module and an 
epidemiological module. 
 Sexual partnerships were assumed to be exclusively heterosexual, and two types 
of partnerships, distinguished by duration, were considered. The population size 
remained constant, with individuals maturing into the network to offset those who die or 
mature out of the network.  In accord with the highest resolution of relevant data, a 
monthly time step was used. With this model, the effects of network structure on disease 
transmission, relationship type, and co-infection with other infectious diseases were 
evaluated. 
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 For the estimation of the main parameters of the sexual network, data were used 
from a study of Malawi by the University of Pennsylvania Population Study Center and 
called “The Malawi Social Network Project” (University of Pennsylvania, 2003), as well 
as data from the Demographic and Health Survey (DHS) database from Malawi (National 
Statistical Office). The study was conducted in three districts of Malawi, and the 
sampling strategy is explained elsewhere (Helleringer et al., 2007a; Helleringer et al., 
2007b). The study focuses on the description of the sexual behavior in the Malawi 
population, where the more important characteristics such as age distribution, number of 
sexual partners per year, type of relationship, duration of the relationship and age mixing 
patterns of marriage were derived. Table A.1 in Appendix A lists the key assumptions of 
the behavioral module. 
 Equal numbers of individuals of each sex were created and assigned an age and 
node degree (maximum number of partners per year). Consequently, individual age was 
used to determine when individuals should be removed from the sexual network and was 
the basis for other age-specific traits. The epidemiological module was subdivided into 
two steps, the spread of the infections, and the progression and recovery of each 
infection. We selected gonorrhea and syphilis as examples of bacterial STIs concentrated 
in the high-risk (core) groups based on the amplification effect on HIV transmission, and 
their relevance in terms of prevalence in the Malawi population (Lule et al., 1994; 
Mensch et al., 2008). The dynamics of these infections are well known, and the effect of 
each infection on the transmission of HIV has been determined.  
 We also included two infections with high prevalence in the general population: 
herpes simplex virus type 2 (HSV-2) and malaria. The chronic nature of HSV-2 and its 
relatively high transmission efficiency make it sustainable in the general population. 
HSV-2 reactivations increase HIV transcription (Golden et al., 1992), which in turn 
generates an increase in the HIV plasma viral load (Mole et al., 1997) and supports 
higher HIV infectivity in dually infected individuals (Quinn et al., 2000). The evidence 
suggests an epidemiologic synergy between both diseases, and HSV-2 has been 
postulated as the most important STI driving the HIV prevalence in sub-Saharan Africa 
(Abu-Raddad et al., 2008).  
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 We included malaria as an example of a parasitic infection, given its geographical 
overlap with HIV and its high prevalence in Malawi. Malaria is endemic in all parts of 
Malawi and many other countries in sub-Saharan Africa. According to The World Health 
Organization, 6 million of episodes of malaria occurred in 2006, accounting for about 
33% of all outpatient visits in Malawi. In one study malaria, infection was associated 
with a 78% higher HIV RNA concentration than in malaria-free individuals also infected 
with HIV (Kublin et al., 2005). Table A.2 in Appendix A lists the key assumptions of the 
epidemiological module. 
 A key assumption for the epidemiological module is that the interaction caused by 
co-infection has only one direction. In other words, we assumed that HIV infection has 
no effect on the natural history of the other infectious diseases included in the model. 
This assumption may be seen as an oversimplification, because studies have shown that 
HIV infection affects the transmission and progression of other infectious diseases such 
as HSV-2 and malaria. Yet, studies have mainly focused on the impact of co-infection on 
HIV. As a result, uncertainty about the effect of co-infection on the other diseases is still 
high. 
 The core of our model is the spread of HIV infection, through penile-vaginal 
contact. Before the introduction of HIV infected individuals, the model simulates for 
several months the dynamic of the other infectious diseases previously mentioned. When 
an endemic steady state for all infectious diseases is reached (after about 500 monthly 
time steps),  the model introduces HIV infected individuals until the HIV prevalence 
reaches 1%, which is the prevalence observed in Malawi in 1981 (Crampin et al., 2002). 
  For our simulation, the algorithm assessed whether the individual infected with 
HIV has another infectious disease, and if co-infection was present, the HIV transmission 
probability was increased depending on the amplification factor. Then, the new HIV 
transmission probability including the amplificatory effect was calculated by 
 
 *cT T cofactor= .   
where T is the stage or sex-specific transmission probability per sexual contact (Table 
A.2 parameter 1-6). The HIV transmission probability per partnership per month is then 
calculated using the binomial (Bernoulli) model as 
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nc
p cT T= − −
where Cn is the number of sexual contacts the individual has with the partner.  
 Cofactor values of the STI's included in the model were obtained from 
population-based estimations expressed as odds ratios and relative risk per sexual contact. 
For malaria, we assume that the enhancement on the transmission probability per sexual 
contact depends on the logarithmic (base 10) incremental change in the viral load 
according to . The 2.45 factor is the rate ratio increase in transmission 
probability with each one-log increment in viral load (Quinn et al., 2000); see Kublin et 
al. (2005) for malaria increment data. Cofactor values included in the model are listed in 
Table A.2 in Appendix A (parameter 49-53). 
' *2.45LogIncd dT T=
 When multiple co-infections are present, we assumed a saturation effect of the 
enhancement on the transmission probability. Thus, when more than one co-infection is 
present, the transmission probability is amplified only by the highest cofactor. For the 
special case of HSV-2, the amplification factor is only effective if the HSV-2 infection is 
reactivated (shedding) (Celum et al., 2004). Therefore, the algorithm not only verifies the 
presence of HSV-2 co-infection but also its reactivation. On the other hand, HSV-2 not 
only enhances the transmissibility of HIV but also affects the susceptibility to being 
infected with HIV (Celum et al., 2004). For this reason, the algorithm verifies if the 
susceptible receptor is infected with HSV-2 and its reactivation  stage. In this case, the 
transmission probability is also increased by the respective amplification factor (Table 
A.2 parameter 53 in Appendix A). A detailed description of the methodology can be 
found in the Appendix A. 
Calculation of the epidemiologic synergy 
HIV infections caused by co-infection with other infectious diseases may also generate 
secondary HIV infections, regardless of the presence of co-infection (Abu-Raddad et al., 
2008). Therefore, the HIV prevalence measures both the HIV transmissions caused by the 
direct biological effect of co-infection and the secondary or indirect infections caused by 
co-infection. We estimated the effect of co-infection on the dynamic of the HIV epidemic 
in the sexual network by comparing the prevalence for different scenarios: no co-
infection, all co-infections (default scenario), no HSV-2 co-infection, and no malaria co-
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infection. We also measured the direct effect of co-infection on the HIV incidence by 
using  population attributable fractions (PAF) (Heller et al., 2003; Heller et al., 2002; 
Rockhill et al., 1998). We estimated the PAF of HIV incidence attributable to all co-
infections, HIV-2, malaria, and gonorrhea and syphilis. The PAF is calculated by   
 
( )
( ) 1 100%
( )
nocofactor
defaultcofactor
IR t
PAF t
IR t
⎛ ⎞
= − Χ⎜ ⎟⎜ ⎟
⎝ ⎠
,   
 
 where ( )nocofactorIR t is the incidence rate of HIV in the different scenarios with the 
cofactor effect removed at time t,  and  ( )defaultcofactorIR t is the HIV incidence rate with the 
default cofactor effect at time t (simulation 2) (Abu-Raddad et al., 2008; White et al., 
2008).  
 To identify the epidemiologic synergy at different periods of the HIV epidemic, 
we calculated the PAF for different time points in a separate set of simulations by 
removing the cofactor effect on HIV transmission over two years, starting at times (t) 0, 
8, 15, and 20 after the introduction of HIV. This allows us to measure of the direct role of 
co-infection in HIV incidence at each time point (t). Results from all different scenarios 
are based on means over 200 simulations. 
Uncertainty and sensitivity analyses of the key parameters 
To conduct uncertainty and sensitivity analyses of the key parameters, we adopted the 
Latin Hypercube Sampling/Partial Rank Correlation Coefficient (LHS/PRCC) technique 
(Blower and Dowlatabadi, 1994; Marino et al., 2008). In LHS the estimation of 
uncertainty for each key parameter is modeled by treating each input parameter as a 
random variable with a uniform probability distribution function. Upper and lower 
bounds on these distributions were assigned based upon the available data. 
 To study the uncertainty of the parameters for the two different modules, we 
conducted three different uncertainty analyses. For the behavioral module, the 
simulations did not include the amplification cofactor caused by co-infection. Hence, we 
used the default probability of HIV transmission T= 0.003, and we performed a LHS of 
the more important behavioral parameters. For the epidemiological module, the 
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simulations included the amplification co-factor caused by confection and we conducted 
a LHS of the cofactor values. In the third uncertainty analysis, we performed a LHS of 
both the behavioral parameters and the cofactor values. 200 simulations were run for each 
uncertainty analysis. The variability in the outcome variable (HIV prevalence) was then 
estimated by simple descriptive statistics. Sensitivity analyses were then performed by 
calculating PRCCs for each input parameter. The details of these analyses can be found 
in the Appendix A. 
 
Results 
Sexual network 
The graphical representation of the degree distribution (i.e. number of sexual partners per 
year) for both males and females shows that the gamma distribution provides a good fit to 
the data (Figure A.1). For males, the mean number of sexual partners per year was µ = 
2.12, with standard deviation SD = 1.23, and with a scale parameter θ = 1.1 and shape 
parameter k = 1.9 for the gamma distribution. For females, the mean number of sexual 
partners per year was µ = 1.84 with standard deviation SD = 1.04, and with scale 
parameter θ = 0.4 and shape parameter k = 3.8 (Table A.1).  
 The resulting number of sexual partners per year obtained from the simulations 
for both males and females seems to agree with the estimated annual degree distribution 
from Malawi (Figure A.1), the age distribution of the entire population (Figure A.2), and 
the age distribution of married individuals (Figure A.3). We found, however, that 
individuals accumulated more long-term relationships (marriages) throughout their entire 
sexual life than indicated by the data (Figure A.4). This inconsistency could result from a 
low estimate of the average duration of marriage (~7 years) in the simulations.  
 Since long-term relationships increase the number of exposures, the risk of 
transmission or acquisition of the virus also increases. Consequently, the observed 
discrepancy between the lifetime number of long-term relationships observed in the 
simulations and the data may generate an overestimation of the HIV prevalence. 
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 Using the number of connections per month (Appendix A, eq. 9) and the number 
of connections generated by individuals who already have one connection, we found that 
the frequency of concurrency estimated from the model was 0.3. In other words, 30% of 
the individuals who had a sexual partner were in at least one concurrent relationship. This 
value seems to be consistent with some estimates of concurrency from sub-Saharan 
Africa (Lagarde et al., 2001). See also (Helleringer et al., 2009), where the concurrency 
estimate was higher, but concurrent relationships were not clearly distinguished from 
serial monogamy (Kretzschmar et al., 2010).  
Simulation 1: no co-infection 
The first simulation, which included the most recent estimate of the male-to-female 
probability of HIV transmission T = 0.003 (Boily et al., 2009), suggests that with this 
constant probability of HIV transmission the infection does not survive in the population: 
no epidemic can be generated, and HIV prevalence decreases to extinction (Figure 2.1). 
On the other hand, with  T = 0.005 we observed that the infection can persist and reached 
an endemic steady state at a prevalence equal to the initial prevalence (1%). Finally, with 
a T = 0.0068 we could generate an epidemic curve similar to the HIV epidemic observed 
in Malawi (Figure 2.1). This value is slightly above the 95% confidence interval 
estimated for male-to-female probability of HIV transmission (Boily et al., 2009) (see 
details in Appendix A). 
Simulation 2: amplification cofactor 
For this simulation, we used the baseline probability of HIV transmission for low income 
countries T = 0.003 (Boily et al., 2009), but we also included the amplification cofactor 
for HIV transmission generated by co-infection with HSV-2, gonorrhea, syphilis and 
malaria. The results from this scenario showed that the amplification effect caused by co-
infection was sufficient to generate an HIV epidemic curve similar to the curve observed 
in Malawi (Figure 2.2 B, HIV prevalence estimated for 2005 ~17%).  
 From our model, we observed that the prevalence for gonorrhea (~2%), syphilis 
(~4%), HSV-2 (~40%) and malaria prevalence in dry (30%) and rainy (40%) seasons 
resemble the prevalence observed for these STIs in Malawi and other countries of sub-
Saharan Africa (Buvé et al., 2001a; Crampin et al., 2002; Ghani et al., 1998; Holmes et 
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al., 2004; Marion and Schecter, 1992; Pinkerton and Abramson, 1997; Salomon and 
Murray, 2001; Zetola and Klausner, 2007) (Figure 2.2 A).  
 Even when parameter values of the model were obtained independently of the 
Malawi data, our results resemble the HIV prevalence as well as the age distribution 
prevalence observed in that country (Figure A.5 A, B). As reported in the data, the female 
HIV prevalence was higher than the male prevalence; the resulting age distribution of 
prevalence, however, differs somewhat from the distribution reported for Malawi. In our 
results, the peak of the prevalence is located at ages 25-29 for both males and females, 
while the data suggest that the peak is at ages 30-34. The model also overestimates the 
HIV prevalence at early ages (Figure A.5 A, B).  
 We compared the simulated age distribution of HSV-2 prevalence with the 
observed prevalence in Malawi. The age distribution for HSV-2 obtained from the 
simulation is consistent with the data, but the resulting HSV-2 prevalence is somewhat 
lower than the prevalence observed in Malawi (Figure A.5 C, D). 
Our results also showed that more than 40% of the HIV infections were 
associated with HSV-2 co-infection (Figure 2.3 A), and more than 70% of the total HIV 
transmissions were associated with STI or malaria co-infection (Figure 2.3 C).  
Significantly, these values indicate that transmission was commonly by co-infected 
individuals, but the results do not estimate the incidence of HIV due to the direct effect of 
co-infection. 
Simulation 3: no HIV-HSV-2 co-infection  
Because HSV-2 was the most important infectious disease in terms of co-infected 
individuals who transmitted the HIV infection (Figure 2.3 A), we simulated the absence 
of the amplificatory effect generated by HSV-2. For this simulation, the prevalence 
decreased to ~6% in comparison with the prevalence observed in simulation 2 (Figure 2.4 
A).  
Simulation 4: no HIV-malaria co-infection 
Without the malaria amplification effect, the HIV prevalence declined to ~10%, 
indicating that malaria contributed ~7% to the overall HIV prevalence (Figure 2.4 B). 
This result is higher than the result obtained by Abu-Raddad and coworkers (Abu-Raddad 
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et al., 2006), who simulated the co-infection effect of malaria on HIV infection in 
Kisumu, Kenya, using a system of differential equations. They found that excess of HIV 
prevalence caused by malaria was 2.1%.  
Population attributable fraction 
The results indicated that the proportion of new HIV infections due to all co-infections 
together was >50% and that this value remained constant over time (Figure 2.5 A). When 
we obtained the PAF for each infection, however, we observed different patterns 
throughout the simulation. At the beginning of the HIV epidemic, infections such as 
gonorrhea and syphilis had the highest PAF (~26%). Over time, their influence on the 
spread of HIV decreased to a final PAF of 13%, 20 years after the introduction of HIV 
(Figure 2.5 B). In contrast, common infections in the general population such as malaria 
and HSV-2 had a low initial PAF (~12%), followed by an increase. In  agreement with 
previous studies (Abu-Raddad et al., 2008; Freeman et al., 2007) we found that the PAF 
due to HSV-2 increases during the first 10 years and then remained constant  after 15 
years from HIV introduction  at the highest PAF (~30%).  
 Likewise, the proportion of new HIV infections caused by malaria increased 
during the early years of the epidemic, and then remained constant after 15 years from 
HIV introduction, with a PAF of ~ 25% (Figure 2.5 B); this value is in close agreement 
with previous results for eastern sub-Saharan Africa based on regression analysis 
(Cuadros et al., 2011b). 
 
Discussion 
Our results indicate that a data-supported fixed value for HIV infectivity fails to describe 
the dynamics of the epidemic. Regardless of the low probability of heterosexual 
transmission per sexual contact, the inclusion of individual variation in HIV infectivity 
generated by transient but repeated increases in HIV viral loads associated with co-
infections may substantially increase the transmission rate (Cohen et al., 2007). 
 Our model thus suggests that the HIV epidemic in sub-Saharan Africa may be 
explained by heterosexual transmission, and supports the hypothesis that variation among 
individuals and through time caused by biological cofactors such as co-infection may 
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have triggered the vast HIV epidemic observed in sub-Sahara Africa. The high 
prevalence of infectious diseases such as malaria and HSV-2 probably provided suitable 
conditions for the spread of the infection in the general population. 
 The remarkably high HIV prevalence observed in sub-Saharan Africa may thus 
reflect the particular environment at the early and mature stages of the epidemic that are 
unique to this part of the world (Abu-Raddad et al., 2008). These results highlight the 
possibility that co-infection is a necessary rather than merely a contributing factor in the 
successful spread and survival of HIV in populations where heterosexual vaginal-penile 
contact is the main mechanism of transmission. 
 According to our results, 50% of all new HIV infections throughout the epidemic 
can be attributed to co-infection with the infectious diseases included in the model. 
However, we observed opposite time trends in the contribution from two infections with 
low prevalence in the general population (i.e. decreasing trends for gonorrhea and 
syphilis), and from infections with high prevalence (i.e. increasing trends for HSV-2 and 
malaria).  
 Some similar results have been obtained in previous studies (Abu-Raddad et al., 
2008; Freeman et al., 2007; White et al., 2008), but none has documented the pattern in 
PAF that we observed for malaria throughout the epidemic. Our model is the first to 
include not only the co-factor effect of other STIs on HIV transmission but also the co-
factor effect of a parasitic disease such as malaria in the same simulation. The  expected 
high frequency of malaria-HIV co-infected individuals who transmitted the HIV infection 
(Figure 2.3 A) raises the possibility that parasitic diseases like malaria with high 
prevalence in Africa,  may be playing a similar role  to that STI like HSV-2 in terms of 
new HIV infections. This similarity should be greatest in populations with a mature HIV 
epidemic and where both infections overlap geographically. Despite the low co-factor 
effect on HIV transmission generated by malaria (Table A.2, parameter 5), the high 
prevalence of this infection may have increased its effect on the HIV incidence as the 
HIV epidemic invaded the general population.  
  Our analysis suggest that the synergy among sexually transmitted infections and 
parasitic infections allowed the HIV epidemic to reach the general population, which may 
not have been possible without the cofactor effect on HIV transmission generated by co-
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infection (Abu-Raddad et al., 2008). This in turn suggests that an HIV epidemic may be 
mitigated or halted through measures that decrease viral infectivity. The control and 
treatment of several common infectious diseases could decrease the incidence of HIV 
over the long-term.  
 Although interventions aimed at reducing the incidence of STIs have a prominent 
place in control strategies, some studies have failed to show an impact of STI treatments 
on HIV incidence (Kamali et al., 2002; Wawer et al., 1999). Some authors have 
suggested that population differences in sexual behavior, differences in STI prevalence 
and the stage of the HIV epidemic may explain the poor impact of this control 
intervention (White et al., 2004). These studies (Kamali et al., 2002; Wawer et al., 1999) 
commonly focused on STIs with low prevalence in the general population, such as 
syphilis, trichomoniasis, gonorrhea and chlamydia.  
 However, as our study and other studies (Baeten et al., 2008; Modjarrad et al., 
2008; Schacker et al., 2002) have indicated, infectious diseases present in the general 
population  such as HSV-2 and parasitic diseases have the highest impact on the HIV 
incidence in mature HIV epidemics. A transmission study conducted to determine 
whether HSV-2 suppression in HIV/HSV-2 co-infected individuals reduces the risk of 
HIV transmission indicated that, despite a notorious reduction in the prevalence of genital 
ulcer diseases generated by HSV-2, and a 0.25 log10 copies/ml reduction in plasma HIV-
RNA levels, HSV-2 suppression with acyclovir did not prevent HIV transmission (Celum 
et al., 2010). In a subsequent work, however, Lingappa and coworkers demonstrated that 
a 0.74 log10 copies/ml reduction in HIV plasma RNA concentration is necessary to reduce 
the HIV transmission rate by half (Lingappa et al., 2010). HSV-2 suppression with 
acyclovir may thus have been insufficient to yield a detectable reduction in HIV 
transmission risk. They concluded that treatment of co-infections capable of reducing 
plasma HIV levels by > 0.7 log10 copies/ml might be a valuable tool for suppressing of 
HIV transmission. 
Limitations of the model 
The results of this study derive from a simulation model and depend on the validity of the 
underlying assumptions and parameter magnitudes. Uncertainties about the magnitudes 
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of these parameters suggest that the conclusions presented here should be interpreted with 
caution. HIV transmission probability and the effect of behavioral and biological 
cofactors on HIV transmission require more thorough quantification (Abu-Raddad et al., 
2008; Freeman et al., 2007; White et al., 2008), and we hope that our results will help 
motivate this work.  
 Additionally, cofactor values are commonly estimated from population-based 
observations of co-infection status in individuals or couples (Korenromp et al., 2000). In 
these cases, the association between the transmission of HIV and the presence of an STI 
is generally expressed in terms of odd ratios, hazard ratios or relative risk per sexual 
contact (Boily and Anderson, 1996). These estimates, however, can be particularly 
difficult to interpret as a consequence of multiple potential biases.  
 To reduce confounding effects resulting from other behavioral and biological risk 
factors, estimates of cofactor effects are statistically adjusted for the influence of these 
risk factors. But these analyses may not completely control for the confounding effects 
because STIs, HIV and other behavioral and biological risk factors may cluster not only 
in study subjects but also in the unknown partners of the individuals included in the study 
(Korenromp et al., 2000). Moreover, the confounding generated by the characteristics of 
the sexual network such as concurrency, mixing patterns and numbers of sexual partners 
is virtually impossible to control for completely (Korenromp et al., 2000). 
 On the other hand, the high variation in HIV prevalence produced by the model 
observed in the uncertainty analysis compromises the accuracy of the model's predictions 
(Table A.9). The sensitivity analysis indicated that the model is highly sensitive to the 
behavioral parameters that influenced the per-partner probability of HIV transmission, 
such as the average duration of casual relationships and the mean number of sexual 
contacts, and to the biological parameters responsible for the cofactor effect of infections 
present in the general population, such as malaria and HSV-2 (Table A.10). Thus, efforts 
focused on more precise estimation of these parameters will improve the accuracy of 
predictions from models exploring the causes of the HIV epidemic in sub-Saharan Africa. 
 Lastly, the model assumes that HIV is transmitted exclusively by penile-vaginal 
heterosexual contact, and thus the model does not include anal intercourse as a 
mechanism of HIV transmission. Since anal intercourse increases the probability of 
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transmission (Boily et al., 2009), this type of sexual behavior has been proposed as an 
important risk factor of HIV transmission. Although many authors claim that 
heterosexual penile-vaginal contact is the main mechanism of transmission in sub-
Saharan Africa, more of information about the frequency of anal intercourse, including 
men who have sex with men, would allow an evaluation of this possibly important but 
little-studied mechanism of transmission in the epidemic in sub-Saharan Africa (Smith et 
al., 2009). 
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Figure 2.1 HIV epidemic curves with constant probability of HIV transmission (no 
co-infection) 
At T = 0.003 no epidemic can be generated, and HIV prevalence decreases leading to 
extinction (prevalence estimated for 2010 = 0%)). With a T = 0.005 the infection can 
persist and reached and endemic steady state at a prevalence equal to the initial 
prevalence (HIV prevalence estimated for 2010 = 1%). At T = 0.0068 the epidemic curve 
generated is similar to the HIV epidemic observed in Malawi (HIV estimated prevalence 
for 2010 = 10%). 
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Figure 2.2 Time course of HIV with the inclusion of the amplification effect caused 
by co-infection (simulation 2) 
In (A), the dynamics of HSV-2, syphilis, gonorrhea and malaria were simulated and 
allowed to approach steady state before the introduction of HIV into the population. Once 
endemic steady states of these infections were reached, 1% of individuals were infected 
with HIV, and HIV established in the population. (B) shows in more detail the time 
course of HIV in Malawi simulated by the inclusion of the amplification effect generated 
by co-infection (Simulation 2). The measured HIV prevalence from Malawi, for both 
males and females in general population, was extracted from several studies (USAIDS, 
2006). 
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Figure 2.3 Fraction of new infections when the HIV infectious (transmitter) 
individual had a co-infection (simulation 2) 
The model tracks the mechanism of the transmission of the infection. For the simulated 
period, if an HIV infection takes place, we recorded the presence in the infectious 
individual of any of the four infectious diseases included in the model, or in the case of 
HSV-2 due to the enhanced susceptibility caused by HSV-2 infection, we also recorded 
the presence of this infection on the susceptible individual and identified the cause of the 
amplification of the transmission caused by co-infection. (A) shows that HSV-2 was the 
most prevalent infection in co-infected individuals who transmitted the HIV infection, 
followed by malaria. This result is associated with the high prevalence of both infections 
in the general population.  Grouping all STIs, more than 50% of the HIV infections were 
associated with an STI (B). More than 70% of the total HIV infections were caused by 
co-infected individuals (C).   
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Figure 2.4 Removing the amplification effect on HIV transmission 
(A) shows the time course of HIV when HSV-2 does not have an amplification effect on 
HIV (simulation 3) and the prevalence for 2005 decays to ~6% (C).In the scenario where 
malaria does not have an amplification effect on HIV transmission (simulation 5), the 
resulting prevalence decays to ~10% (B). 
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Figure 2.5 Population Attributable Fraction (PAF) due to co-infection 
We measured the direct effect of co-infection on the HIV incidence by using the 
population attributable fractions.  (A) The PAF due to co-infection in general, and (B) the 
PAF due to HSV-2 (solid line), syphilis and gonorrhea (dotted line) and malaria (dashed 
line).  
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Chapter 3 - HIV-malaria co-infection: effects of malaria on the 
prevalence of HIV in East sub-Saharan Africa 
 
Introduction 
The heterosexual transmission of HIV is characterized by a low transmission rate, 
estimated to be ~ 1/300 per coital act in low income countries (Boily et al., 2009; 
Gisselquist and Potterat, 2003). Despite this low probability of transmission per sexual 
contact, some studies have demonstrated that the risk of HIV transmission can be 
strongly correlated with variations in blood viral burden (Attia et al., 2009; Cohen et al., 
2007; Pilcher et al., 2007). The viral set point is not constant and may be perturbed by 
reactivations of the immune system such as those resulting from the invasion of other 
pathogens (Bentwich et al., 1995).   
 The average African host is usually exposed to numerous bacterial, viral and 
parasitic infections. Of special importance is the very high prevalence of sexually 
transmitted infections (STIs), particularly genital ulcerations caused by herpes simplex 
virus type 2 (HSV-2) (Bentwich et al., 1995). The ulcers caused by HSV-2 contain 
substantial numbers of CD4+ lymphocytes, the target cell for HIV, and therefore are 
likely to facilitate the acquisition of HIV in HIV-negative individuals (Celum et al., 
2004). Additionally, the high levels of HIV-RNA in herpetic lesions from dually infected 
patients (Schacker et al., 1998) may be explained by studies in vitro demonstrating that 
HSV-2 increases HIV transcription, which supports the higher infectivity in co-infected 
individuals.  
 The activation of the immune system, however, is not only produced by  STIs 
such as HSV-2, syphilis and gonorrhea. Parasitic infections such as malaria might 
produce a strong response from the immune system and consequently generate similar 
effects on the replication of the virus in HIV co-infected individuals (Bentwich et al., 
1995; Korenromp et al., 2005; Kublin et al., 2005; Pisell et al., 2002; Reina et al., 2006). 
The geographical overlap observed between malaria and HIV infections has suggested a 
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possible interaction influencing HIV transmission in some countries of sub-Saharan 
Africa. Malaria occurs throughout the tropical world, where it remains one of the most 
prevalent infectious diseases with an estimated 300 million cases per year (CDC). 
Approximately 90% of these cases occur in sub-Saharan Africa (Snow et al., 2005). This 
region has also experienced the greatest burden of HIV-1 infection, with an estimated 25 
million infected individuals over the past two decades (WHO). The geographic overlap of 
these diseases has sparked much interest in their potential interactions (Dolores et al., 
2007; Idemyor , 2007; Whitworth and Hewitt, 2005). Several in vitro studies have found 
that malaria antigens significantly enhanced HIV-1 replication (Kublin et al., 2005; Pisell 
et al., 2002; Reina et al., 2006; Xiao et al., 1998). A population-based study conducted 
with HIV-1 infected adults in rural Malawi indicated that the HIV-1 RNA concentration 
almost doubled between baseline (96 215 copies per ml) and those co-infected with 
malaria (168 901 copies per ml). Researchers estimated that, on average, malaria 
generates a 0.25 (95% CI 0.11-0.39) log increment on the mean HIV RNA concentration 
(Kublin et al., 2005). Abu-Raddad and coworkers generated a mathematical model to 
examine the impact of this increment on the HIV epidemic in Kisimu, Kenya (Abu-
Raddad et al., 2006). Using the functional relationship between HIV plasma viral load 
and transmission probability per coital act, in which a logarithmic increase in viral load is 
associated with a 2.45-fold increase in transmission probability (Quinn et al., 2000), they 
demonstrated that the enhancement on the HIV infectivity of co-infected individuals may 
account for a cumulative 8500 excess HIV infections in Kisumu district. 
  Despite the evidence about the relationship between malaria and HIV in vitro and 
in silico, the causes and implications of this co-infection at the population level are still 
unclear. One important limitation is the inaccurate documentation of geographical 
overlap between the two infections in sub-Saharan Africa. Visual analysis of the spatial 
distribution of each infection may be misleading in the absence of adequate statistical 
adjustment. Moreover, assessing the impact of the co-infection is impeded by the scarcity 
of data on co-infection prevalence and consequences in the transmission of HIV 
infection.  
 In the present study, we measure the association between malaria and HIV 
prevalence. To achieve this goal we combined current comprehensive databases for these 
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two infections, namely the Demographic and Health Survey (DHS) for HIV and the atlas 
malaria project for malaria, by using Geographical Information Systems (GIS) tools in a 
representative area of East sub-Saharan Africa. Our hypothesis was that individuals in 
locations with high prevalence of the vector that transmits malaria, namely the 
Plasmodium falciparum parasite, which is the species responsible for most of the 95% of 
the malaria cases in the region studied (USAID, 2008a; USAID, 2008b; USAID, 2009), 
have increased likelihood of being infected with HIV.  
 
Methods 
Data 
Data were extracted from DHS for 2003 in Kenya (KDHS) (Central Bureau of Statistics, 
2003) and Malawi (MDHS) (National Statistical Office), and for 2003-04 in Tanzania 
(THIS) (TACAIDS, 2005), to cover the population residing in households in these 
countries. These countries exemplify the HIV epidemic in East sub-Saharan Africa 
because they present similar HIV epidemic levels and risk factors for HIV infection as 
the other East sub-Saharan countries (Buvé et al., 2002; Johnson and Way, 2006; Msisha 
et al., 2008; Orroth et al., 2007), and the malaria prevalence in the region covered by 
these three countries is heterogeneous for comparisons (Hay et al., 2009). A 
representative probability sample of almost 10 000 households was selected from the 
KDHS, 13 664 from the MDHS and 6900 from the THIS survey. 
 All DHS surveys were based on two-stage sampling of the households. The first 
stage involved selecting sample points (clusters), 400 clusters in Kenya (129 in urban and 
271 in rural areas), 522 clusters in Malawi (64 in urban and 458 in rural areas), and 345 
clusters in Tanzania (87 in urban and 258 in rural areas).  The global position system 
(GPS) was used to establish and record the geographic coordinates of each of the DHS 
clusters (TACAIDS, 2005).  
 Adult men (aged 15-59 years) and women (aged 15-49 years) in the selected 
household were eligible for the survey, with a response rate of  86% and 96% for men 
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and women in Kenya (Central Bureau of Statistics, 2003) and Malawi (National 
Statisitcal Office Malawi, 2004), and 91% and 96% for men and women in Tanzania 
(TACAIDS, 2005).  In all households selected, anonymous HIV testing was performed 
with the consent of all eligible men and women. We restricted the analysis to only 
sexually active people and after combining all three DHS surveys and excluding missing 
data, the final sample population for data analysis consisted of 8919 men and 10 816 
women.   
 We used the dichotomous HIV serostatus for each individual as the response 
outcome (TACAIDS, 2005). The HIV serostatus was identified by collecting drops of 
blood from each individual for HIV testing with the Vironostika Uniform 2 Ag/AB kit. 
All samples that tested positive and a random sample of 10% of samples that tested 
negative on the first ELISA (enzyme-linked immunosorbent assay) test were tested with a 
second ELISA, the Vironostika Uniform 2 plus O. A confirmatory INOLIA HIV Western 
blot kit was done for all samples that were still discrepant (Central Bureau of Statistics, 
2003; National Statisitcal Office Malawi, 2004; TACAIDS, 2005).    
Socio-economic and demographic covariates 
To adjust for socioeconomic and demographic factors, we conducted preliminary 
univariate analyses with a total of 14 socioeconomic and demographic covariates 
extracted from the DHS of each country. The covariates included age, place of residence 
(urban or rural), highest educational level, main floor material of the house, main roof 
material of the house, main wall material of the house, religion, current marital status, 
ever been tested for AIDS, wealth index, number of sex partners, age at first intercourse, 
responder have a bednet for sleeping, and responder sleeps under bednet. Covariates with 
a P<0.2 in univariate analysis were included in the final model, which included age, 
urban or rural residence, education, wealth index, marital status and religion. These 
covariates have also been identified from previous studies conducted in Tanzania and 
Kenya as the most relevant covariates for the risk of HIV infection in these countries 
(Johnson et al., 2006; Msisha et al., 2008).  
 Education level was evaluated as a categorical variable with four levels: no 
education, primary education, secondary education and higher education. Wealth index is 
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an ordinal variable that characterizes standard of living as determined by material 
possessions. The DHS calculated the living standard of a household based on key assets 
such as television and bicycles, materials used for housing construction, and types of 
water access and sanitation facilities. The data were analyzed and weighted by principal 
component analysis. The resulting asset scores were then used to define wealth quintiles: 
poorest, poorer, middle, richer, richest. Marital status has been found in many studies as 
an important risk factor for being HIV-infected (Auvert et al., 2001; Glynn et al., 2001; 
Nunn et al., 1994). In the current study, marital status was represented by three 
categories: never married, currently married and formerly married. Religion was also 
included for its potential confounding effects and was composed of four categories: 
Moslem, Catholics, Protestants or other Christians, and other religions. 
Biological covariates 
Previous studies have found that reporting any (STIs during the 12 months previous to 
the interview was not correlated with being HIV-positive (Johnson et al., 2006; Msisha et 
al., 2008). For that reason, and with the aim to control for potential confounding by STIs, 
we included the reported presence of genital ulcerations during the last 12 months 
previous to the interview. Male circumcision is a well known risk factor for being HIV-
positive (Auvert et al., 2001; Gray et al., 2000; Rakwar et al., 1999).  Males with a lack 
of circumcision have nearly twice the risk of being HIV-positive than circumcised males. 
For the risk analysis performed for males, we included male circumcision as a co-
variable. 
Malaria covariate 
We used the largest and most contemporary spatial database for Plasmodium falciparum 
parasite rate (PfPR) (Hay et al., 2009; Hay et al., 2006). This database contains nearly 
9000 distinct community surveys across 78 malaria endemic countries. To create a 
continuous surface of malaria endemicity, previous research produced a model-based 
geostatistical procedure in a Bayesian framework to incorporate factors such as the 
spatial density and location of the data, and the number of people sampled in each survey 
(Hay et al., 2009). Geostatistical algorithms generate a continuous map by imputing 
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values at unsampled locations by using a weighted linear combination of the available 
(neighboring) sample data. One of the most important characteristics of this database is 
age-standardization for malaria prevalence (the PfPR reported by the atlas malaria project 
is age-standardized to 2-10 years old), which provides a valid estimate of the 
transmission intensity (Hay et al., 2009). Further details on the malaria data  and 
statistical procedures for mapping it have been described elsewhere (Hay et al., 2009). 
 To display and extract the PfPR from each DHS cluster we used the program 
ArcGIS version 9.2 (ESRI, 2004).  From each geo-referenced cluster we obtained the 
PfPR, the value of which was assigned to each individual who belonged to that cluster.   
Statistical analysis 
We generated unadjusted models for each covariate using a simple logistic regression 
model. To generate the final adjusted analysis, which included all covariates and 
accounted for correlated data, generalized linear mixed models (GLMM) stratified by 
gender (in order to include circumcision as a covariate for men) were then fitted with the 
cluster as a normally distributed random effect. We included PfPR as a continuous 
variable.  In a second analysis, we categorized PfPR by its empirical quartiles. All 
statistical analyses were conducted using R version 2.11.1 (R. Core Team, 2010). 
 Adjusted Probability Ratio (PR) parameters were used to compare regions with 
varying degrees of PfPR, separately for men and women (Rockhill et al., 1998). To 
calculate PRs, we dichotomized PfPR using its first quartile to define low malaria 
prevalence.  Areas with PfPR higher than the first quartile were defined to have high 
malaria prevalence.  
 
Results 
Overall malaria and HIV prevalence 
Results of the 2003-04 DHS from the region studied indicated that the HIV prevalence in 
responders who have had sex was 6.66% for men and 9.46% for women. The prevalence 
of HIV peaked for age group 35-39 for men and 30-34 for women (Table 3.1). The mean 
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PfPR in the region was 0.27, with a standard deviation of 0.18. The quartiles of PfPR led 
to four groups, namely  PfPR less than or equal to 0.10, PfPR between 0.11 to 0.30 , 
PfPR between 0.31 to 0.42, and PfPR higher than 0.42 (Table 3.1). Areas where the PfPR 
is 40% or more are identified as areas with high stable transmission, where theory 
predicts that mixed control interventions need to be considered for the interruption of 
malaria transmission (Hay et al., 2008). Hay and coworkers (Hay et al., 2009) estimated 
that in Africa these areas cover 8.5 million Km2, which contains 345.28 million people at 
risk. 
 Individuals (males and females) with higher education and with higher wealth 
index were primarily distributed in (mainly urban) areas with low PfPR (PfPR <= 10%), 
whereas individuals with lower education level and lower wealth index (poorest, poorer) 
were mainly in rural areas with high PfPR (PfPR > 42%) (Table 3.2).  In areas with low 
malaria prevalence (PfPR < 0.10), the HIV prevalence was 5.11% for males and 8.27% 
for females, whereas in areas with high malaria prevalence (PfPR > 0.42) the HIV 
prevalence was 7.67% for males and 10.73% for females (Table 3.1). 
Malaria 
With PfPR modeled as a continuous variable, the unadjusted analysis indicated that PfPR 
was a risk factor for HIV infection in both men (P < 0.001) and women (P = 0.013). 
After adjusting for measured socio-economic and biological characteristics the PfPR 
remained as a risk factor of being infected with HIV in both men and women ( P < 0.001 
for both). After categorizing the PfPR we observed that malaria is positively and 
monotonically related to HIV-infection (Table 3.3 and 3.4). The adjusted model indicated 
that men and women who live in areas with high PfPR (>0.42) are nearly twice as likely 
to be HIV-positive as those who live in areas with low PfPR (<0.10) (men: estimated OR 
2.24, 95% CI 1.62-3.12; women: estimated OR 2.44, 95% CI 1.85-3.21). 
 To perform the probability ratio estimation we created a dichotomous variable for 
malaria prevalence where low PfPR indicates low risk of being infected with malaria (for 
individuals who live in areas with a PfPR≤ 0.10) and high PfPR indicates high risk of 
being infected with malaria (for individuals who live in areas with  PfPR >0.10). The 
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calculated probability ratio attributable to malaria was 27% for males and 29% for 
females.  
Socio-economic characteristics 
Men and women formerly married had the highest odds of having HIV compared with 
individuals never married, (estimated OR 6.27, 95% CI 4.38-8.97) and (estimated OR 
6.83, 95% CI 5.39-8.66), respectively in the unadjusted model.  Controlling for all other 
socio-economical and biological risk factors attenuated the estimated odds ratios to 3.15 
(95% CI 2.03-4.90) for men (Table 3.3), and 4.20 (95% CI 3.09-5.71) for women (Table 
3.4). 
 As expected (Johnson et al., 2006; Msisha et al., 2008), unadjusted models 
indicated that men and women living in rural areas had lower odds of being HIV-infected 
than those living in urban areas, with an estimated OR of 0.52 (95% CI 0.45-0.62) for 
men and an estimated OR of 0.57 (95% CI 0.5-0.66) for women.  In the adjusted analysis 
the estimated effect remained similar with odds ratio 0.54 (95% CI 0.41-0.70) for men 
and 0.59 (95% CI 0.46-0.77) for women. In the unadjusted model (Table 3.4), women 
with a secondary educational level had increased odds of having HIV compared to 
women with any level of education (estimated OR 1.45, 95% CI 1.15-1.83). Education 
was not a risk factor for being infected with HIV in adjusted models for women 
(likelihood ratio P = 0.12). 
 As observed in previous studies (Johnson et al., 2006; Msisha et al., 2008), the 
wealth index for both men and women is positively correlated with HIV. In unadjusted 
models, men and women in the highest wealth category were estimated to have 2.64 
(95% CI 1.97-3.54) and 2.74 (95% CI 2.19-3.44) times the odds of being HIV infected 
compared with those in the poorest category. The adjusted model attenuated the 
estimated odd ratio for men to 2.32 (95% CI 1.58-3.42), but increased the estimated odd 
ratio for women to 2.92 (95% CI 2.12-4.02). 
Biological characteristics 
In unadjusted models the estimated OR of having HIV was 2.59 (95% CI 1.76-3.8) for 
males who had genital ulcerations during the last 12 months (Table 3.3). For women the 
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odds were considerably higher than for males (estimated OR 3.21, 95% CI 2.94-4.05). 
This difference was maintained in the adjusted model with 1.99 (95% CI 1.30-3.03) for 
men and 2.79 (95% CI 2.07-3.76) for women. These results are consistent with previous 
studies, which have found that the presence of an STI increases the risk of being HIV-
positive (Blower and Ma, 2004; Freeman et al., 2006; Glynn et al., 2008b; Nunn et al., 
1994; Waver et al., 2005).   
 Lack of male circumcision has been proposed as one of the most important 
biological risk factors of being HIV-positive in men (Auvert et al., 2001; Gray et al., 
2000; Jewkes et al., 2006; Orroth et al., 2007; Rakwar et al., 1999). In our analysis, the 
adjusted models indicated that circumcised males had slightly more than half the risk of 
those who were not circumcised to be HIV-positive (estimated OR 0.62, 95% CI 0.50-
0.79). 
 
Discussion 
The factors related to high HIV-1 prevalence in sub-Saharan Africa are incompletely 
recognized. The epidemic in this part of the world is widely distributed across the general 
population, and heterosexual penile-vaginal mechanism of transmission has been 
proposed to account for more of the 80% of the new cases (Orroth et al., 2007; Vernazza 
et al., 1999; Waver et al., 2005). For many years, behavioral factors such as commercial 
sex, concurrency and promiscuity have been proposed as driving the epidemic in sub-
Saharan Africa (Lagarde et al., 2001; Morison et al., 2001). Recent behavioral studies 
carried out in different populations from Africa, however, have found no significant 
differences compared to populations in developed countries such as the United States or 
Europe, and in some cases had no correlation with the risk of HIV infection (Brewer et 
al., 2007; Lurie et al., 2009; Orroth et al., 2007; Reniers et al., 2010). In addition, a 
previous cross-sectional population-based study, called the Four City study (Orroth et al., 
2007), examined the differences in the spread of HIV in four cities from the western and 
eastern regions of sub-Saharan Africa and found that differences in sexual behavior could 
not explain the differences between the HIV epidemics (Ferry et al., 2001; Lagarde et al., 
2001; Morison et al., 2001). The authors postulated that biological factors may be 
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responsible for these differences (Buve et al., 2001). Biological cofactors such as male 
circumcision and other STIs, especially Herpes Simplex Virus type 2 (HSV-2), thus have 
been proposed as a plausible explanation for these observed differences (Orroth et al., 
2007).   
 The substantial evidence that sexually transmitted infections, HSV-2 in particular, 
enhanced the transmission and acquisition of HIV infection contrasts with the scarce 
information about the cofactor effect of malaria on HIV at the population level. Like 
HSV-2, malaria contributes to transient viral load increases in co-infected individuals 
(Kublin et al., 2005; Pisell et al., 2002; Xiao et al., 1998). Due to the methodological 
difficulties in designing cross-sectional or prospective studies for measuring the 
significance of malaria on the risk of HIV infection, however, the effect of malaria on the 
spread of HIV in the population is virtually unknown.  
 This is the first study to report malaria as a risk factor for concurrent HIV 
infection at the population level. After adjusting for important socio-economic and 
biological covariates, we found that the PfPR of the area of residence is positively and 
monotonically correlated with HIV prevalence (Table 3.3 and 3.4). According to our 
results, men who live in areas with high PfPR ( > 0.42) have at least twice the risk of 
being HIV-positive (estimated OR 2.24, 95% CI 1.62-3.12)  in comparison to men who 
live in areas with low PfPR (≤ 0.10). As we expected, the risk of malaria infection was 
not related to gender; thus women who live in areas with high PfPR have nearly the same 
OR (2.44, 95% CI 1.85-3.21). 
 The probability ratio attributable to PfPR indicated that malaria may account for 
~27% of incidental HIV infections in areas with a PfPR higher than 0.1. This value is 
similar to the value reported previously by Cuadros and coworkers (2011a), who by 
computer simulations estimated that malaria might account for more than 20% of new 
HIV infections in Malawi in 2003. The probability ratio due to malaria resembles the 
population attributable fraction (PAF) associated with HSV-2, estimated by 
epidemiological and mathematical models (Abu-Raddad et al., 2008; Blower and Ma, 
2004; Freeman et al., 2007). This similarity may be due to the high prevalence of both 
infections in the general population. 
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 Some studies have shown that curable STIs such as gonorrhea, syphilis or 
chlamydia have had the biggest impact on HIV transmission at early stages of the HIV 
epidemic (Freeman et al., 2007; White et al., 2008). These infections generally are 
present in high-risk groups such as prostitutes or individuals with a high number of 
sexual partners (Abu-Raddad et al., 2008; White et al., 2008). The effect of curable STIs 
on HIV has decreased as the HIV epidemic has moved from the core group to the general 
population. Prevalent infections, such as HSV-2, in the general population may then play 
the most important role driving the HIV prevalence in populations with a mature HIV 
epidemic (Abu-Raddad et al., 2008; Cuadros et al., 2011a; White et al., 2008). Although 
malaria infection has a non-sexual mechanism of transmission, its high prevalence in the 
general population and its ability to generate an immune activation associated with 
increases in systemic HIV viral load suggests that malaria may have a similar role to 
HSV-2 in mature HIV epidemics.  
 Although our work makes use of the most complete and contemporary databases 
for both HIV and malaria, our results were based on geographical estimates for PfPR in 
locations where demographic and health surveys were made. Despite the use of this 
indirect measure of the possible synergistic interaction between malaria and HIV at the 
population level, our results suggest that malaria is likely to be a frequent co-infection in 
HIV infected individuals living in those areas with high malaria prevalence. Hence, we 
emphasize that malaria might be playing an important role in the present HIV epidemic 
of these areas. The scenario could be more complicated if we take into account infections 
such as chronic helminth infections and water borne pathogens that, like malaria, are 
associated with similar immune activation by inducing viral replication (Bentwich et al., 
1995; Lawn and Folks, 2001) and could also be affecting the HIV transmission risk and 
the natural history of HIV in sub-Saharan Africa.  
 Our work emphasizes the need for field studies on the interaction among parasitic 
infections and the risk of HIV infection and on the impact of control interventions. Thus, 
it would be important to obtain data on individuals who are known to be dually infected 
with malaria and HIV. Reducing malaria transmission becomes even more important to 
address in the context of HIV. With the high numbers of cases of HIV and malaria, even 
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small decreases in malaria prevalence could have an important impact on the relative risk 
of HIV infection in areas with high malaria prevalence.  
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Table 3.1 HIV prevalence by socio-economic and biological characteristics for 
sexually active people surveyed in Kenya, Malawi and Tanzania 
 
Characteristics N(%HIV-positive) 
Women Men 
Age   
15-19 2285(2.67) 2018(1.24) 
20-24 2276(9.31) 1578(3.99) 
25-29 1939(10.93) 1483(7.75) 
30-34 1543(14.32) 1237(9.54) 
35-39 1172(12.8) 954(11.53) 
40-49 1601(10.43) 1372(10.28) 
50-59 - 277(7.94) 
Religion  
Moslem 2610(9.00) 1996(5.96) 
Catholic 2998(9.71) 2530(7.19) 
Protestant/other Christian 4060(9.70) 3222(6.55) 
Other 1148(9.97) 1171(7.00) 
Place of  residence  
Urban 2629(13.47) 2064(10.22) 
Rural 8187(8.17) 6855(5.59) 
Marital status   
Never married 2434(4.27) 3457(2.37) 
Currently married 7137(8.80) 5046(9.06) 
Formerly married 1245(23.37) 416(13.22) 
Highest educational level  
None 2388(7.79) 947(5.17) 
Primary school 6979(9.77) 6218(6.38) 
Secondary  1280(10.94) 1497(8.86) 
Higher 169(8.88) 275(6.18) 
Wealth index  
Poorest 2067(5.27) 1507(4.11) 
Poorer 2111(7.01) 1811(4.36) 
Middle 2101(8.66) 18.21(5.93) 
Richer 2127(12.46) 1863(8.05) 
Richest 2410(13.24) 1917(10.17) 
Circumcision  
Uncircumcised - 3423(8.41) 
Circumcised - 5496(5.57) 
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Genital ulceration  
No genital ulceration last 12 months 10489(8.99) 8708(6.45) 
Genital ulceration last 12 months 327(24.46) 211(15.17) 
Malaria  
PfPR <= 0.1 2612(8.27) 2113(5.11) 
PfPR  [0.11-0.3] 2899(9.07) 2480(6.61) 
PfPR [0.31-0.42] 2415(9.69) 2071(7.19) 
PfPR > 0.42 2890(10.73) 2255(7.67) 
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Table 3.2 Socio-economic characteristics distribution by different PfPR levels (males 
and females combined) 
 
 Total individuals (% per PfPR category) 
Characteristics PfPR <=0.1 PfPR   
[0.11-0.3]
PfPR  
[0.31-0.42] 
PfPR > 0.42
Age     
15-19 1054(24) 1285(30) 941(22) 1023(24)
20-24 926(24) 1049(27) 895(23) 984(26)
25-29 785(23) 876(26) 809(24) 952(27)
30-34 665(24) 733(26) 634(23) 748(27)
35-39 521(25) 590(27) 480(23) 535(25)
40-49 678(23) 790(27) 665(22) 840(28)
50-59 96(35) 56(20) 62(22) 63(23)
Religion  
Moslem 1130(25) 1253(27) 548(12) 1675(36)
Catholic 1162(22) 1510(27) 1626(29) 1230(22)
Protestant/other 
Christian 
2240(31) 2123(29) 1577(22) 1342(18)
Other 193(8) 493(21) 735(32) 898(39)
Place of residence  
Urban  2202(47) 1172(25) 803(17) 516(11)
Rural 2523(17) 4207(28) 3683(24) 4629(31)
Marital status   
Never married 1784(30) 1767(30) 1159(20) 1181(20)
Currently married 2558(21) 3167(26) 2971(24) 3487(29)
Formerly married 383(23) 445(27) 356(21) 477(29)
Highest educational level  
None 543(16) 901(27) 798(24) 1093(33)
Primary school 2865(22) 3659(27) 3103(24) 3570(27)
Secondary 1008(36) 744(27) 549(20) 458(17)
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Higher 309(70) 75(17) 36(8) 24(5)
Wealth index  
Poorest 521(15) 1193(33) 771(22) 1089(30)
Poorer 491(13) 1005(26) 979(25) 1447(36)
Middle 608(16) 1120(28) 1058(27) 1136(29)
Richer 1037(26) 983(25) 1033(26) 937(23)
Richest 2068(48) 1078(25) 645(15) 536(12)
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Table 3.3 Unadjusted and adjusted results: men's HIV serostatus according to 
selected socio-economic and biological characteristics 
 
Indicator 
OR(95% CI) 
Unadjusted Adjusted 
Malaria 
PfPR <= 0.1 1.00 1.00
PfPR  [0.11-0.3] 1.31(1.02-1.69) 1.73(1.27-2.35)
PfPR [0.31-0.42] 1.44(1.11-1.86) 1.74(1.25-2.41)
PfPR > 0.42 1.54(1.20-1.98) 2.24(1.62-3.12)
Age   
15-19 1.00 1.00
20-24 3.13(2.08-5.29) 2.54(1.52-4.25)
25-29 6.69(4.32-10.38) 4.14(2.42-4.07)
30-34 8.40(5.42-13.01) 4.84(2.78-8.44)
35-39 10.38(6.68-16.15) 6.58(3.75-11.57)
40-49 9.13(5.93-14.05) 5.66(3.24-9.88)
50-59 6.87(3.82-12.37) 4.67(2.26-9.23)
Religion 
Moslem 1.00 1.00 
Catholic 1.22(0.96-1.55) 1.05(0.78-1.40)
Protestant/other Christian 1.11(0.88-1.39) 1.06(0.80-1.41)
Other 1.19(0.89-1.58) 0.93(0.64-1.33)
Place of  residence 
Urban 1.00 1.00
Rural 0.52(0.43-0.62) 0.54(0.41-0.70)
Marital status  
Never married 1.00 1.00
Currently married 4.10(3.28-5.21) 1.85(1.31-2.62)
Formerly married 6.27(4.38-8.97) 3.15(2.03-4.90)
Highest educational level 
None 1.00 1.00
Primary school 1.25(0.92-1.69) 1.15(0.83-1.61)
Secondary  1.78(1.26-2.49) 1.34(0.91-1.98)
Higher 1.21(0.68-2.13) 0.68(0.36-1.29)
Wealth index 
Poorest 1.00 1.00
Poorer 1.06(0.76-1.49) 0.94(0.66-1.36)
Middle 1.47(1.07-2.02) 1.34(0.96-1.91)
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Richer 2.04(1.51-2.77) 1.94(1.38-2.71)
Richest 2.64(1.97-3.54) 2.32(1.58-3.42)
Circumcision 
No circumcised 1.00 1.00
Circumcised 0.64(0.54-0.75) 0.62(0.50-0.79)
Genital ulceration 
No genital ulceration last 12 months 1.00 1.00
Genital ulceration last 12 months 2.59(1.76-3.8) 1.99(1.30-3.03)
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Table 3.4 Unadjusted and adjusted results: women's HIV serostatus according to 
selected socio-economic and biological characteristics 
 
Indicator 
OR(95% CI) 
Unadjusted Adjusted 
Malaria 
PfPR <= 0.1 1.00 1.00
PfPR  [0.11-0.3] 1.11(0.92-1.34) 1.61(1.23-2.12)
PfPR [0.31-0.42] 1.19(0.98-1.45) 1.68(1.27-2.23)
PfPR > 0.42 1.33(1.11-1.60) 2.44(1.85-3.21)
Age   
15-19 1.00 1.00
20-24 3.75(2.80-5.01) 3.31(2.36-4.65)
25-29 4.47(3.34-5.99) 3.92(2.75-5.59)
30-34 6.10(4.55-8.16) 5.29(3.69-7.58)
35-39 5.35(3.94-7.27) 4.33(2.97-6.32)
40-49 4.24(3.14-5.73) 3.30(2.27-4.80)
Religion 
Moslem 1.00 1.00
Catholic 1.09(0.91-1.30) 1.22(0.97-1.52)
Protestant/other Christian 1.09(0.92-1.29) 1.28(1.03-1.59)
Other 0.99(0.78-1.27) 0.95(0.70-1.29)
Place of  residence 
Urban 1.00 1.00
Rural 0.57(0.50-0.66) 0.59(0.46-0.77)
Marital status  
Never married 1.00 1.00
Currently married 2.16(1.75-2.67) 1.22(0.92-1.60)
Formerly married 6.83(5.39-8.66) 4.20(3.09-5.71)
Highest educational level 
None 1.00 1.00
Primary school 1.28(1.08-1.52) 1.16(0.95-1.41)
Secondary  1.45(1.15-1.83) 1.05(0.78-1.42)
Higher 1.15(0.67-2.00) 0.71(0.38-1.35)
Wealth index 
Poorest 1.00 1.00
Poorer 1.36(1.05-1.75) 1.43(1.07-1.89)
Middle 1.70(1.33-2.17) 1.83(1.39-2.43)
Richer 2.56(2.03-3.22) 2.69(2.04-3.56)
47 
 
Richest 2.74(2.19-3.44) 2.92(2.12-4.02)
Genital ulceration 
No genital ulceration last 12 months 1.00 1.00
Genital ulceration last 12 months 3.21(2.52-4.26) 2.79(2.07-3.76)
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Chapter 4 - No evidence of association between HIV and 
malaria in populations with low HIV prevalence 
 
Introduction 
Malaria has been proposed as an important facilitator for the spread of HIV-1 in areas 
where both infections geographically overlap (Abu-Raddad et al., 2006; Dolores Herrero 
et al., 2007; Idemyor, 2007; Kublin and Steketee, 2006; Renia et al., 2006). This parasitic 
infection is one of the most prevalent infectious diseases worldwide. Of the estimated 300 
million cases per year, 90% occur in sub-Saharan Africa (Snow et al., 2005). Most of the 
African continent is considered to have stable malaria transmission, with  prevalence that 
exceed the threshold (40%) above which theory predicts it is unlikely that malaria 
transmission can be interrupted with insecticide-treated bed nets alone (Hay et al., 2009). 
This region covers 8.5 million km2 of the continent, with 354.28 million people at risk. 
Areas with malaria prevalence between 5% and 40%, the range in which theory predicts 
that malaria transmission could be reduced with insecticide-treated bed nets, cover 5.6 
million km2 of the continent, with 196.83 million people at risk.  
 Sub-Saharan Africa has also experienced a severe HIV-1 epidemic, with an 
estimated 25 million infections over the past two decades (WHO Joint United Nations 
Programme on HIV/AIDS (UNAIDS)/World Health Organization). The epidemic, 
however, is not homogeneous, and its spread has been more intense in the southern and 
eastern part of the continent, with the western region experiencing a slower growing and 
less severe epidemic. The causes of this difference are not well understood (Buve et al., 
2001). In the western part of the continent, the epidemic seems to be more concentrated 
in the high-risk (core) groups, such as female sexual workers and individuals with high 
number of sexual partners, while the epidemic is more widely distributed across the 
general population in countries located in the east and south part of the continent.  
 In previous work (Cuadros et al., 2011b), we showed that the prevalence of 
malaria caused by the parasite Plasmodium falciparum is associated with HIV-1 infection 
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in eastern sub-Saharan Africa. Our results indicated that individuals who lived in areas 
with high P. falciparum parasite rate (PfPR > 0.42) were approximately twice as likely to 
be infected with HIV than individuals who lived in areas with low P. falciparum parasite 
rate (PfPR ≤ 0.10) [men: estimated odds ratio (OR) 2.24, 95% confidence interval (CI) 
1.62–3.12; women: estimated OR 2.44, 95% CI 1.85–3.21]. In western sub-Saharan 
Africa, the pattern of the HIV-1 epidemic is different and less severe, yet the prevalence 
of malaria is high. To examine the association between malaria and the prevalence of 
HIV-1 under these conditions, and to measure this association in a region with 
intermediate HIV-1 prevalence in central Africa, we used the most current and 
comprehensive database, namely the Demographic and Health Survey (DHS) for HIV-1. 
We also utilized a new source of data for P. falciparum malaria endemicity, the malaria 
atlas project. 
 To complement our knowledge of HIV-malaria co-infection, the objective of this 
work was to assess the relationship between malaria and HIV-1 prevalence in the western 
and central regions of sub-Saharan Africa. The primary aim was to examine the 
difference in the likelihood of current infection with HIV between individuals who lived 
in locations with high transmission intensity of the most common vector that transmits 
malaria in the region, namely the P. falciparum parasite, and individuals who lived in 
areas with low malaria transmission intensity.  
 
Methods 
HIV data 
This study refers to HIV-1 exclusively. We considered the following countries from the 
western part of sub-Saharan Africa: Burkina Faso, Ghana, Guinea, Liberia and Mali. 
These countries have similar HIV prevalence (between 1% and 2%), and the collective 
geographic region has heterogeneous prevalence of malaria for comparisons (Hay et al., 
2009). We also included Cameroon in a separate analysis to investigate for an association 
between HIV and malaria in a country with an intermediate HIV prevalence (~5%) and 
with similar malaria transmission intensity to the western region included in the study.    
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 To cover the population residing in households in these countries, we extracted 
data from DHS for 2003 in Burkina Faso (EDSBF-III) (Institut National de la Statistique 
et de la Démographie MdlÉedD)  and Ghana (GDHS) (Ghana Statistical Service 
NMIfMR), for 2004 in Cameroon (EDSC-III) (National Statistical Office aOM (2005) 
Cameroon Demographic andHealth Survey 2004), for 2005 in Guinea (EDSG-III) 
(National Statistical Office CG) , for 2006 in Mali (EDSM-IV) (Cellule de Planification 
et de Statistique Ministère de la Santé DNdlSedlI), and for 2007 in Liberia (LDHS) 
(Liberia Institute of Statistics and Geo-information Services LISGIS). Methods used in 
these demographic and health surveys have been described in detail elsewhere (National 
Statistical Office aOM (2005) Cameroon Demographic andHealth Survey 2004; National 
Statistical Office CG). Briefly, the surveys used a two-stage cluster sampling technique. 
The first stage involved selecting sample points (clusters); 400 clusters in Burkina Faso 
(300 in urban and 100 in rural areas), 412 in Ghana (240 in urban and 172 in rural areas), 
297 in Guinea (209 in urban and 88 in rural areas), 408 in Mali (265 in urban and 143 in 
rural areas), 297 in Liberia (117 in urban and180 in rural areas), and 466 in Cameroon 
(224 in urban and 242 in rural areas). The global position system (GPS) was used to 
identify and record the geographic coordinates of each of the DHS clusters.  
 The second stage used by each DHS included in this study involved the 
systematic sampling of households from the selected clusters. Adult men (aged 15-59 
years) and women (aged 15-49 years) in the selected households were eligible for the 
survey. In all DHS surveys included in this study, HIV testing was performed using blood 
samples. The DHS reported that participation in HIV testing was voluntary, and before 
collecting the samples, each selected participant was asked to provide informed consent 
to the testing. Further details of the performed HIV test have been described elsewhere 
(Ghana Statistical Service NMIfMR; National Statistical Office OM (2005) Cameroon 
Demographic and Health Survey 2004). In summary, HIV testing was conducted in a 
laboratory by following a standard testing algorithm that uses two HIV enzyme 
immunosorbent assays based on different antigens. Discordant samples that were positive 
on the first test were retested with the same enzyme immunosorbent assays. A 
confirmatory HIV Western blot kit was used for all samples that were still discrepant.    
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 We used the HIV serostatus reported by the DHS for each individual as the 
dichotomous response outcome and restricted the analysis to only sexually active people. 
After combining all DHS surveys and excluding missing data, the final sample 
population for data analysis consisted of 41 064 individuals: 18 385 men and 22 679 
women for West sub-Saharan Africa, and 10 088 individuals: 4986 men and 5102 women 
for Cameroon.  
Malaria data 
A commonly used index of malaria transmission intensity is the P. falciparum parasite 
rate (PfPR), defined as the proportion of the population found to carry asexual blood-
stage parasites. The enhancement of HIV replication generated by infection with malaria, 
which supports higher HIV infectivity in co-infected individuals (Quinn et al., 2000), is 
produced by the presence  of any parasitaemia, and not only during clinical episodes 
(Kublin et al., 2005). For that reason, this index of malaria transmission might be a 
measure for use in the initial assessment of the association between malaria and HIV. 
For this study, we used the largest and most contemporary spatial database for the 
Pf PR for children aged 2 to 10 years old (Hay et al., 2006; Hay et al., 2009). This 
database contains nearly 9000 distinct community surveys across 78 malaria-endemic 
countries. Many of these surveys, however, reported crude PfPR without stratifying by 
age. Thus, in previous research (Smith et al., 2007), an algorithm was developed to age-
standardize PfPR data. The PfPR in children aged 2-10 years is correlated with the 
entomological inoculation rate the number of infected bites per person per unit of time) 
(Hay et al., 2008), and has provided a basis for the most common categorical measures of 
malaria transmission (Smith et al., 2007). Therefore, the PfPR reported by the malaria 
atlas project is age-standardized to 2-10 years old (Hay et al., 2009). Since the PfPR in 
children aged 2-10 years is related to the entomological inoculation rate, which is an 
estimate of the force of infection, we used this measure as an approximation of the 
prevalence of malaria infections in the adult population studied. This assumption, 
however, has some implications on the study results, which are discussed in the 
limitations of the study. 
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 To create a continuous surface of malaria endemicity, previous research (Hay et 
al., 2009) produced a model-based geostatistical map using a Bayesian framework to 
incorporate factors such as the spatial density and location of the data, and the number of 
people sampled in each survey. Geostatistical algorithms generate a continuous map by 
interpolating values at unsampled locations using a weighted linear combination of the 
available (neighboring) sample data. Further details on the malaria data and statistical 
procedures for generating the map have been described elsewhere (Hay et al., 2009). To 
display and extract the PfPR from each DHS cluster, we used the program ArcGIS 
version 9.2 (ESRI, 2004).  From each geo-referenced cluster, we obtained the PfPR and 
assigned its value to each individual who belonged to that cluster.   
Socio-economic and biological covariates 
Socio-economic and biological covariates of potential importance were investigated for 
inclusion into the final model. To select the covariates to be included in the final model, 
we first conducted preliminary unadjusted bivariate analyses from a pool of 16 socio-
economic and biological variables: age, place of residence (urban or rural), highest 
educational level, main floor material of the house, main roof material of the house, main 
wall material of the house, religion, current marital status, previous AIDS testing, wealth 
index, number of sexual partners in the last year, age at first intercourse, presence of bed 
net for sleeping, use of a bed net for sleeping, male circumcision, and reported presence 
of genital ulceration during the last month. Covariates of a priori importance with P<0.2 
in the unadjusted analyses were included in the final multivariable model relating HIV 
and malaria. 
 Several factors were included as categorical variables. Marital status was 
comprised of three categories: never married, currently married and formerly married. 
Wealth index is an ordinal variable that characterizes standard of living as determined by 
material possessions. The DHS calculated the living standard of a household based on 
relevant assets such as television and bicycles, materials used for housing construction, 
and the availability of amenities such as electricity and source of drinking water. The 
resulting asset scores, constructed using principal component analysis, were then used to 
define wealth quintiles: poorest, poorer, middle, richer, richest (National Statistical Office 
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aOM (2005) Cameroon Demographic and Health Survey 2004; National Statistical Office 
CG). Religion was subdivided into four categories: Muslim, Catholic, traditional religion, 
and other religions. Education level was included as a categorical variable with four 
levels: no education, primary education, secondary education and higher education. 
Statistical analysis 
Data analysis used generalized linear mixed models (GLMM), specifically logistic 
regression models with normally distributed random cluster effects to include covariates 
and account for correlated data among individuals within the same cluster. We first 
conducted unadjusted analyses for each covariate. We then generated an adjusted model, 
where the PfPR was categorized into two transmission intensity levels, namely areas with 
stable malaria transmission (PfPR > 0.46), which corresponds to areas with PfPR higher 
than the first quartile, and areas with PfPR  ≤ 0.46).  We analyzed the data from the 
western region and Cameroon separately. All statistical analyses were conducted using R 
version 2.11.1 (R.Core Team, 2010). 
 
Results 
West sub-Saharan Africa 
The HIV prevalence in responders included in the study for western sub-Saharan Africa 
was 1.53%: 1.15% for men and 1.80% for women (Table 4.1). The mean PfPR in the 
region was 0.52, with a standard deviation of 0.12. In areas with stable malaria 
transmission (PfPR > 0.46) the HIV prevalence was 1.48%, whereas in areas with PfPR ≤ 
0.46 the HIV prevalence was 1.58% (Table 4.1). 
 The final model included age, gender, urban or rural residence, education, 
religion, wealth index, marital status and the presence of genital ulcerations. Male 
circumcision was not significantly associated with being HIV-positive in men 
(unadjusted OR 0.63, 95% 0.31-1.26). A similar result has been reported by other studies 
(De Walque et al., 2006; Mishra et al., 2007), and might be a consequence of the 
extremely high prevalence of male circumcision in the area of study. We estimated that 
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94% of the male individuals from the western region and 95% of the male individuals 
from Cameroon were circumcised.  For that reason, we combined the data for men and 
women into a single analysis, and included gender to adjust for confounding in the final 
models.  
 The results indicated no evidence that PfPR predicted HIV infection in western 
sub-Saharan Africa, where we observed no statistical difference in the odds of being 
HIV-positive between individuals who lived in areas with stable malaria transmission 
(PfPR > 0.46) and individuals who lived in areas with PfPR ≤ 0.46 (estimated OR 1.14, 
95% CI 0.86-1.50).  Other categorizations of PfPR, such as grouping by quartiles, gave 
the same qualitative conclusions. Men have almost half the likelihood of being HIV 
seropositive compared to women (estimated OR 0.63, 95% CI 0.51-0.78), which could be 
connected to the protective effect of male circumcision for HIV acquisition. As observed 
in eastern sub-Saharan Africa (Cuadros et al., 2011b), age was found to be a strongly 
associated with HIV infection. The HIV prevalence peaked at age group 30-34 years, and 
these individuals had higher odds of being HIV seropositive compared with the age group 
15-19 years (estimated OR 4.11, 95% CI 2.60-6.51).  
 As expected and in agreement with other studies (Johnson et al., 2006; Msisha et 
al., 2008), the adjusted model indicated that individuals living in rural areas had lower 
odds of being HIV-positive compared to those living in urban areas, with an estimated 
OR of 0.58 (95% CI 0.43-0.78). Unadjusted analysis indicated that reported genital 
ulcerations during the last 12 months increased the likelihood of current HIV infection 
(estimated OR 1.65, 95% CI 1.21-2.26). The presence of genital ulcerations, however, 
was not a significant factor after adjusting for the other variables. Following the same 
pattern observed in the eastern part of the continent, being currently married was not a 
significant factor compared with individuals that had never been married (estimated OR 
1.17 95% CI 0.85-1.63), whereas individuals formerly married had higher odds of having 
HIV compared with individuals never married (estimated OR 2.55, 95% CI 1.73-3.77).  
Among the socio-economic covariates considered, the lone discrepancy between 
the current study and results obtained from our previous study of eastern sub-Saharan 
Africa (Cuadros et al., 2011b) was the relationship between wealth index and HIV. While 
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in the eastern part of the continent the wealth index was found to be positively and 
monotonically associated with HIV, where individuals in the richest category had the 
highest odds of being HIV-positive compared with individuals in the poorest category 
(Cuadros et al., 2011b; Johnson et al., 2006; Msisha et al., 2008), we observed no 
significant association between wealth index and current HIV status in western sub-
Saharan Africa (Table 4.2).    
Cameroon 
The general HIV prevalence in Cameroon was 5.4%: 4.0% for men and 6.7% for women 
(Table 4.1). The mean PfPR in this country was 0.44, slightly lower than the PfPR 
estimated for the western region. In areas with stable malaria transmission (PfPR > 0.46) 
the HIV prevalence was 6.4%, whereas in areas with PfPR ≤ 0.46 the HIV prevalence 
was 4.1% (Table 4.1). 
 The adjusted analysis indicated that PfPR predicted HIV infection in Cameroon 
and suggested that individuals who lived in areas with stable malaria transmission had 
increased odds of being HIV-positive compared to individuals who lived in areas with 
PfPR ≤ 0.46 (estimated OR 1.56, 95% CI 1.23-2.00).The difference in magnitude of the 
association between PfPR and current HIV status for Cameroon and west sub-Saharan 
Africa was also identified in an analysis that included an interaction term between PfPR 
and region (western sub-Saharan or Cameroon) in an adjusted model. The significant 
interaction term (P = 0.04) indicated that the association between HIV and the PfPR was 
different among these regions.  
Unlike the countries from the western region included in the study, higher wealth 
index was associated with higher odds of being HIV seropositive compared to individuals 
in the poorest category (Table 4.3), resembling the relationship between wealth index and 
HIV observed in East sub-Saharan Africa. Contrary to the results from the western and 
the eastern parts of Africa, the adjusted model indicated that living in urban areas did not 
increase the odds of being HIV-positive compared to  rural areas (estimated OR 0.76, 
95% CI 0.57-1.01). 
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Discussion 
In contrast to the observations from eastern sub-Saharan Africa, the results from this 
study suggest the absence of evidence for an association between malaria transmission 
intensity and current infection with HIV in western sub-Saharan Africa. The lower HIV 
prevalence in the western region compared to the eastern region of the continent might be 
a contributing factor for this difference. Unlike the eastern region, where the HIV 
epidemic is present in the general population, the low HIV prevalence observed in 
western countries might indicate that the HIV epidemic is concentrated in high-risk 
groups. 
 Our collective work provides evidence that the epidemiology of co-infection is 
not a simple additive relationship. The effect of co-infection on the spread of HIV might 
be influenced by other external factors such as the stage of the epidemic, individual and 
community behavior, and the HIV prevalence in the population, among others. 
Mathematical models have suggested that the number of HIV infections attributable 
directly to co-infection, estimated as the population attributable fraction, depends on the 
stage of the HIV epidemic and the epidemiology of the parasite involved in the co-
infection (Abu-Raddad et al., 2008; Cuadros et al., 2011a; Freeman et al., 2007; Orroth et 
al., 2007).  These models indicate that co-infections with sexually transmitted infections 
prevalent in high-risk groups, such as syphilis, trichomoniasis, gonorrhea and chlamydia, 
have the highest impact on the spread of HIV when the epidemic is concentrated in these 
subgroups. On the other hand, infections that are highly prevalent in the general 
population, such as herpes simplex virus type 2 and malaria, are more important 
contributors to fueling the spread of HIV infection when the epidemic has invaded the 
general population. 
 The results from this study and our previous work are thus consistent with the 
results obtained from mathematical models and indicate that co-occurrence of HIV and 
infections present in the general population, like malaria, might not play an important 
role in the spread of HIV in populations where its prevalence is low. Malaria apparently 
acts as a facilitator and fuels the spread of HIV when the epidemic is present in the 
general population but it is not the cause of the invasion of HIV in the general population. 
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This hypothesis is supported by the results obtained from data for Cameroon, where 
regardless of the similar PfPR and prevalence of male circumcision compared to the 
studied western region, the higher HIV prevalence in Cameroon was observed together 
with a significant association between HIV and malaria. 
 In agreement with other studies (Auvert et al., 2001b; Buve et al., 2001b), we 
found no difference in the socio-economic and demographic cofactors for HIV infection 
between the eastern and western regions of sub-Saharan Africa. Circumcision, however, 
was not significantly associated with HIV infection for men in our study. Circumcision is 
almost universal in western sub-Saharan Africa (Auvert et al., 2001a), where 94% of the 
male individuals included in our study were circumcised. In contrast, only 62% of the 
male individuals included in the study for the eastern region were circumcised. This 
difference has been proposed as a key factor for the difference between both epidemics 
(Auvert et al., 2001a; Auvert et al., 2001b). Circumcision is a cultural practice, and 
therefore it is plausible to hypothesize that the current prevalence of circumcision might 
be similar to the prevalence at the early stage of the HIV epidemic in sub-Saharan Africa. 
Consequently, the high rate of male circumcision observed in western sub-Saharan Africa 
could have generated a protective effect that prevented the invasion of the epidemic to the 
general population. 
 The results from Cameroon, however, did not support this hypothesis. Despite the 
extent of male circumcision (95%), the higher HIV prevalence indicates the likely 
presence of an HIV epidemic in the general population, which in turn might have 
governed the interaction between HIV and malaria that is suggested by our results. Thus, 
the factors (biological and behavioral) that trigger the movement of an HIV epidemic 
from high-risk groups to the general population remain indeterminate. The identification 
of these factors may give us a better understanding of the geographical differences 
observed in the HIV epidemic and a better comprehension of the complex co-infection 
relationship between HIV and other parasites. 
The present work as well as our previous study (Cuadros et al., 2011b) indicate 
that the presence of a parasite influencing the transmission of HIV, even when the 
parasite is highly prevalent in the population, does not fully explain the interaction and 
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the outcome of co-infection on the spread of HIV. Other factors such as the HIV 
prevalence and the distribution of the infection in the population may dictate the role of 
co-infection in fueling the epidemic.  
 Our work highlights the importance of identifying factors for the implementation 
of effective control interventions focused on co-infection. The effect of co-infection 
might not be the same in different populations, and control strategies will not necessarily 
have the same impact in each population. Understanding the epidemiological effects of 
co-infection and the relevant factors involved in this relationship is a prerequisite to 
developing accurate and effective recommendations for population-level control 
strategies.  
Limitations of the study 
Although our study makes use of the most complete and contemporary databases 
for both HIV and malaria, it is important to emphasize that our results were based on 
geographical estimates of PfPR in children aged 2 to 10 years old in locations where 
DHS surveys were made, and thus we estimated the effect of malaria on the prevalence of 
HIV based on indirect measures of malaria transmission intensity. Therefore, the results 
obtained in this study depend on the quality of these secondary data and on the 
methodology implemented in our and in previous analyses. Consequently, they should be 
interpreted with caution.  
Furthermore, it is important to highlight that our estimates are based on 
prevalence data for HIV. Since HIV prevalence is highly influenced by other independent 
factors, such as the stage and distribution of the epidemic in the population, this 
epidemiological measure might not be the most appropriate for evaluating the interaction 
between both infections. We used this measure based on the availability and quality of 
the data derived from different DHS surveys. Other epidemiological estimates such as 
HIV incidence, however, would be a more appropriate measure for direct estimation of 
the association between incident HIV and malaria. Therefore, our collective work 
represents a preliminary step to elucidate the role of malaria on the HIV epidemic in sub-
Saharan Africa, and highlights the necessity of more appropriate data for understanding 
the malaria-HIV relationship in order to implement effective control interventions.   
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  On the other hand, the PfPR values used in our study were obtained by 
mathematical algorithms that standardized the malaria transmission intensity in children 
aged 2-10 years (Hay et al., 2008). Whereas this estimation is a widely accepted 
approximation of the malaria transmission intensity in a specific region (Smith et al., 
2007), it is important to note that most HIV infections occur in the adult population. 
Repetitive malaria infections during childhood generate partial immunity to the infection 
and thus decrease the prevalence of clinical malaria in adults, especially in areas where 
malaria is endemic (Kamya et al., 2006). Although the PfPR in children aged 2-10 has 
been widely accepted as a measure of the transmission intensity, this variable is only an 
approximation to the malariological index. Furthermore, the relationship between this 
variable and the transmission intensity in the adult population is still not well defined, 
and most likely the PfPR in adults would be somewhat different.  For that reason, it is 
important to note that other malariological measures, such as the entomological 
inoculation rate or the prevalence of malaria in the adult population, would be alternative 
ways to investigate for the association between the co-infection studied here. These 
alternative data, however, are scarce, whereas the database for malaria used here allowed 
us to obtain the proxy data necessary for performing the analysis in this study. Moreover, 
we expect that the geographic distribution of the intensity of malaria transmission 
remains the same for all populations (children and adults), in which case the geographic 
variability of the PfPR used here represents a useful approximation for the comparisons 
made in this study.  
 Additionally, the relationship between malaria and HIV is bilateral, where HIV 
infection might alter the natural history of malaria (and vice versa), especially in areas 
with high HIV prevalence and unstable malaria transmission (Grimwade et al., 2004; 
Korenromp et al., 2005; Whitworth et al., 2000). In our study, however, we focused on 
the association between an ecological proxy of malaria infection and current HIV 
infection rather than the potential effect of HIV on malaria. Since the region studied is 
characterized by an endemic malaria epidemic (Hay et al., 2006) and low prevalence of 
HIV, we expect that this assumption would not drastically affect the outcome of our 
study.  
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Table 4.1 HIV prevalence by socio-economic and biological characteristics in 
western sub-Saharan Africa and Cameroon 
 
Characteristics 
Western Africa 
N (% HIV-positive) 
Cameroon 
N (% HIV-positive) 
Malaria 
PfPR ≤ 0.46 10 207 (1.58) 4871 (4.1)
PfPR > 0.46 30 857 (1.48) 5217 (6.4)
Gender   
Female 22 768 (1.80) 5102 (6.7)
Male 18 296(1.15) 4986 (4.0)
Age   
15-19 8690 (0.52) 2443 (1.4)
20-24 6844 (1.18) 1940 (5.0)
25-29 6006 (2.00) 1582(8.2)
30-34 5247 (2.19) 1245 (8.5)
35-39 5009 (2.15) 966 (8.3)
40-49 7614 (1.60) 1476 (5.6)
50-59 1654 (1.75) 436 (2.0)
Place of residence 
Urban 13 589 (2.25) 4887(6.6)
Rural 27 475 (1.16) 5201(4.3)
Marital status  
Never married 11 575 (0.83) 3160 (2.7)
Currently married 27 349 (1.60) 6013 (5.8)
Formerly married 2140 (4.06) 915 (12.0)
Religion 
Muslim 19 884 (1.31) 1628 (4.70)
Christian 12 755 (1.65) 4051 (5.60)
Traditional religion 388 (0.25) 271 (1.85)
Other 8037 (1.87) 4138 (5.58)
Wealth index 
Poorest 8469 (1.02) 1569 (2.9)
Poorer 8235 (1.25) 1819 (3.2)
Middle 8219 (1.27) 2264 (6.0)
Richer 7937 (1.88) 2189 (7.0)
Richest 8204 (2.17) 2247 (6.7)
Highest educational level 
None 21 502 (1.30) 1504 (3.6)
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Primary school 8460 (1.45) 4007 (5.7)
Secondary  10 268 (1.94) 4217 (5.9)
Higher 834 (1.99) 360 (4.4)
Genital ulceration 
No genital ulceration last 12 months 40 644 (1.42) 9843 (5.5)
Genital ulceration last 12 months 420 (2.22) 245 (9.7)
Male circumcision 
No circumcised 17 364 (1.79) 253 (1.59)
Circumcised 1021 (1.31) 4733 (4.18)
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Table 4.2 Unadjusted and adjusted results from western sub-Saharan Africa: HIV 
serostatus according to selected socio-economic and biological characteristics 
 
Indicator 
OR (95% CI) 
Unadjusted  Adjusted 
Malaria 
PfPR ≤ 0.46 1.00 1.00
PfPR  > 0.46 0.95 (0.74-1.21) 1.14 (0.86-1.50)
Gender   
Female 1.00 1.00
Male 0.64 (0.53-0.77) 0.63 (0.51-0.78)
Age   
15-19 1.00 1.00
20-24 2.39 (1.58-3.62) 2.12 (1.38-3.25)
25-29 4.18 (2.82-6.17) 3.66 (2.35-5.68)
30-34 4.68 (3.16-6.94) 4.11 (2.60-6.51)
35-39 4.62 (3.10-6.87) 4.18 (2.62-6.67)
40-49 3.46 (2.34-5.12) 3.14 (1.97-4.99)
50-59 3.91 (2.28-6.72) 5.30 (2.84-9.88)
Place of residence 
Urban 1.00 1.00
Rural 0.48 (0.39-0.60) 0.58 (0.43-0.78)
Marital status  
Never married 1.00 1.00
Currently married 2.19 (1.70-2.82) 1.17 (0.85-1.63)
Formerly married 5.45 (3.90-7.62) 2.55 (1.73-3.77)
Religion 
Muslim 1.00 1.00
Christian 1.28 (1.01-1.62) 1.11 (0.86-1.46)
Traditional religion 0.24 (0.02-2.45) 0.28 (0.02-2.87)
Other 1.39 (1.07-1.80) 1.24 (0.94-1.63)
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Wealth index 
Poorest 1.00 1.00
Poorer 1.20 (0.85-1.69) 1.15 (0.82-1.62)
Middle 1.21 (0.86-1.70) 1.10 (0.78-1.56)
Richer 1.81 (1.31-2.51) 1.40 (0.97-2.01)
Richest 2.01 (1.45-2.77) 1.38 (0.92-2.08)
Highest educational level 
None 1.00 1.00
Primary school 1.03 (0.80-1.32) 1.21 (0.93-1.57)
Secondary  1.33 (1.07-1.66) 1.38 (1.06-1.79)
Higher 1.31 (0.74-2.29) 1.01 (0.56-1.82)
Genital ulceration 
No genital ulceration last 12 months 1.00 1.00
Genital ulceration last 12 months 1.65 (1.21-2.26) 1.27 (0.93-1.76)
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Table 4.3 Unadjusted and adjusted results from Cameroon: HIV serostatus 
according to selected socio-economic and biological characteristics 
 
Indicator 
OR (95% CI) 
Unadjusted Adjusted 
Malaria 
PfPR ≤ 0.46 1.00 1.00
PfPR > 0.46 1.64 (1.29-2.07) 1.56 (1.23-2.00)
Gender   
Female 1.00 1.00
Male 0.55 (0.46-0.67) 0.58 (0.47-0.71) 
Age   
15-19 1.00 1.00
20-24 4.05 (2.67-6.13) 3.59 (2.33-5.52)
25-29 6.65 (4.42-9.98) 5.86 (3.76-9.14)
30-34 7.07 (4.66-10.71) 6.07 (3.82-9.63)
35-39 6.45 (4.18-9.95)  5.65 (3.48-9.15)
40-49 4.58 (2.99-7.02) 3.98 (2.46-6.43)
50-59 1.36 (0.60-3.10) 1.72 (0.73-4.09)
Place of residence 
Urban 1.00 1.00
Rural 0.63 (0.50-0.78) 0.76 (0.57-1.01)
Marital status  
Never married 1.00 1.00
Currently married 2.41 (1.86-3.13) 1.17 (0.86-1.60)
Formerly married 5.39 (3.95-7.37) 2.66 (1.87-3.79)
Religion 
Muslim 1.00 1.00
Christian 1.17 (0.86-1.59) 0.94 (0.67-1.30)
Traditional religion 0.45 (0.17-1.20) 0.51 (0.19-1.37)
Other 1.14 (0.84-1.55) 0.92 (0.66-1.27)
Wealth index 
Poorest 1.00 1.00
Poorer 0.99 (0.64-1.51) 0.88 (0.57-1.36)
Middle 1.94 (1.33-2.83) 1.66 (1.12-2.47)
Richer 2.26 (1.55-3.29) 1.90 (1.24-2.93)
Richest 2.09 (1.43-3.06) 1.70 (1.06-2.93)
Highest educational level 
None 1.00 1.00
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Primary school 1.44 (1.03-2.02) 1.33 (0.91-1.94)
Secondary  1.45 (1.03-2.04) 1.24 (0.82-1.86)
Higher 1.05 (0.57-1.96) 0.7 (0.37-1.43)
Genital ulceration 
No genital ulceration last 12 months 1.00 1.00
Genital ulceration last 12 months 1.81 (1.14-2.88) 1.39 (0.87-2.22)
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Chapter 5 - Heterogeneity in the HIV infectivity generated by 
co-infection: insights from a mathematical model 
 
Introduction 
At present, the role of viral genetic factors in the HIV epidemic is poorly understood. 
Many different HIV genetic subtypes circulate worldwide as well as their recombinant 
forms (Saathoff et al., 2010). Moreover, there is a substantial variation in the length of 
the asymptomatic (chronic) phase of HIV infection, ranging from few months to many 
years. This variation has been correlated with the so-called set point viral load (spVL), 
defined as the measure of the HIV RNA concentration in blood during the chronic stage 
of the infection, representing the quasi-steady state equilibrium between virus production 
and clearance (Perelson et al., 1996; Stafford et al., 2000).  
 The functional differences and the epidemic significance of these variations are 
still unclear (Geretti, 2006). Some studies, however, have revealed potential differences 
in the replicative capacity among different virus genotypes (Åsjö et al., 1986; Ayele et 
al., 2010; Betts et al., 2001; Blaak et al., 1998; Hu et al., 2001; Kivelä et al., 2005). As a 
result, it has been suggested that if viral factors can affect the efficiency of viral 
replication and can be preserved from one infection to the next, this would imply a 
significant role of viral genetic factors determining the spVL (Hollingsworth et al., 2010). 
 Recent studies conducted to assess this hypothesis have evidenced that virus 
characteristics might indeed explain a significant proportion of the variation in the spVL 
observed among individuals. They demonstrated a correlation of the spVL between 
transmitting couples and suggested that the spVL might be a heritable factor. Even a 
weak correlation between spVL of individuals in transmitting couples might correspond 
to a large estimate for the role of viral genetic factors (Alizon et al., 2010; Fraser and 
Hollingsworth, 2010; Hecht et al., 2010). This result has profound implications for 
important virus-related processes in which the spVL is a key determinant, such as the 
progression and transmission of the infection. The evidence suggests a strong correlation 
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between HIV plasma viral load (VL) and HIV transmission rates (Quinn et al., 2000; 
Wilson et al., 2008). It has been estimated that a ten-fold increment in VL almost doubles 
the risk of HIV transmission per sexual contact (Quinn et al., 2000). Consequently, if 
viral genetic factors influence the concentration of the virus during the chronic stage of 
the infection, these viral characteristics might indeed play an important role on the 
transmission of the infection.  
 The spVL, however, is not in an absolute equilibrium state; it is frequently 
perturbed by immune activations generated by the invasion of other pathogens, resulting 
in a significant amplification of the VL. Changes in the host immune response induced by 
concomitant infections may account for increments in the VL that could make the host 
more infectious and increase the risk of transmission of the virus during the chronic stage 
of the infection (McLeans and Nowak, 1992; Modjarrad et al., 2008; Modjarrad and 
Vermund, 2010). The amplification of the VL generated by co-infection may be an 
important contributor to the successful transmission of the infection; especially in areas 
were the immune system is constantly challenged by multiple infections, such as in sub-
Saharan Africa (Barnabas et al., 2011; Bentwich et al., 1995; Lawn, 2004).  
 Furthermore, there is substantial heterogeneity in the effect of co-infection at the 
individual and population levels. Within individuals, the co-infection induced increment 
of the VL varies greatly (Kublin et al., 2005; Ostrowski et al., 1998; Rosok et al., 1996). 
Likewise, the effect of co-infection at the population level depends on several behavioral 
and epidemiological factors related to the stage and the distribution of the HIV epidemic 
within the population. Co-infections with sexually transmitted infections (STI) such as 
gonorrhea and chlamydia would have the highest impact on the transmission of the virus 
in populations where the epidemic is concentrated in the high risk (core) groups. 
Conversely, infections prevalent in the general population such as malaria and herpes 
simplex virus type 2 (HSV-2) would be important contributors to the spread of the 
infection when the epidemic has invaded the general population (Abu-Raddad et al., 
2008; Cuadros et al., 2011a). 
 Based on the biological evidence previously discussed, I suspect that viral factors 
might contribute to the variation of the effect of co-infection at host and population level. 
Here, taking a simple modeling approach, I examined how viral factors that dictate the 
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spVL can alter the dynamics of the virus population in presence of co-infection and can 
introduce heterogeneity among individuals. I expect that viruses with high replicative 
capacity that sustain elevated spVL would also generate larger increments in the VL in 
response to host immune activations induced by co-infection. In contrast, viruses with 
poor capacity to infect target cells and replicate would generate lower spVL and 
consequently lower VL increments in response of co-infection. Since the transmission 
efficiency of the virus among individuals is associated with viral burden, highly 
infectious individuals would have viral characteristics that maximize the increment of the 
VL in presence of co-infection. This result might have important implications at both the 
individual and the population levels. 
 To assess this hypothesis, I generated a mathematical model that describes the 
dynamics of HIV and a concomitant pathogen within the host to evaluate the 
heterogeneity of viral replicative capacity on the spVL and the increment on the VL in 
response of co-infection. Additionally, I evaluated the effects of these variations at 
population level.   
 
Methods 
I developed a deterministic differential equation compartment model based on two 
independent models that describe the dynamics of HIV and another parasite, namely 
malaria. 
HIV model 
The basic model of HIV dynamics implemented here has three variables: T the 
population sizes of uninfected cells,  infected cells, and V free virus particles 
(Callaway and Perelson, 2002; Stafford et al., 2000). These quantities denote the total 
abundance of the given population per milliliter (ml) of blood, and their dynamic is 
described by the following system of differential equations:  
*T
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where s represents the production rate of activated immune (CD4+ T) cells, dt the natural 
death rate of activated immune cells,  the HIV infection rate of activated immune cells, 
δ death rate of HIV infected cells, N the HIV production rate by an infected cell, and c 
the HIV removal rate. The magnitudes of these parameters are summarized in Table 5.1. 
From this system of differential equations it is possible to determine the concentration of 
the virus population at equilibrium, which might be associated with the spVL in the 
chronic stage of the infection, and is described by the following equation (Callaway and 
Perelson, 2002): 
vk
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This equation shows that virus concentration at equilibrium may depend on virus 
factors that determine its replicative capacity: the infection rate of immune cells ( ) and 
the production rate by infected cells (N). This result has been used by other authors to 
estimate these parameters using least squares parameter estimation techniques (Perelson 
and Nelson, 1999; Stafford et al., 2000). Since these parameters represent intrinsic 
characteristics of the virus, and their variation generates different spVL, I focused on 
evaluating the effect of such variations on the VL burden generated by the presence of a 
concomitant pathogen. 
vk
Malaria model 
Malaria was selected as the concomitant pathogen based on substantial biological and 
epidemiological evidence suggesting an important malaria-HIV interaction, especially in 
areas where the infections overlap geographically. Several studies have demonstrated the 
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increment of VL in individuals with acute malaria (Barnabas et al., 2011; Chen et al., 
2003; Hoffman et al., 1999; Kublin et al., 2005). Likewise, the risk of HIV infection is 
higher in areas with high malaria prevalence (Cuadros et al., 2011b), and malaria has 
been proposed as an important facilitator for the spread of HIV in sub-Saharan Africa 
(Abu-Raddad et al., 2006; Cuadros et al., 2011a). 
 To introduce malaria into the system, I implemented a minimal model developed 
earlier (Anderson et al., 1989) and used by several authors (Hellriegel, 1992; Mideo et 
al., 2008; Mugisha et al., 2008; Thibodeaux, 2010) to study the population dynamics of 
X uninfected red blood cells, Y  infected red blood cells, M free merozoites, and T  
malaria activated immune cells. The system is described by the following system of 
differential equations: 
m
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where  stands for the rate of red blood cell production, Δ xμ  the natural death rate of 
uninfected red blood cells,  the infection rate of red blood cells by merozoites, mk 1μ  the 
differentiation rate of merozoites, yμ  natural death rate of infected red blood cells, cμ  
clearance rate of infected red blood cells due to the immune system, mμ  natural death 
rate of free merozoites, hμ  death rate of merozoites by contact with immune cells,  
merozoite production per infected cell, 
r
ε rate of immune cell production, yλ  p
rate of immune cells in response to infected red blood cells, and m
rol ion iferat
λ  proliferati  r
immune cells in response to merozoites. The parameter values are summarized in Table
5.1. 
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Within-host co-infection model 
As previously discussed, co-infection activates host immunity, which in turn 
enhances HIV replication (Modjarrad and Vermund, 2010). This phenomenon has been 
suggested to be a direct consequence of T helper cell (CD4+ T) activation that 
consequently raises the number of target cells susceptible to virus infection and 
replication (Obrien et al., 1995). This increment in the pool of susceptible target cells has 
been observed in reaction to different agents that induce an immune response such as 
influenza vaccine (Staprans, 1995), tetanus immunization (Cheynier et al., 1994; 
Ostrowski et al., 1998), and malaria (Hoffman et al., 1999; Xiao et al., 1998). This 
biological argument was used to link both models in a single co-infection model. This 
approach was also used by Jones and Perelson (2002) to model the effect of vaccination 
on chronically HIV positive persons and the effect of opportunistic infections on patients 
treated with antiretroviral therapy (Jones and Perelson, 2005). But this is the first model 
to include the dynamics of more than one infection simultaneously to evaluate the effect 
of a concomitant infection on the dynamics of HIV. It is important to notice, however, 
that the immune stimulation that promotes HIV replication is multifactorial, and cell 
proliferation is only one of these mechanisms. Malaria also stimulates HIV transcription 
in other ways such as the activation of viral transcription via cytokines (Xiao et al., 
1998). Therefore, the model presented here is a simplification of the effect of co-infection 
on the virus population and only describes one of the possible mechanisms in which 
parasites might affect the immune pathway that could alter the replication of the virus. 
For the complete model of co-infection, the two models were linked by describing 
the mechanism in which malaria stimulates an immune response in terms of activation 
and proliferation of  malaria activated immune cells ( ), which in turn will become 
available to HIV infection. The model includes a maximum number of immune cells per 
ml of blood ( ) (Perelson et al., 1993); thus, the immune cell population will grow in a 
logistic fashion. After linking the two models, the dynamic of the HIV-malaria co-
infection is described by the following system of differential equations:  
mT
maxT
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 I estimated the effect of the HIV infection rate ( ) and production rate (N) on the 
increment of the VL induced by co-infection by conducting several numerical 
simulations of the model evaluated over the bi-dimensional parameter space generated by 
the range parameter values of 1.5
vk
×10-6 to 2×10-5/day for the HIV infection rate ( ), and 
20 to 300 virions/cell for the HIV production rate (N). Due to the uncertainty associated 
with HIV infection rate of immune cells produced by the presence of malaria ( k ), I 
explored four different values for this parameter, which were proportional to the values 
used for the HIV infection rate ( ): 
vk
Tm
vk Tm vk k= , /10Tm vk k= , / 20Tm vk k= , and 
. The simulations started with the introduction of HIV alone; when the 
dynamics of the virus reached a steady state equilibrium (the spVL), malaria was 
introduced into the system (day t = 600). I recorded the VL immediately before the 
introduction of malaria, which represented the value for the spVL, and the following 30 
days after the introduction of malaria. The values recorded during these 30 days were 
then averaged to estimate the increment on the VL generated by co-infection.  
/ 30Tm vk k=
To compare spVL and the increment on the VL induced by co-infection, I 
sampled the parameter space evaluated to generate different combinations of the two 
parameters evaluated, and N. These combinations were then used to calculate the spVL vk
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and its corresponding increment on the VL induced by co-infection. Lastly, a geometric 
per capita growth rate of the virus was estimated for each combination of parameters. 
Effect of co-infection at the population level 
Understanding how concomitant infections could influence between-host transmission 
and epidemic dynamics represents a major challenge in epidemiology. The scenario is 
even more complicated when possible viral genetic differences might introduce 
heterogeneity into the outcome of co-infection. For that reason, using the within-host 
model described previously, I attempted to evaluate the effect of virus heterogeneity on 
transient co-infection-induced amplification of the VL at population level. 
To estimate the effect of co-infection on the spread of HIV at population level, I 
implemented a standard deterministic population model constructed by Abu-Raddad and 
coworkers (Abu-Raddad et al., 2008; Abu-Raddad et al., 2006). The model is a 
deterministic compartment model that stratifies the population into compartments 
according to HIV sero-status and stage of HIV infection, and sexual-risk activity group. 
Details of the model are described elsewhere (Abu-Raddad et al., 2008; Abu-Raddad et 
al., 2006), and a short description of the model is included in the Appendix B. 
 For this model, the functional relationship between VL and the probability of 
transmission per sexual contact was used as the within-host and between-host interface. 
VL is one of the principal determinants of heterosexual HIV transmission (Fideli et al., 
2001; Gray et al., 2001; Operskalski et al., 1997; Pedraza et al., 1999). It has been 
estimated that each one log10 increase in the VL doubles the per coital-act probability of 
HIV transmission (Lingappa et al., 2010; Quinn et al., 2000). Consequently, transient co-
infection-induced increments in VL could potentially enhance between-host transmission 
(Abu-Raddad et al., 2006; Cattadori et al., 2007). 
 The model assumes that the effect of the VL on the infectiousness follows the 
empirical relationship between VL and transmission probability per sexual contact as 
observed initially by Quinn and colleagues (Quinn et al., 2000): 
log( / )
( ) ( ) 2.45
HIV vlH vlB HIV
I i S jp p→ = , where  stands for the probability of 
transmission per sexual contact for an infected individual from the risk group  to a 
( ) ( )
HIV
I i S jp →
( )i
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susceptible individual from the risk group ( )j ,  is the baseline probability of 
transmission per sexual contact in the chronic stage of the infection,  is the amplified 
VL, and  is the baseline VL. The baseline probability of transmission per sexual 
contact in chronic stage was assumed to be
HIVp
V
vlH
vlB
H Ip = 0.0008, with a VL of = 15 000 
virion copies/ml (Quinn et al., 2000). Thus, as an example of the calculations performed, 
at VL = 33 478 virion copies/ml, the probability of transmission per sexual contact in the 
chronic stage is . Finally, to account for 
the potential effect of the VL on the HIV disease progression to AIDS, each log10 rise in 
the VL increases the rate of HIV progression to the latest stage of the infection by 
twofold (Modjarrad et al., 2008). 
vl
=
B
log(33478/
( ) ( ) 2.45 8 0.00109
HIV
I i S jp → =
15000) * 0.000
 The spVL and its corresponding co-infection induced increment on the VL for 
each combination of parameters evaluated previously were used to compare the spread of 
HIV in two different populations: one population free of co-infection, in which the 
probability of transmission per sexual contact was estimated at the spVL, and the 
corresponding population affected by co-infection, in which the probability of 
transmission was estimated by including the increment on the VL induced by the 
concomitant infection with malaria. To calculate the probability of transmission in the 
population affected by co-infection, it was assumed that each individual has, in average, 
one episode of malaria infection per year. Thus, the mean VL per year was the average of 
the spVL during 11 months and the increased VL for the month of the co-infection. The 
model was also evaluated assuming two and four episodes per year. 
The system was evaluated at the endemic equilibrium (see appendix B). After the 
equilibrium solution was found through convergent successive approximations, the total 
prevalence and incidence were calculated. Finally, to evaluate the effect of co-infection 
under different viral replicative capacities, the direct effect of co-infection on the HIV 
incidence was measured by using population attributable fractions (PAF) calculated as: 
 
1 100%
l
⎛ ⎞
×⎜ ⎟
⎠
vlIR
IR
= −
⎝
sp
Hv
PAF
, 
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where is the incidence rate of HIV with the spVL,  and  vlspIR HvlIR is the HIV incidence 
rate with the heightened VL in presence of co-infection for each combination of 
parameters and N as defined previously. vk
 
Results 
Within-host model 
In general, the within host co-infection model indicated that small values for the two 
parameters evaluated, the HIV production rate by infected cell (N) and the HIV infection 
rate ( ), produced small increments on the VL when dual infection with HIV and 
malaria is present. Conversely, the increment on the VL increased as both parameters 
increased (Figure 5.1). Different values for , however, generated different patterns. 
When , the differences on the increment of the VL in response to co-infection 
were determined by the variation on the HIV production rate per infected cell (N) (Figure 
5.1 A). The highest VL amplification was produced at a very low HIV infection rate (  
= 1×10-6 ) and high HIV production rate per infected cell (N= 300). Contrary to 
expectation, when  increases, the increment in the VL generated by co-infection 
decreases. This behavior is derived from the ability of the virus to infect new target cells 
activated by malaria. At high , the virus rapidly infects the new target cells impeding 
the proliferation of these immune cells. Consequently, this overexploitation of the new 
target cells by the virus at early stages of co-infection prevents an effective immune 
response to control malaria. This scenario seems to be unrealistic since individuals 
infected with HIV are able to have an immune response and cell proliferation in presence 
of concomitant infections (Wyler, 1976; Chougnet et al., 1992). In addition, the 
increment on the VL in individuals dually infected with HIV and another pathogen is 
associated with an increment on the CD4+ T cells (Chen et al, 2003; Hoffman et al., 
1999). 
vk
Tm
Tmk
vk k=
vk
vk
vk
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  On the other hand, when the was a fraction of the , the increment of both 
parameters, the HIV production rate per infected cell and the HIV infection rate, induced 
larger increments in the VL in response of co-infection. This result suggests that large 
HIV infection rates might affect the availability of the new target cells for infection by 
the virus by diminishing the potential cell proliferation. When 
Tmk vk
/10Tm vk k=  the effect of 
the overexploitation of target cells by the virus is still evident at high HIV infection rate 
(starting from = 1×105) (Figure 5.1 B). This effect is diluted when 
pparently, the target cell concentration stabilizes with no substantial change
at smaller fractions of vk  (Figure 5.1 D). For that reason, and to include possible 
differences on the HIV infection rate generated by the availability of the new target cells 
for HIV infection, the remaining results were derived assuming / 20Tm vk k= . 
vk / 20vk kTm = (Figure 
5.1 C), and a s 
 Figure 5.2 illustrates the dynamics of the virus according to the variation of the 
st 
 in 
nd returned to baseline levels four weeks 
rica 
(Hoffman et al., 1999; Kublin et al., 2005). 
virus parameters used. The combination of parameters generating low spVL were almo
unable to produce an increment on the VL when malaria was introduced into the system 
(Figure 5.2 A, B, and C). Conversely, larger spVL might be associated with more 
efficient viral replicative capacity that generated much larger increments in the VL
response to co-infection (Figure 5.2 D, E, and F). After the introduction of malaria, there 
was a transient increment on virus concentration followed by a peak and successive 
decay to the original spVL. These viral dynamics in response to immune stimulations 
have been observed previously in vivo (Staprans et al., 1995; Xiao et al., 1998) and 
replicated by other mathematical models (Jones and Perelson, 2002; Jones and Perelson, 
2005).  
 On average, VL peaked after one week a
ter the imaf mune stimulation, consistent with other studies in which a large increase in 
the VL was observed during acute malaria and after influenza vaccine (Kublin et al., 
2005; Staprans et al., 1995). The average increment in the VL  generated by co-infection 
estimated from the 30 days recorded during the co-infection episode ranged from 500 to 
800 000 virion copies/ml, variation consistent with the ranges estimated from studies 
designed to evaluate the effect of malaria on the VL of HIV-positive individuals in Af
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 The simulations performed using the samples from the parameter space evaluated 
when / 20Tm vk k=  illustrate in more detail the positive correlation between the spVL and 
e 
 
pacity 
The functional relationship between the viral load and the probability of transmission per 
 to link the viral replicative capacity and the effect of co-infection 
 
. 
intain 
f 
 
the increment on the VL induced by co-infection. Viral genotypes with poor replicative 
capacity that produce low spVL were not able to respond to increments in the activated 
target cells induced by the presence of concomitant infections. Consequently, the co-
infection related increment in the VL generated by these viruses was fairly small. At 
lower spVL, the relationship between the increment on the virus concentration and th
spVL increased exponentially, suggesting that viral genotypes with potent replicative 
capacity that were able to produce elevated spVL were also associated with large co-
infection induced increments in the VL. The pattern followed a logistic function, 
suggesting a saturation effect at very high spVL (Figure 5.3 A). Additionally, the high
per capita growth rate observed at large spVL might reflect the high replication ca
of these viruses that were able to effectively respond to increments in the target cell 
population (Figure 5.3 B). 
Between-host model 
sexual contact was used
at the population level. As expected, and in accordance with the immunological model, 
the PAF analysis indicated that co-infection would have a negligible impact in 
populations where the circulating virus has low replicative capacity, reflected in low 
spVL. Conversely, the impact of co-infection would increase as the spVL of the
population increased, reaching a maximum effect at spVL around 1×105 (Figure 5.4)
This result indicates that viruses with high replicative capacity that are able to ma
elevated spVL would have a substantial impact on the spread of the infection in terms o
new HIV infections directly caused by co-infection. This result was consistent regardless
of the average number of co-infection episodes per year. In addition, the number of co-
infection episodes has almost no impact on the PAF at low spVL; even four episodes 
were not able to produce a PAF larger than 1% when the spVL is lower than 2 ×106. 
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Discussion 
In this work, I explored factors that could introduce heterogeneity in the effect of co-
infection at individual and population levels. I postulated that if the HIV replication 
capacity was an important determinant of the spVL, it would also determine the effect of 
co-infection on the dynamics of the virus. Here, using a simple mathematical model to 
describe the dynamics of HIV at host level, it was possible to determine that the variation 
in the viral replication capacity described by two parameters, the HIV infection rate ( ) 
and the HIV production by infected cell (N), generated different spVL. Moreover, the 
influence of the heterogeneity in these parameters on the increment of the VL in response 
of co-infection, evaluated using a within-host mathematical model of HIV-malaria co-
infection, indicated that the viral replication capacity would strongly influence the 
induced increment of the VL when a concomitant infection is introduced in the system.  
vk
 In addition, the model suggests the existence of differences in the HIV infectivity 
rate for new target cells generated by co-infection. Infections such as malaria generate 
localized immune response occurring in specific organs such as the spleen (Chougnet et 
al., 1992).This infection also produces a decrease in peripheral T cells consequence of a 
sequestration of these cells to specific lymphoid organs (Wyler, 1976). These 
characteristics might generate a compartmentalization of the system in which not all new 
target cells would be available to the virus. Consequently, the HIV infection rate for the 
new target cells generated by co-infection might be a fraction of the HIV infection rate 
for non-specific immune cells ( ), as suggested by the model. Poor virus replicative 
capacity, associated with low spVL, generated modest increments on the VL in response 
to co-infection. Regardless of the co-infection induced proliferation of target cells, the 
low replicative capacity of these viruses prevented an effective viral response to the 
newly available activated target cells. Conversely, viruses with more efficient replicative 
capacity, reflected in high spVL, were able to produce much stronger increments on the 
VL when the population of target cells were incremented. Regardless of the introduction 
of new target cells to the system, the effect of co-infection could mainly depend on the 
ability of the virus to efficiently exploit the temporal rise of the target cell population. 
This in consequence would generate a considerable increment on the VL when the 
vk
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immune system of the host is stimulated by the presence of a concomitant pathogen. This 
result might indicate that viral factors could play an important role not only in 
determining the spVL but also in driving several virus-related processes such as the 
increment of the VL induced by co-infections.  
 This result would have important implications for the identification of highly 
infectious individuals. HIV-positive persons that sustain high spVL might therefore be 
able to produce large increments in virus concentration in response to immune 
stimulations and consequently become much more infectious individuals, compared to 
those maintaining low spVL, even in presence of the same concomitant pathogen. This 
argument was then evaluated at the population level by linking the results from the 
within-host model with a population model using the functional relationship between 
viral load and probability of HIV transmission per sexual contact. I generated several 
virtual populations with different viral replicative capacities that sustained different mean 
spVL, in which the direct effect of co-infection on the incidence of HIV was then 
evaluated.  The results from these simulations were consistent with the results from the 
host level model and raise the possibility that co-infection might play a substantial role in 
the spread of HIV in populations where the circulating virus maintains elevated spVL. 
Conversely, co-infection would not be an important driver of the epidemic in populations 
with low spVL. 
 This work underscores the possibility that viral factors might have an important 
impact on the role of co-infection on the spread of HIV. Therefore, understanding their 
variation would be a key element in the design of control interventions to prevent HIV 
transmission. To pursue this goal, however, it would be necessary to evaluate the results 
from the theoretical model proposed here with experimental data. These kinds of studies 
should be conducted in HIV positive individuals in the chronic stage of the infection with 
similar CD4+ T cell count, and whose spVL have being well established. Their immune 
systems can be challenged with the application of previously used antigen immune 
stimulants such as tetanus toxoid vaccine (Ostrowski et al., 1998) or influenza vaccine 
(Obrien et al., 1995; Rosok et al., 1996).  The VL should then be measured frequently 
(preferably daily) over a considerable period of time (at least one month), to accurately 
delineate the dynamics of the virus during co-infection.    
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 I emphasize that this work relies entirely on a hypothetical relationship between 
viral genotypic factors and the spVL. As noted previously, regardless of the evidence 
about the relationship between viral genetic factors and the spVL (Alizon et al., 2010; 
Fraser and Hollingsworth, 2010; Hecht et al., 2010), the evidence about the role of virus 
genotype on the natural history of HIV is controversial (Hemelaar et al., 2006; Thomson 
et al., 2002), and the evidence about differences in VL among populations is limited 
(Geretti, 2006; Morison et al., 2001b). Therefore, our study indicates the importance of 
conducting such studies that focus on estimating the spVL to elucidate possible 
differences at population level. Such studies would help us better understand the 
extensive variation on the HIV epidemic.  
 As suggested by the model, biological differences could alter the effect of co-
infection and underscore the importance of identifying these factors for the 
implementation of effective control interventions focused on co-infection. The effect of 
co-infection might not be the same among individuals and populations, and control 
strategies will not necessarily have the same impact in each population. Understanding 
the role of viral genetic factors on co-infection becomes an important element for 
developing accurate and effective recommendations for population-level control 
strategies.  
Limitations of the model 
This study is a theoretical exercise aimed to explore further implications of the variation 
of viral genetic factors on the natural history of HIV. To achieve this goal, we developed 
a within-host co-infection model based on two well known and extensively used 
mathematical models describing the within-host dynamics of HIV and malaria. These two 
models were linked by the activation of the immune cells induced by the concomitant 
infection with malaria, increasing the target cell population for HIV infection.  
 This mechanism, however, is only one of the several mechanisms in which the 
invasion of another pathogen stimulates the replication of HIV (Chen et al., 2003; 
Copeland et al., 1996; Pisel et al., 2002; Staprans et al., 1995). The interaction between 
HIV and concomitant pathogens appears to be multi-factorial at cellular and 
immunological levels (Copeland et al., 1996). For example, the transcriptional signaling 
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used by lymphocyte cells to regulate cell functioning is also used by HIV to regulate 
virus production. During co-infection, cytokines [small proteins secreted by specific cells 
of the immune system used for local signals between cells during response to infection 
(Nathanson et al., 2002)] might enhance their susceptibility to HIV infection and 
stimulate production of viruses for weeks to months without significant cytopathic effects 
(Kedzierska et al., 2003; Vicenzi et al., 1997).  
 Moreover, other infections might have additional mechanisms in which they 
could affect the transmission of HIV. For example, the genital reactivations of HSV-2 
generate local immune activations in genital ulcerations that might increment HIV 
shedding in the genital tracks (McClelland et al., 2002). This STI infection not only 
affects the risk of transmission but also increases the risk of acquisition in HIV-negative 
individuals, characteristic that considerably affects the mode in which HSV-2 influences 
the pattern of HIV transmission at the population level (Abu-Raddad et al., 2008; 
Freeman et al., 2006). The differences in which other infections besides malaria interact 
with HIV are not considered in this study, and they might alter the results observed at the 
population level.    
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Table 5.1 Co-infection within-host model parameter values 
 
Parameter                  Value Reference 
Rate of red blood cell production (Λ) 2.5*108 cells/day/ml (Saul, 1998; 
Thibodeaux, 2010; 
Tumwiine et al., 
2008)
Natural death rate of uninfected red 
blood cells (µx) 
0.0083/day (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Infection rate of red blood cells by 
merozoites (km) 
2.5*10-10/day (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Differentiation rate of merozoite (µ1) 0.5/day (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Natural death rate of infected blood 
cells (µy) 
0.025/day (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Clearance rate of infected red blood 
cells due to the immune  
system (µc) 
1*10-8/cell day (Thibodeaux, 2010)
Natural death rate of free merozoites 
(µm) 
48/day (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Death rate of merozoites by contact 
with immune cells (µh) 
1*10-8/day (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Merozoite production per infected 
red blood cell (r) 
16 (Anderson et al., 
1989; Tumwiine et 
al., 2008)
Rate of immune cells production 
(malaria specific) (ε) 
0.0001/cell day (Hellriegel, 1992)
Proliferation rate of immune cells in 
response to infected red blood cells 2*10-8/cell day (Thibodeaux, 2010)
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(λy) 
Proliferation rate of immune cells in 
response to merozoites (λm) 
3*10-8/ cell day (Thibodeaux, 2010)
Maximum number of activated 
immune cells per ml of blood (Tmax) 
1.5*106/day (Perelson et al., 1993)
HIV infection rate for nonspecific 
immune cell (kv) 
[0.5× 10-6 - 2× 10-5]/day Representative value
Production rate of immune cells (s) 1*104 cells/ml/day (Callaway and 
Perelson, 2002)
Natural death rate of immune cells 
(dt) 
0.01/day (Mohri et al., 1998)
Death rate of HIV infected cells (δ) 0.7/day (Perelson et al., 1997)
HIV production rate by an infected 
cell (N) 
[20 - 296] virions/cell Representative value
HIV removal rate (c) 23/day (Ramratnam et al., 
1999)
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Figure 5.1 Increment on the VL induced by co-infection using different values for 
the parameters and N vk
The effect of the heterogeneity of the HIV infection rate ( ) and production rate (N) on 
the increment of the VL generated by co-infection was evaluated using the bidimensional 
parameter space generated by the range parameter values of 1
vk
×10-6 to 2 10-5/day for the 
HIV infection rate ( ), and 20 to 300 virions/cell for the HIV production rate (N). I 
explored different values for , in (A) 
×
vk
Tmk Tm vk k= ; (B) /10Tm vk k= ; (C) ; and 
(D) . 
/ 20vk k=Tm
/ 30Tm vk k=
 
A B
C D
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Figure 5.2 Time course of the VL in presence of co-infection with different set of 
parameters  and N vk
Figures illustrate the HIV dynamics from day 550, to day 800. In (A)  = 2×10-6 and  vk
N = 50; (B)  = 5×10-6 and N = 120; (C)  = 6vk vk ×10
-6 and N = 170; (D)  = 9vk ×10
-6 
and N = 220, (E)  = 14×10-6 and N = 260; (F)  = 18vk vk ×10
-5 and N = 280. 
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Figure 5.3 Correlation between the spVL and the increment on the VL in response 
to co-infection 
Model estimations are indicated in blue dots and triangles; the black lines represent the 
logistic fitted line. In (A) the results suggest that viruses with replicative capacity that 
produce low spVL are not able to generate considerable increments on the VL. 
Conversely, viruses with potent replicative capacity that are able to produce elevated 
spVL would generate much larger increments on the VL. The pattern follows a logistic 
fit, which suggests a saturation effect at very high spVL. In (B) the geometric per capita 
rate of growth was estimated for each spVL evaluated. Large spVL are accompanied with 
high per capita rate of growth, which might reflect the high replicative capacity of the 
virus. 
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Figure 5.4 Correlation between the spVL and the PAF 
The between-host model indicated that co-infection would have a negligible impact in 
populations where the circulating virus has low replicative capacity reflected in low 
spVL. Conversely, the impact of co-infection would increase as the spVL of the 
population increases, until it reaches a maximum effect at spVL around 1×105.  
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Chapter 6 - HIV prevention randomized clinical trials: 
quantitative and analytical insights on the failure to measure 
efficacy 
 
Introduction 
HIV infection remains as one of the major public health problems especially in sub-
Saharan Africa (UNAIDS/WHO, 2009). During the nearly 30 years of research on HIV, 
the improved understanding of the determinants of HIV transmission has identified key 
candidate interventions to prevent HIV infection. More than 40 randomized controlled 
trials (RCT) were designed to measure the efficacy of interventions on HIV incidence 
ranging from HIV vaccines to behavioral interventions and male circumcision (Padian et 
al., 2010). Despite the solid foundation on observational epidemiological evidence, 
almost 90% of the RCTs failed to measure a statistically significant efficacy against HIV 
incidence (Padian et al., 2010). The reasons behind the failure of most RCTs to measure 
efficacy, despite the robust scientific evidence supporting the intervention concept, 
continue to be poorly understood.   
The disappointing results of these trials after massive scientific field work and 
cost exceeding often tens of millions of dollars per RCT has generated a flurry of 
scientific research to elucidate plausible explanations for these failures (Cohen et al., 
2011; Hayes et al., 2010a; Hayes et al., 2010b; Padian et al., 2010). In this article, we 
explore further factors that may explain the outcome of such trials by conducting the 
RCTs in silico thereby simulating the actual RCTs and investigating the drivers of their 
failures.  
We focused on the Partners in Prevention HSV/HIV Transmission Study RCT, 
which was designed to test the efficacy of acyclovir suppressive therapy for herpes 
simplex virus type 2 (HSV-2) on reducing HIV transmission (Celum et al., 2010). This 
study found that, despite a significant reduction in the mean plasma HIV concentration 
and in the genital ulcerations in the acyclovir group, there was no significant effect of 
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acyclovir on the incidence of HIV. For comparisons, we also generated a model that 
simulates the effect of male circumcision on the risk of HIV infection. We chose this kind 
of intervention based on the positive results obtained from three RCTs designed to test 
the efficacy of male circumcision on the prevention of HIV infection (Hayes et al., 
2010b), and the accurate estimation of its effect based on substantial amount of 
observational data (Weiss et al., 2000). We particularly focused on the RCT study 
conducted in Rakai, Uganda (Gray et al., 2007). Using a mechanistic mathematical model 
and RCT simulation, we assessed the drivers and implications of these findings.   
 
Methodology 
Simulation of RCTs is a growing area of interest in different fields including HIV 
prevention (Desai et al., 1999). In pharmacology, simulation of RCTs is a well-
established procedure to evaluate alternative trial designs, test hypotheses, and interpret 
trial outcome (Holford et al., 2000; Karlsson and Sheiner, 1993; Sheiner and Steimer, 
2000). The greatest benefit of RCT simulation is the ability to conduct a trial thousands 
of times in silico, and under variable spectrum of assumptions, at very limited cost versus 
the highly costly and demanding implementation of a single trial in the field.  In this 
article, we developed a Monte-Carlo approach based in the Partners in Prevention 
HSV/HIV Transmission Study RCT (Celum et al., 2010), and the Rakai circumcision 
RCT study (Gray et al., 2007). We generated a population of virtual individuals and 
simulated the two different interventions proposed in these clinical trials. For this in silico 
experiment, the unit of replication was an individual RCT trial. 
 Partners in prevention trial simulation 
To simulate the Partners in Prevention trial, the model generates a population of 
individuals and simulates the administration of acyclovir suppressive therapy as an 
intervention in an RCT trial just as the clinical trial. The total number of individuals 
simulated in each realization (which corresponded to an individual RCT trial) was 3400 
(1700 in the control group and 1700 in the acyclovir intervention group). To match the 
number of HIV sero-conversions within the control group in the Partners in Prevention 
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trial, the probability of HIV transmission per sexual contact was fixed at  = 
0.0012; nicely in unison with the values estimated from the state of the art empirical 
measures for this parameter of 0.0012 in the cohort of the Rakai Study (Gray et al., 2001; 
Wawer et al., 2005) and 0.0011 in the cohort of the Partners in Prevention Study (Celum 
et al., 2010). 
un treatp −
The core of our simulation is the calculation of the effect of acyclovir on the 
reduction of HIV transmission per sexual contact. Acyclovir acts to reduce HIV plasma 
viral load, and subsequently HIV transmission probability per coital act. We assumed that 
the effect on reducing HIV infectiousness is according to the empirical relationship 
between HIV plasma viral load and HIV transmission probability per coital act as 
observed initially by Quinn and colleagues (Quinn et al., 2000), and affirmed recently in 
the Partners in Prevention trial (Lingappa et al., 2010): ( )10log2.45 vltreat un treatp p −= × . Here  
 is HIV transmission probability per coital act in absence of intervention (control 
group), which was fixed at 0.0012, 
un treatp −
treatp  is HIV transmission per coital act in presence of 
intervention (intervention group), and ( )10 vl
10og
log
l
is the logarithmic (base 10) reduction in 
HIV plasma viral load with the intervention.  The Partners in Prevention RCT reported an 
HIV plasma viral load reduction of 0.25  (95% CI 0.22-0.29) (Celum et al., 2010) 
implying 20.1% reduction in the transmission probability per coital act with the 
intervention . If the HIV plasma viral load reduction was 0.75 , as in 
the higher dose acyclovir proof-of-concept studies, the reduction in the transmission 
probability per coital act with the intervention is 48.9% leading to .  
0.0010treatp = 10log
0.0006treatp =
The number of coital acts per susceptible individual per month was randomly 
chosen from a gamma distribution parameterized by the data of the Partners in Prevention 
trial (Lingappa et al., 2009) (Table 6.1). The coital acts are then divided into condom 
protected acts with efficacy of 80%, based on a systematic review of condom efficacy 
(Weller and Davis, 2001), and un-protected coital acts. The fraction of acts that are 
condom protected is 93% based on the Partners in Prevention data. Using these data, the 
number of un-protected exposures per month per susceptible individual to HIV infection 
is then estimated by drawing from a binomial distribution, where the number of events 
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indicates the number coital acts per month per susceptible individual, and a probability o
unprotected coital exposures of 
f 
( )93% 1.00 0.80 7% 26%− + = .  
For this simulation, the total number of individuals simulated in each realization 
(which  
ted 
val 
 Circumcision trial simulation 
onducted to assess the effect of male circumcision on 
 
 corresponded to an individual RCT trial) was 3400 (1700 in the control group and
1700 in the acyclovir intervention group). The 2-year follow-up of the study was 
simulated in 24 monthly time steps. Each time step (month), and for each unprotec
sexual contact, the simulation draw a random number from an uniform distribution to 
decide if the sero-negative individual remains uninfected or if the individual becomes 
HIV infected. If a transmission occurs, the time is recorded to perform a log-rank survi
analysis. Figure 6.1 illustrated the algoritm implemented for the Partners in prevention 
RCT simulation. 
To simulate the Rakai RCT study c
the prevention of HIV infection, we estimated the probability of HIV transmission per 
month based on the number of cases per 100 persons per year. The Rakai study reported
1.33 new infections per 100 persons-year, which gave us a baseline probability of HIV 
transmission per month, mp = 0.0008. We assumed that circumcision decreases the risk 
of infection by 60% (Auvert et al., 2005; Bailey et al., 2007; Gray et al., 2007; Weiss et 
al., 2000); therefore the probability of HIV transmission per month for individuals 
allocated in the intervention group was m treatp − = 0.00032. We allocated 2522 indivi
in the control group and 2474 individual e intervention group. The model simulates 
the HIV transmission every month over a period of 24 months.  
To measure the efficacy of the interventions, we p
duals 
s in th
erformed two statistical 
analyses for each replication: log-rank survival analysis and relative risk (RR) estimation. 
The power of a specific RCT design was then determined from the number of trials that 
rejected the null hypothesis. All results were based on means of 1000 repetitions. Figure 
6.2 ilustrate an example of a survival curve obtained from the tree scenarios 
implemented.  
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We designed three distinct scenarios for the RCT simulations. In the first 
scenario, we assumed an effect size based on the reduction in HIV plasma viral load 
as reported in the actual Partners in Prevention trial (0.25 ). In the second scenario, 
we assumed a larger reduction in HIV plasma viral load of 0.75  consistent with a 
stronger dosage of acyclovir. In the third scenario, we simulated the male circumcision 
RCT assuming a 60% efficacy for the intervention as measured in the three male 
circumcision trials to date (Auvert et al., 2005; Bailey et al., 2007; Gray et al., 2007).  
10log
10log
10log
We generated a population of virtual individuals and simulated the two different 
interventions proposed in these clinical trials. For this in silico experiment, the unit of 
replication was an individual RCT trial. To measure the efficacy of the intervention 
(acyclovir or male circumcision), we performed two statistical analyses for each 
individual trial realization: log-rank survival analysis and relative risk (RR) estimation. 
The power of the RCT to yield a statistically significant result was then determined as the 
fraction of realizations that rejected the null hypothesis (Burton et al., 2006). All reported 
results in this article were based on 1000 realizations of the model. 
We designed three distinct scenarios for the RCT simulations. In the first 
scenario, we assumed an effect size based on the log10 reduction in HIV plasma viral load 
generated by a dosage of acyclovir of 400 mg twice a day, and reported in the actual 
Partners in Prevention trial (0.25 log10). In the second scenario, we assumed a larger 
reduction in HIV plasma viral load of 0.75 log10 consistent with a stronger dosage of 
acyclovir. In the third scenario, we simulated the male circumcision RCT. We also 
assessed the effect of the number of unprotected coital exposures on the RR estimation 
and statistical power of the RCT.  
 
Results 
Table 6.2 summarises the results from all simulations. 
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Scenario1: Partners in prevention trial with 0.25 log10 reduction in HIV plasma 
viral load 
T In this scenario, the mean number of HIV sero-conversions was 35 in the intervention 
group and 44 in the control group (Figure 6.3 A) leading to a mean RR of 0.79 (95% CI: 
0.51-1.25), where the CI represents the mean of the upper and lower bounds estimated 
from the 1000 realizations of the model. The log-rank test indicated that 14% of the RCT 
realizations showed statistically significant efficacy for the intervention, whereas the RR 
analysis indicated that 16% of the realizations were statistically significant. The RR 
distribution (Figure 6.3 B) displayed wide variation in RR outcome across the 1000 
realizations, ranging from RR point estimates of 0.45 to 1.6 (Figure 6.3 B).   
Scenario 2: Partners in Prevention trial with 0.75 log10 reduction in HIV 
plasma viral load 
In this scenario, mean number of HIV sero-conversions was 22 in the intervention group 
and 44 in the control group (Figure 6.3 C) leading to a mean RR of 0.51 (95% CI: 0.31-
0.85). The log-rank test indicated that 75% of the RCT realizations showed statistically 
significant efficacy for the intervention, whereas the RR analysis indicated that 77% of 
the realizations were statistically significant. The RR distribution (Figure 6.3 D) 
displayed wide variation in RR outcome across the 1000 realizations, ranging from RR 
point estimates of 0.2 to 1.1. 
Scenario 3: Rakai male circumcision trial 
In this scenario, the mean number of HIV sero-conversions was 19 in the intervention 
group and 48 in the control group (Figure 6.3 E) leading to a mean RR of 0.41 (95% CI: 
0.26-0.64). The log-rank test indicated that 94% of the RCT realizations showed 
statistically significant efficacy for the intervention, whereas the RR analysis indicated 
that 95% of the realizations were statistically significant. The RR distribution (Figure 6.3 
F) displayed wide variation in RR outcome across the 1000 realizations, ranging from RR 
point estimates of 0.15 to 0.9.  
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Scenario 4: Optimal trial design 
We estimated an optimal trial design to detect significant differences between the 
intervention and control arm. We used the same parameters used in simulation 1 (Table 
6.1), but the population and the time of the follow-up were increased five and four times, 
respectively. Thus, the total number of individuals simulated was 20 000 (10 000 in the 
control group and 10 000 in the acyclovir group) and 96 time steps (months). For this 
scenario, both the log-rank test and the RR analysis indicated that 99% of the repetitions 
showed statistical differences. The mean HIV incidence was 778 in the intervention arm 
and 966 in the control arm (Figure 6.4), and the mean RR was 0.80 (95% CI 0.76-0.88).  
Data Effect of the number of unprotected coital exposures on the RR estimation 
We explored the effect of the number of unprotected coital exposures on the RR by 
varying the number of unprotected exposures from five up to 200 for the total duration of 
follow-up. We did so for both Scenario 1 and Scenario 3 as described above. The results 
indicated that few unprotected sexual contacts per partnership generate a broad CI, which 
then shrinks as the number of sexual contacts increases (Figure 6.5), evidencing the 
dependence of the level of statistical significance on the number of unprotected sexual 
contacts. 
 
Discussion 
It has been suggested that acyclovir is insufficiently effective to produce a reduction in 
HIV plasma viral load necessary to generate an effect on HIV transmission (Hayes et al., 
2010b). As a result, acyclovir therapy has been discredited as an alternative control 
intervention for HIV prevention (Cohen et al., 2011; Hayes et al., 2010b).  The reduction 
on the plasma concentration of HIV, however, suggests that acyclovir (in a dosage of 400 
mg twice a day) may be able to produce in average a 20% reduction on the risk of HIV 
transmission. This information, complemented with the computer simulation of the trial, 
indicated that the RCT designed by the Partners in Prevention team could not be expected 
to detect a significant reduction of the incidence of HIV in response to acyclovir. 
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 We observed that only 14% of the realizations of the simulation obtained 
statistically significant results, and evidenced the low power of the study to detect any 
significant efficacy of acyclovir. Moreover, despite a reduction on the relative risk of 
HIV transmission in the intervention group by 0.79 (95% CI: 0.51-1.25), the wide CI 
indicated a high variation in the outcome of the simulation, which was consistent with the 
findings of the study (hazard ratio with acyclovir 0.92; 95% CI: 0.60-1.41) (Celum et al., 
2010).  
 Based on the effect of acyclovir dosage used and other parameters estimated from 
the trial, our model indicated that a sample size of ~20 000 couples with a follow-up time 
of ~8 years would be necessary to provide enough power to detect a statistically 
significant effect (Figure 6.4). However, the modest clinical significance of 20% 
reduction on the HIV incidence might avert the implementation of such expensive and 
logistically intensive clinical trial.  Conversely, our results suggest that higher dosage of 
acyclovir (or other antiviral drugs that generates a larger reduction on the mean 
concentration of plasma HIV viral load) might generate the clinical efficacy desired 
(Schacker et al., 2002), and indeed, increase the likelihood of success of the clinical trial.   
 Additionally, the Partners in Prevention team calculated the power of the study 
based on an incidence of 4.0 per 100 persons-years in the control group, whereas the 
incidence observed was 1.8 per persons-year. Like the expected effect size of the 
intervention, the event rates assumed also play an important role in the calculation of the 
statistical power (Schulz and Grimes, 2005). Our results suggest that the small number of 
exposures to the infection (unprotected sexual contacts), which was associated with high 
frequency of condom use, might be an important reason for the low observed incidence 
and consequently, the failure on the detection of significant effect.  
 For the Partners in Prevention trial, a minimum number of sexual contacts would 
be necessary to observe a statistical effect of the intervention. Despite the reduction on 
the RR of HIV transmission generated by acyclovir, it would not be possible to detect a 
significant effect on the reduction of the HIV transmission with fewer than 100 
unprotected sexual contacts (Figure 6.5 A). Assuming a high rate of condom use (80% of 
protected sexual contacts), which (in agreement with ethical issues) is the norm in this 
97 
 
kind of studies (Hayes et al., 1997), gives an average of 19 unprotected sexual contacts 
per partnership during the entire study. According to our analysis, this number of 
exposures to the infection is far too low to detect a significant effect of the intervention, 
and cannot provide the basis for an evaluation of the effectiveness of acyclovir.  
Conversely, the more effective the intervention the smaller the number of 
unprotected sexual contacts required to detect a significant difference. Due to the strong 
effect of male circumcision in reducing the hazard of HIV infection (60% reduction), 
even with a small number of unprotected sexual contacts, it would be possible to observe 
a significant effect of the intervention (Figure 6.5 B). This may explain why all RCT 
studies designed to test the effect of circumcision have shown significant results, and it is 
consistent with the high power estimated from the simulation of the Rakai study, where 
94% of the realizations showed statistically significant results. The estimated mean RR of 
0.41 (95% CI 0.26-0.64) nicely agrees with the estimation from the Rakai study (Kaplan-
Meier risk ratio 0.40; 95% CI 0.23-0.70) (Gray et al., 2007), and suggests a high accuracy 
of the mechanistic approach implemented here. 
Our work highlights the risk of designing clinical trials to evaluate interventions 
to prevent HIV infections solely based on results from sample size calculations and 
statistical power estimations. Standard formulas used to calculate the sample size of an 
RCT are unlikely to capture the entire complexity generated by several factors that might 
play an important role in the transmission of HIV. Key parameters such as frequency of 
condom use, number of exposures to the infection, duration of the follow-up, measured 
efficacy of the intervention based on biological data, adherence to the intervention, 
among others, could be evaluated by the use of computer simulations to observe their 
influence in the range of outcomes, and to design the most appropriate clinical trial.  
 The implementation of these virtual trials (i.e. computer simulations) that 
synthesize the mechanistic process of the intervention (and the system in which it is 
implemented) would help us to evaluate the design and performance of future HIV 
prevention trials. It will help to succed in implementing costly and logisitcally intensive 
clinical trials, and more importantly, it will avert confusing evidence on the effectivenes 
of potential interventions.  
98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Diego Fernando Cuadros 2011 
99 
 
Table 6.1 Key parameters used in the RCT simulations 
 
Parameter Value Reference 
Time of the follow-up 24 months (Celum et al., 2010)
Average number of sexual contacts per 
month 
4 (95% CI 2 - 8) (Lingappa et al., 2009)
Percentage of unprotected sexual contacts 
per month  
26%  (Myer et al., 2002)
Number of individuals 
 Scenario 1 (Celum et al., 2010)
  Control group 1700
  Intervention group 1700
 Scenario 2 (Celum et al., 2010) 
  Control group 1700
  Intervention group 1700
 Scenario 3 (Gray et al., 2007)
  Control group 2522
  Intervention group 2474
Probability of HIV transmission in the 
control group 
 Scenario 1 0.0012 per sex act (Celum et al., 2010)
 Scenario 2 0.0012 per sex act (Celum et al., 2010)
 Scenario 3 0.0008 per month (Gray et al., 2007)
Reduction on the probability of HIV 
transmission in the intervention group 
 Scenario 1 20.1% (Celum et al., 2010; 
Quinn et al., 2000)
 Scenario 2 48.9% (Celum et al., 2010; 
Quinn et al., 2000)
 Scenario 3 60% (Gray et al., 2007; 
Weiss et al., 2008)
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Table 6.2 Summary of the RCT simulations from the different scenarios 
 
Result Value 
Mean HIV incidence rate per 100 persons/year  
 Scenario 1  
  Control group 1.29 
  Intervention group 1.03 
 Scenario 2  
  Control group 1.29 
  Intervention group 0.65 
 Scenario 3  
  Control group 0.95 
  Intervention group 0.38 
Percentage of simulations with significant results  
 Scenario 1  
  Log-rank test 14% 
  RR analysis 16% 
 Scenario 2  
  Log-rank test 75% 
  RR analysis 77% 
 Scenario 3  
  Log-rank test 94% 
  RR analysis 95% 
Relative risk estimation  RR (95% CI) 
 Scenario 1 0.79 (0.51-1.25)
 Scenario 2 0.51 (0.31-0.85)
 Scenario 3 0.41 (0.26-0.64)
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Figure 6.1 Flow diagram of the algorithm implemented to simulate the Partners in 
Prevention HSV/HIV transmission study RCT  
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Figure 6.2 Example of the survival curves estimated from a single realization 
In (A) 20% reduction on the probability of HIV transmission per sexual contact (scenario 
1); (B) 50% reduction (scenario 2); and (C) male circumcision (scenario 3). 
 
 
A B C
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Figure 6.3 Number of HIV infections and RR distribution for the different scenarios 
In (A) 20% reduction on the probability of HIV transmission per sexual contact (scenario 
1), distribution of the number of HIV infections for intervention group (red bars), and 
control group (blue bars); (B) its corresponding RR distribution, in this simulation for a 
number of realizations, the RR exceeded one implying that despite the actual reduction in 
the probability of HIV transmission per coital act, it is possible just because of stochastic 
statistical nature, to observe higher HIV incidence in the intervention group compared to 
the control group; (C) 50% reduction (scenario 2), and (D) its corresponding RR 
distribution; (E) male circumcision (scenario 3), and (F) its corresponding RR 
distribution.  
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Figure 6.4 HIV incidence distribution for the optimal RCT designed to evaluate 
acyclovir  
In (A) distribution of the HIV incidence for intervention arm (red bars), and control arm 
(blue bars); (B) its corresponding RR distribution. 
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Figure 6.5 Effect of the number of unprotected sexual contacts on the RR estimation 
The red line represents the RR trends and the blue lines its corresponding CI for (A) 
assuming 0.25 log10 reduction on the HIV plasma viral load, and (B) male circumcision. 
While the point estimate for the RR in Scenario 1 (acyclovir) was 0.80, the confidence 
interval around this estimate varied from 0.70-0.93 at 200 un-protected coital exposures 
to 0.32-1.99 at five un-protected coital exposures. Similarly, for Scenario 3 
(circumcision), while the point estimate for the RR was 0.4, the confidence interval 
around this estimate varied from 0.37-0.50 at 200 un-protected coital exposures to 0.14-
0.99 at five un-protected coital exposures.   
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Chapter 7 - Conclusions 
 
This work aimed to explore the limitations of the notion that the existent heterogeneity of 
the HIV epidemic could be explained merely by variations on sexual behavior. Instead, 
the inclusion of temporal and individual variation on the HIV infectiveness generated by 
co-infection might affect the pattern of the spread of the epidemic at population level, and 
could potentially explain the differences on the HIV epidemic among populations. 
 Co-infection has been consistently proposed as one of the main factors fueling the 
spread of HIV in sub-Saharan Africa. Here, I investigated the role of co-infection on the 
spread of HIV in this part of the world. Using different methodological approaches, I 
conducted statistical and mathematical analyses to assess the relationship between 
different infections and HIV in sub-Saharan Africa. This study was based on the 
hypothesis that the natural history of HIV in sub-Saharan Africa cannot be fully 
understood if individual and temporal variation in infectiousness is neglected. A single 
value for HIV infectivity would fail to describe the dynamics of the epidemic, and 
regardless of the low probability of heterosexual transmission per sexual contact, the 
inclusion of temporal and individual variation generated by transient increases in HIV 
viral loads associated with co-infections might provide a biological basis for the 
accelerated spread of HIV in sub-Saharan Africa. 
 The results here suggest that the HIV epidemic in sub-Saharan Africa can be 
explained by heterosexual transmission, and that the amplification effect caused by 
biological cofactors such as co-infection may have triggered the vast HIV epidemic 
observed in sub-Sahara Africa. The high prevalence of infectious diseases such as 
malaria and HSV-2 in sub-Saharan Africa probably provided suitable conditions for the 
spread of the infection. The remarkably high HIV prevalence observed in sub-Saharan 
Africa probably reflects the particularly suitable environment for the epidemic that is 
unique to this part of the world. These results highlight the possibility that co-infection 
might be a necessary rather than merely a contributing factor in the successful spread and 
survival of HIV in populations where heterosexual vaginal-penile contact is the main 
107 
 
mechanism of transmission, such as in sub-Saharan Africa. Because most studies 
attempting to identify the infectivity of HIV have not explicitly accounted for important 
cofactors, population average estimations cannot capture the variation in infectivity 
associated with these cofactors.  
 This study emphasize the need for additional research focused on the infectivity 
of HIV and underscore the importance of including cofactor effects in HIV infectivity 
studies and epidemic models. Here, the results evidence the necessity for more and better 
quality data to assess the role of co-infection in the spread of HIV. The results discussed 
in chapter 3 and 4 indicate the possible relationship between malaria and HIV in areas 
where both infections geographically overlap. This result, however, was derived using 
indirect measures of the effect of malaria on the risk of HIV infection, and several 
potential confounders such as the impact of HIV on the prevalence of malaria were not 
taken into account. Therefore, it would be imperative to compare these results with field 
studies designed to estimate the impact of malaria on the incidence of HIV. Currently, 
active and efficient control interventions to reduce malaria infections have been 
notoriously successful in countries such as Malawi, Kenya and Zimbabwe. This event is 
generating a convenient scenario that would allow the study of the direct impact of 
reductions on malaria prevalence in the incidence of HIV.  
 Likewise, results from chapter 5 evidence the priority to continue investigating 
the role of viral genetic factors on the transmission of the virus. Despite the controversy 
and skepticism surrounding this topic, the mathematical model developed here suggests 
some potential implications resulted from the combination of biological factors. In this 
chapter, several experiments were proposed to elucidate the potential interactions that 
could be useful for understanding the differences observed among HIV epidemics. 
 Cofactor-enhanced infectivity of the virus might be a key determinant of the HIV 
epidemic in sub-Sahara Africa. This suggests that an HIV epidemic may be mitigated or 
halted through individual measures that decrease viral infectivity. On the other hand, 
whereas limiting the number of sexual partners may be an effective strategy for reducing 
an individual’s risk of HIV transmission; this strategy is unlikely to prevent an epidemic. 
The control and treatment of several common infectious diseases would decrease the 
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incidence of HIV over the long-term. The public health implications of our results are 
clear: broad population-based control strategies to decrease infectivity such as condom 
distribution, antiretroviral therapies, circumcision and especially control strategies for the 
reduction of other sexual and parasitic infectious diseases, may therefore be effective in 
reducing the spread of HIV and could be an effective strategy against the progression of 
the epidemic in sub-Saharan Africa. 
 Several studies have been conducted to evaluate the efficacy of these kinds of 
interventions on the reduction of HIV incidence. Unexpectedly, and in contrast with the 
epidemiological evidence discussed in this study, the majority of the studies have shown 
no significant effect of co-infection treatment on the incidence of HIV. Chapter 6 was 
devoted to explore the possible causes for the failure of such operational intensive and 
costly studies. The results from this chapter evidenced the methodological failures from 
these studies that prevented the detection of significant effects of control interventions 
focused on co-infection. The treatment of co-infections might indeed be an effective 
control intervention; the implementation of studies aimed to evaluate the efficacy of these 
interventions, however, need more thorough design, in which computer simulations 
might be a powerful tool assessing the role of several unexpected behavioral an 
biological factors on the final outcome of the study. 
 In summary, the general findings from this study have direct implications on the 
design of mathematical models attempting to replicate the epidemic curve observed in 
sub-Saharan Africa, as well as control interventions focusing on decreasing the incidence 
of HIV. If highly infectious individuals can be identified, then the efficiency of control 
measures could be greatly increased. The realization of these kinds of targeted 
interventions, however, requires a better understanding of factors determining individual 
infectiousness such as co-infections.    
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Appendix A - Supplementary methods and results Chapter 2 
 
Supplementary methods 
Sexual partnerships were assumed to be exclusively heterosexual, and two types of 
partnerships, distinguished by duration, were considered.  The population was assumed 
closed and stable, with only maturation and mortality into and out of the sexual network.  
The population size remained constant, with individuals maturing into the network to 
offset those who die or mature out of the network.  In accord with the highest resolution 
of relevant data, a monthly time step was used.  With this model, the effects of network 
structure on disease transmission, relationship type, and co-infection with other infectious 
diseases were evaluated. 
Behavioral module 
Building individuals 
In the model, equal numbers of individuals of each sex were created and assigned an age 
and node degree (maximum number of partners per year). The initial age was assigned 
with a gamma probability distribution, with a range between 15 to 60 years old (Table 
A.1, parameters 5-8). 
 Consequently, individual age was used to determine when individuals should be 
removed from the sexual network, and was the basis for other age-specific traits. 
 We adopted a likelihood framework to estimate model parameters of the annual 
degree node distribution by using the number of sexual partners reported in the Malawi 
study for both males and females. For both males and females, the reported number of 
sexual partners follows a gamma distribution: 
 
/
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−
−=
Γ
,   (1)       
where the annual degree distribution is defined as the frequency of node degrees n  
in the network, with shape parameter k and scale parameter θ . 
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 Because the time step of the simulation is one month, and with the aim of 
preserving the degree distribution of the network, we estimated the monthly probability 
of generating a partnership according to the degree node for each individual, and we 
calculated the maximum number of connections that should be generated in the network 
each month. We assumed that casual partnerships were temporally independent, began at 
uniformly distributed random times throughout the year, and lasted for a set duration, d.  
Further, as marriages generally last more than one year, we assumed that if an individual 
was married, the relationship did not end during any observation year. 
 Thus, the expected number of casual partnerships within a year, cy, is the expected 
number of marital partnerships, my, subtracted from the expected number of total 
partnerships, ny or 
 y yc n my= − .    (2) 
Pm, the probability that a casual partnership recorded within the year, would also be 
recorded within one particular month of the year given by 
 
1
12m
dp
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+
=
+
 .     (3) 
 Here a partnership is recorded within the observation month if its center point 
falls within an interval of length 1+d centered on the middle of the month, and a 
partnership is recorded within the observation year if its center point falls within an 
interval of length 12+d.  Because yearly casual partnerships are assumed to be temporally 
independent, the expected number of monthly partnerships, nm, for an individual with ny 
yearly partnerships is the expected number of yearly casual partnerships, plus the 
expected number of yearly marital partnerships, my. 
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 The vector nm  was used for estimating the probability of generating a connection 
according to the node degree of each individual. 
 For calculating the maximum number of connections that should be generated 
each month, we assumed that the expected numbers of yearly casual partnerships are 
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Poisson distributed; therefore, for each nm, the probabilities that the expected cy 
partnerships generate nm casual partnerships during the month, are found according to 
 ( , )
!
ym cn
y
y m
m
c e
p c n
n
−
=  ,  (5) 
evaluated from nm = 0 to nmax.  These probabilities are then weighted by the yearly degree 
frequencies, correcting for the fraction of individuals that are married, and summing over 
partnership numbers.  The probabilities for casual partnerships, weighted by the node 
degree distribution  fy (n)  are 
 ( , ) ( , )*(1 )* ( )c y m y m y mp c n p c n m f n= −  . (6) 
The probabilities for marital partnerships, weighted by  fy (n)   are 
 ( , ) ( , )* * ( )m y m y m y mp c n p c n m f n=  . (7) 
The probabilities for all partnerships, weighted by   fy (n)  are 
 ( , ) ( , ) ( , )t y m c y m m y mp c n p c n p c n= +  .  (8) 
The total monthly partnership frequencies are then 
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= n∑  .   (9) 
  Each frequency includes both males and females; therefore we divided it by two 
to obtain the maximum number of connections that should be generated in one month.  
Forming initial partnerships 
We allowed for two types of relationships; casual relationships, which lasted on average 
6 months (Table A.1 parameter 14), and marriage (long-term relationship), which lasted 
more than 1 year. Partnership formation occurs in two steps.  First, the age mixing pattern 
of marriage is generated by estimating the probability of generating a marriage using a 
gamma probability distribution (eq 1) according to age and gender (Table A.1, parameter 
9-12). This step generates the age mixing pattern of marriage. Then marriages are 
generated until the fraction of the married population estimated for Malawi is reached 
(Table A.1, parameter 13). Casual partnerships are then formed with the remaining 
available individuals (married or single) according to their node degree, and then these 
available individuals are randomly connected until the monthly number of connections   
fy (eq 9) is reached.   
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Dynamic of the network 
Partnerships are broken and reformed with data-determined probabilities each month; 
thus, with the aim of keeping the yearly degree distribution, individuals may sometimes 
have zero partnerships in a particular month. For Malawi, the probability of ending a 
marital relationship follows an exponential distribution as a function of the duration of 
the marriage X, with an average duration of marriage of 6.92 years. Hence, each marriage 
has a probability of ending in each time step according to an exponential cumulative 
probability function with a scale parameter λ (eq 10).  Casual partnerships break up 
following the same function but at a higher rate λ (Table A.1, parameter 14):  
 ( ) 1 xf x e λ−= − .       (10) 
 As the sexual network represents only individuals engaging in sexual activity, 
population dynamics consist of maturation into and out of the sexual network by 
“mortality” related to age or HIV.  At a maximum age of 60, individuals are assumed to 
no longer be sexually active and are removed from the sexual network and replaced with 
a new individual of age 15.  This new individual has the same sex and node degree as the 
removed individual, so that the sex ratio and network structure is maintained. Individuals 
who have broken a relationship and new individuals who have replaced deceased 
individuals or those who have matured out of the sexual network are reconnected by the 
same process used to make the initial connections.   
Epidemiological model 
The epidemiological module was subdivided into two steps, the spread of the infections, 
and the progression and recovery of each infection. We assumed that HIV transmission is 
caused by penile-vaginal heterosexual contact exclusively. We selected gonorrhea, 
syphilis and herpes simplex virus type-2 (HSV-2) as the infections to be simulated in the 
sexual network, based on the amplification effect on HIV transmission and their 
relevance in terms of prevalence in the Malawi population. The dynamics of these STI's 
are well known, and the effect of each infection on the transmission of HIV has been 
determined.  
 A key assumption for the epidemiological module is that the interaction caused by 
co-infection has only one direction. In other words, we assumed that HIV infection has 
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no effect on the natural history of the other infectious diseases included in the model. 
This assumption may be seen as an oversimplification due to the fact that studies have 
shown that HIV infection affects the transmission and progression of other infectious 
diseases such as HSV-2 and malaria. Yet, studies have mainly focused on the impact of 
co-infection on HIV. As a result, uncertainty about the effect of co-infection in the 
direction of the other diseases is still high. 
Spread of the infections 
For the spread of the STI's, the probability of disease transmission per partnership per 
month depends on the number of sexual contacts per partnership per month and the 
transmission probability per sexual contact for each STI.  The number of sexual contacts 
per partnership per month is assumed to be a function of the number of partnerships of 
the infected sex only.  This function is defined as:  
   ,    (11) 
0.75
1nc c N
−=
where C1 is the number of sexual contacts per month for individuals having one 
partnership according to age (Table A.2 parameter 7-10) , and N is the number of 
partnerships the individual has in the specific month. This function is consistent with 
individuals with more partnerships having more sex but keeps the number of sexual 
contacts per month realistic. 
 For each infection, we obtained the estimated amplification factor on the 
probability of HIV transmission per sexual contact.  For our simulation, the algorithm 
assessed whether the individual infected with HIV has another infectious disease, and if 
co-infection was present, the HIV transmission probability was increased depending on 
the amplification cofactor (Table A.2 parameter 49-53). Then, the new HIV transmission 
probability including the amplificatory effect was calculated by 
 *cT T cofactor= .    (12) 
where T is the stage or sex-specific transmission probability per sexual contact (Table 
A.2 parameter 1-6). When multiple co-infections are present, we assumed a saturation 
effect on the enhancement on the transmission probability. Thus, when more than one co-
infection is present, the transmission probability is amplified only by the highest cofactor. 
For the special case of HSV-2, the amplification factor is only effective if the HSV-2 
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infection is reactivated (shedding) (Celum et al., 2004). Therefore the algorithm not only 
verifies the presence of HSV-2 co-infection but also its reactivation. On the other hand, 
HSV-2 not only enhances the transmissibility of HIV but also affects the susceptibility to 
being infected with HIV (Celum et al., 2004). For this reason, the algorithm verifies if the 
susceptible receptor is infected with HSV-2 and its reactivated stage. In this case, the 
transmission probability is also increased by the respective amplification factor (Table 
A.1 parameter 53).  
 The transmission probability per partnership per month is then calculated using 
the binomial (Bernoulli) model as 
 ,   (13) 1 (1 )
nc
p cT = − −T
where Tp is the stage or sex-specific transmission probability per sexual contact (Table 
A.2 parameter 1-6) and Cn is the number of sexual contacts the individual has with the 
partner  (eq 11). The probability of condom use is represented by a gamma probability 
function (eq 1), depending on age (Table A.2 parameter 31, 32). If a condom is used, then 
the probability of transmission of the STI is reduced 94% (Table A.2, parameter 33):  
 
 *0.06condom pT T=   .  (14) 
 For the spread of Malaria infection, we used the daily Entomological Inoculation 
Rate (EIR), defined as the number of infected bites that a person receives per day, for 
both rainy and dry seasons estimated for Malawi, as well as the malaria transmission 
efficiency for an infected bite. Each individual was exposed to a malaria infection by a 
probability of transmission:   
 
Tmalaria = EIR * malaria transmission efficiency  .  (15) 
 
 Because Tmalaria  is calculated based on daily EIR, while the time step of the 
simulation is the month, we calculated the monthly probability of malaria infection, 
TMmalaria, using the Bernoulli model: 
  .    (16) 
301 (1 )malaria malariaTM T= − −
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 In order to include the effect of partial immunity generated by multiple malaria 
infections, each new infection is recorded and then used for calculating the susceptibility 
of a new infection using the model proposed by Gu and coworkers (Gu et al., 2003):  
 
inf
1
1
1
malariaS N
c
θ=
+
,     (17) 
where Ninf is the number of malaria infections an individual has had in his/her life; θ and 
C1 are constants. After calculating the susceptibility coefficient, the new probability of 
malaria infection TM'malaria becomes  
TM'malaria = TMmalaria * Smalaria  . (18) 
 
 The core of our model is the spread of HIV infection. Before the introduction of 
HIV infected individuals, the model simulates for several years the dynamic of the other 
infectious diseases previously mentioned. When an endemic steady state for all infectious 
diseases is reached (after about 500 time steps),  the model introduces HIV infected 
individuals until the HIV prevalence reaches 1%, which is the prevalence observed in 
Malawi in 1981 (Crampin et al., 2002). 
 The HIV transmission probability per month was calculated in the same way as it 
was calculated for the other STI's using the Bernoulli model (eq 12), as was the 
probability of condom use and its effect on the probability of transmission.  However, in 
the spread of HIV the amplification effect caused by co-infection was taken into account.  
 Circumcision is known to affect the dynamics of HIV and has been proposed as 
one of the explanatory variables for contrasting differences in prevalence among 
countries of sub- Sahara Africa. The probability of HIV transmission from infected 
female to uninfected male is approximately halved by circumcision.   
 / 2circum tT T=   .    (19) 
 Circumcision is included in our model at the beginning of the simulation, where a 
percentage of males estimated for Malawi (Table A.2 parameter 62) are randomly 
selected from the male population and identified as circumcised males.  
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HIV transmission caused by commercial sex 
The data available show that males do not report sexual contacts with prostitutes as 
sexual partners; as a result, the degree node distribution estimated for males does not take 
into account sexual contacts with prostitutes.(Ferry et al., 2001; Helleringer et al., 2007a; 
Morison et al., 2001) However, because commercial sex has been considered an 
important risk factor for acquiring HIV infection, we include this mechanism of HIV 
transmission in the model.  
 Data from another study in Cameroon, Kenya and Zambia, called the four cities 
study, was used to parameterize the spread of HIV infections caused by sexual contacts 
with prostitutes (Ferry et al., 2001; Morison et al., 2001). In our model, commercial sex is 
a simple generalized linear equation for calculating the probability that a male gets any of 
the STI's included in our simulation, including HIV. We assumed that in average 8% of 
the male population have six sexual contacts with a prostitute per year.   
 In our model, commercial sex is a simple generalized linear equation for 
calculating the probability that a male gets any of the STI's included in our simulation, 
including HIV. The model is a mass action Bernoulli model, where the probability of 
transmission depends on the actual prevalence of the STI into the population. For HIV, 
because prostitutes are cataloged as a core group, and the prevalence is usually higher 
compared to the total population, we assumed that the HIV prevalence in prostitutes is 
five times the actual HIV prevalence in the population. Thus, the probability of 
transmission caused by sexual contact with a female sexual worker (FSW) is calculated 
as: 
 ,     (20) ( ) 1 {(1 ( )) [ *(1 ) ]}
n
fsw fsw fsw dI t p t p T= − − + −
 where  pfsw(t) is five times the HIV prevalence of the total population at time t, Td  is the 
probability of female to male transmission in chronic stage of HIV infection (Table A.2 
parameter 21)  and n is the number of sexual contacts that a male individual has with the 
prostitute in a month (Table A.2 parameter 60). Every month, a number of male 
individuals (Table A.2 parameter 54) are chosen randomly and become infected via 
commercial sex with a probability IFSW. Because our goal was to measure the impact of 
co-infection on the spread of HIV infection, we allowed to prostitutes to have infections 
with other STIs according to the prevalence of the STI reported for prostitutes. Hence, the 
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baseline HIV transmission probability was amplified according to the presence of co-
infection. 
Progression of the infections 
The model simulates the progression of each infection. Gonorrhea is the simplest one, 
where each month infected individuals have a constant probability of recovery from the 
infection, with an average duration of the infection of ten weeks (Table A.2 parameter 
30). An individual that recovers from gonorrhea infection becomes susceptible again.  
 Syphilis infection has a more complex progression divided in two main stages. 
The primary stage of the infection is the first six months, characterized by a high 
probability of transmission for both sexes and the highest amplificatory effect on HIV 
transmission (Table A.2 parameter 34, 36). After this initial six-month stage, the infection 
remains latent for eight years. The latent stage is characterized by a low probability of 
transmission and no amplification effect on HIV transmission (Table A.2 parameter 35-
37). We assume that individuals infected with syphilis receive treatment; therefore, after 
the latent stage, individuals recover from the infection and become susceptible again.  
 HSV-2 infection has the most complex dynamics. A newly infected individual 
enters a chronic stage of the infection lasting 10 years. During this interval, there are 
about four reactivations of the infection (shedding) per year for non HIV co-infected 
individuals, and six episodes per year for co-infected individuals (Table A.2 parameter 
25,26). These reactivation periods last 15 days and produce the amplificatory effect of 
HSV co-infection on both the transmission and acquisition of HIV (Table A.2 parameter 
27). Hence, for our simulation, only co-infected individuals with HSV-2 in shedding 
episodes have amplified the transmission and acquisition of HIV.  
 In contrast to the other STI's included in the simulation, individuals infected with 
HSV-2 do not recover from the infections; but after the 10-year chronic stage, individuals 
do not transmit the HSV-2 infection, and there is no cofactor effect on HIV transmission 
or acquisition (Table A.2 parameter 23, 24). 
 For malaria, infected individuals recover at a constant rate, with an average 
duration of the infection of two months (Rmalaria). However, with the aim of including the 
effect of partial immunity generated by multiple infections, we used the equation 
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proposed by Gu and coworkers (2003), to calculate a recovery coefficient rmalaria, which 
decreases the duration of the infection:  
 
inf
2
1
1
malariar N
c
ρ=
+
.    (23) 
 Here Ninf  is the cumulative lifetime number of the individual's malaria infections; 
ρ and C2 are constants. After calculating the susceptibility coefficient, the new 
probability of recovery from malaria infections  R'malaria becomes  
 
R'malaria =  Rmalaria * rmalaria  . (24) 
 
  In order to maintain the concept of partial immunity, the recovery coefficient was 
truncated at 20 malaria infections with a minimum value of 0.5.  
 Individuals infected with HIV have a probability of developing AIDS calculated 
by a Weibull cumulative probability function depending of the duration of the infection x, 
with scale parameter  λ, and shape parameter k (Table A.2, parameters 11,12):  
 
( / )( ) 1
kxf x e λ−= − .   (25) 
 We assumed that individuals who develop AIDS are no longer spreaders of the 
infection; they leave the sexual network and are replaced by new individuals in the same 
way that was explained previously for “mortality”.  
 
Supplementary results 
Parameters included in our model are estimated from available published biological and 
behavioral data. Due to the variability generated by the different data collections and 
analyses, all estimations are associated with some degree of uncertainty. Analyses were 
conducted using Latin Hypercube Sampling and Partial Rank Correlation Coefficient 
(LHS/PRCC) through Monte Carlo sampling (Blower and Dowlatabadi, 1994; Marino et 
al., 2008) from specific ranges using the uniform probability distribution function (pdf) 
for 100 runs of the model.  
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 In the absence of published studies about the distribution and the range of most of 
the parameters, ranges were chosen to be as large as possible and represent plausible 
values for these parameters given the empirical evidence. These choices represent the 
most influential parameters in our formalism as seen in multiple analyses of the model 
and there are not precise estimates for them. 
 We conducted three different analyses where we explored the uncertainty and 
sensitivity of each module, behavioral and epidemiological, separately, and then we 
explored the uncertainty and sensitivity of the entire model. 
Uncertainty and sensitivity analyses of the behavioral module 
For the uncertainty and sensitivity analyses of the key parameters of the behavioral 
module, we set the default probability of HIV transmission T = 0.003, but we did not 
include the cofactor effect caused by co-infection. We sampled seven parameters: the 
minimum and maximum age of individuals included in the sexual network, the mean 
number of sexual contacts per month (assuming the same for all ages), the mean 
durations of casual relationships, the proportion of the married population, the proportion 
of the male population that has sex with prostitutes per month, and the number of sexual 
contacts that a male has with a prostitute in a month. The specific range for the sampling 
of each parameter is specified in Table A.3. 
 Descriptive statistics for the uncertainty analysis indicated that the variation 
generated by the uncertainty of the parameters sampled is fairly low (Table A.3). On 
average, all possible combinations of the parameters sampled did not produce an 
epidemic. The 95th percentile, however, indicated that with some combination of the 
behavioral parameters and without the inclusion of co-infection, 5% of the simulations 
generated a HIV close to 5%. 
 The sensitivity analysis revealed that the average number of sexual contacts per 
month and the mean duration of casual relationships were the only statistical significant 
parameters; in other words, these parameters may explain most of the variation observed 
among simulations (Table A.5). The number of sexual contacts and the duration of the 
relationships are parameters related to the HIV transmission risk per partnership. 
According to the binomial model for the calculation of the per-partner probability of HIV 
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transmission, increasing the duration of the relationship or the number of sexual contacts 
will increase the risk of HIV transmission. We observed that simulations with mean 
duration of casual relationship longer than 8 months and with 12 sexual contacts per 
month were able to produce an HIV epidemic higher than 6%. 
Uncertainty and sensitivity analyses of the epidemiological module 
For the uncertainty and sensitivity analyses of the key parameters in the epidemiological 
module we included the cofactor effect caused by co-infection. We sampled from the 
range of the cofactor values of the four infectious diseases included in the model, 
gonorrhea, syphilis, HSV-2 and malaria (Table A.6). 
 The results from this analysis indicated that the variation generated by the 
uncertainty of the cofactors is higher than the variation generated by the uncertainty on 
the behavioral parameters (Table A.7). The first empirical quartile indicated that at least 
in 75% of the simulations the HIV prevalence was higher than 10%. The sensitivity 
analysis indicated that infections with a short infectivity period but with high cofactor 
such as gonorrhea and syphilis, and the cofactor for infections present in the general 
population such as malaria, are the parameters contributing to the variation observed in 
the model (Table A.8).   
Uncertainty and sensitivity analyses of the complete model 
To explore the uncertainty and sensitivity of the complete model to the key behavioral 
and biological parameters, we performed an analysis that combined the ranges previously 
mentioned for both modules and also the proportion of male population with 
circumcision [lower bound = 0.2; upper bound =0.5]. 
 The combination of the uncertainty of the parameters of both modules increased 
the imprecision of the model. One important result from this analysis was that, in contrast 
with the uncertainty analysis for the epidemiologic module, the combination of both 
modules produced some combinations of behavioral parameters that did not allow the 
generation of an HIV epidemic. Thus, even with the inclusion of the cofactor effect, the 
results indicated that in 25% of the simulations an epidemic could not be produced (Table 
A.9).  
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 The results from the sensitivity analysis of the complete model were similar to the 
result of each module separately. The PRCCs showed that as in the behavioral module, 
the model was highly sensitive to the average duration of a casual relationship and the 
mean number of sexual contacts per month (Table A.10). We observed that in 
simulations with an average duration of casual relationships of 2 months the HIV 
prevalence was less than 1%, whereas in simulations with an average duration of casual 
relationship longer than 4 months, the HIV prevalence was higher than 2%.  
 These results indicated the relevance of parameters that measure the risk of HIV 
transmission per partnership. Clearly, an increment in the duration of a relationship as 
well as the number of sexual contacts significantly increased the probability of HIV 
transmission and therefore, the HIV prevalence. Due to the methodological difficulties 
for measuring these parameters (especially the mean duration of a casual relationship), 
they are highly imprecise. Our model indicated however, the relevance of these 
parameters on epidemiological models.  
 Efforts focused on increasing the precision of their estimation will improve the 
accuracy of predictions from mathematical and computational models. On the other hand, 
the cofactors for infectious diseases present in the general population such as malaria and 
the enhanced HIV transmission caused by HSV-2 infection were the most influent 
epidemiological parameters.   
Limitations of the model 
Although the sexual network simulated allows for link dynamics, the degree distribution 
of the nodes and the node degree of each individual is maintained constant throughout the 
entire simulation. This assumption may be unrealistic, since the degree distribution of 
sexual networks on human populations might change over time. The node degree 
distribution of the network was estimated from data collected in 2003, and thus this 
degree distribution might not correspond to the node degree distribution of the sexual 
network in 1980. Intervention programs focused on preventing promiscuity and changes 
in behavior resulting from the HIV epidemic itself could decrease the number of sexual 
partners that a person has in a year. Consequently, the behavioral data for 2003 could 
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underestimate the node degree distribution of the network at the beginning of the 
epidemic.  
 The static degree distribution also has an effect at an individual level. For 
simplification, and given the lack of data, we assume that each individual has the same 
node degree (number of sexual partners per year) during his/her entire sexual life. 
Although the degree distribution of the network may be relatively stable for a long period 
of time, nodes (individuals) may change their degree over time. For example, an 
individual may start having many sexual partners; but marriage, possible infections with 
other STIs, and the HIV epidemic itself may generate a behavioral change in the 
individual, resulting in a lower number of sexual partners or even monogamy. This 
decision-making may be an important process in the network, where the inclusion of 
simulation tools, such as artificial intelligence, may be an interesting approach to 
simulating such behavioral changes. 
 We also assumed no control interventions for the other STIs and malaria, and 
therefore the prevalence of these infections remained constant over the simulation. This 
assumption may appear unrealistic since important efforts to control malaria and STIs in 
sub-Saharan Africa have been effective in reducing their prevalence; consequently, the 
effects of these diseases on HIV may have been decreasing in recent years. 
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Table A.1 Parameters used in the behavioral module of the model 
 
Parameter Value Reference 
Number of sexual partners per year 
Gamma distribution (males) Derived from (University of 
Pennsylvania, 2003)
1. scale 1.1
2. shape 1.9
Gamma distribution (females) Derived from (University of 
Pennsylvania, 2003)
3. scale 3.8
4. shape 0.4
Initial condition age distribution 
Gamma distribution (males) Derived from (National Statistical 
Office)
5. scale 2.24
6. shape 17.32
Gamma distribution (females) Derived from (National Statistical 
Office)
7. scale 2.46
8. shape 13.5
Marriage age distribution  
Gamma distribution (males) Derived from (University of 
Pennsylvania, 2003)
9. scale 2.25
10. shape 17.23
Gamma distribution (females) Derived from (University of 
Pennsylvania, 2003)
11. scale 2.38
12. shape 13.85
13. Percentage of married 
population 
63% Derived from (University of 
Pennsylvania, 2003)
14. Duration of casual 
relationship 
6 months Derived from (University of 
Pennsylvania, 2003)
Separation  probability 
(exponential distribution) 
15. scale 0.15 Derived from (University of 
Pennsylvania, 2003)
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Table A.2 Parameters used in the epidemiological module of the model 
 
Parameter Value Reference 
HIV probability of transmission per sexual contact 
(low income countries) 
(Boily et al., 2009)
1. Acute male-female 0.0276
2. Chronic male-female 0.003
3. Advanced male-female 0.0219
4. Acute female-male 0.03496
5. Chronic female-male 0.0038
6. Advanced female-male 0.02774
Number of sexual contacts per month (by age) (Gray et al., 2001)
7. 15-20 11
8. 21-30 9
9. 31-40 9
10. 41-60 7
Initial HIV infection age distribution (gamma) Derived from 
(National Statistical 
Office)
11. Scale  8
12. Shape 5
HIV progression (Weibull cumulative probability 
function) 
(Marion and 
Schecter, 1992; 
Salomon and 
Murray, 2001)
13. Scale 5
14. Shape 4
HSV-2 probability of transmission per sexual 
contact 
(Abu-Raddad et al., 
2008; Freeman et 
al., 2007)
Primary infection 
15. Male to female 0.3
16. Female to male 0.15
Early  stage 
17. Male to female 0.01
18. Female to male 0.005
Chronic  stage 
19. Male to female 0.005
20. Female to male 0.003
HSV-2 stage duration (Abu-Raddad et al., 
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2008; Freeman et 
al., 2007)
21. Primary infection 3 weeks
22. Early stage 3 months
23. Chronic stage 10 years
24. Latent stage lifetime
HSV shedding frequency per year (Abu-Raddad et al., 
2008)
25. In HIV positive individual 6 per year
26. In HIV negative individual 4 per year
27. Shedding during reactivation 15 days
Gonorrhea probability of transmission (Buvé et al., 2001; 
Orroth et al., 2007)
28. Male to female 0.23
29. Female to male 0.13
30. Gonorrhea duration of infection 3 months (Buvé et al., 2001; 
Ghani et al., 1998; 
Orroth et al., 2007)
Condom use by age (Gamma distribution) Derived from 
(National Statistical 
Office)
31. Scale 14.1
32. Shape 1.78
33. Condom reduction of transmission 94% (Holmes et al., 
2004; Pinkerton 
and Abramson, 
1997)
Syphilis probability of transmission (Buvé et al., 2001; 
Orroth et al., 2007; 
Oxman et al., 1996; 
Pourbohloul et al., 
2003)
34. Early stage male to female 0.175
35. Latent stage male to female 0.018
36. Early stage female to male 0.088
37. Latent stage female to male 0.009
Syphilis stage duration (Buvé et al., 2001; 
Orroth et al., 2007; 
Oxman et al., 1996; 
Pourbohlou et al., 
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2003)
38. Duration early stage 6 months
39. Duration latent stage 8 years
Malaria Entomological Inoculation Rate (EIR) Derived from 
(Doherty et al., 
2005)
40. Rainy season 1.2
41. Dry season 0.6
42. Duration of rainy season 6 months (Aron and May, 
1982; Smith et al., 
2006)
43. Malaria transmission efficiency 0.026
Malaria susceptibility coefficients 
44. Alpha 2 (Gu et al., 2003)
45. N1 200
Malaria recovery coefficients (Gu et al., 2003)
46. Beta  2
47. N2 400
48. Time of malaria parasite clearance 2 months (Anderson et al., 
1991; Kublin et al., 
2005)
Amplificatory factor in HIV transmission 
49. Gonorrhea 3 (Celentano et al., 
1996; Galvin and 
Cohen, 2004; 
Kapiga and 
Lugalla, 1998; 
Kassler et al., 1994; 
Laga et al., 1993; 
Sexton et al., 2005)
50. Syphilis 2.5 (Deschamps et al., 
1996; Otten et al., 
1994; Rakwar et al., 
1999; Sexton et al., 
2005)
51. Malaria 1.25 Derived from (Abu-
Raddad et al., 2006; 
Kublin et al., 2005; 
Quinn et al., 2000)
52. HSV-2 3 (Abu-Raddad et al., 
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2008; Blower and 
Ma, 2004; Celum et 
al., 2004; Corey et 
al., 2004; Freeman 
et al., 2007; Sexton 
et al., 2005; Weiss 
et al., 2001)
53. Enhanced susceptibility to HIV in HSV-2 
infected individual 
3 (Abu-Raddad et al., 
2008; Blower and 
Ma., 2004; Celum 
et al., 2004; Corey 
et al., 2004; 
Freeman et al., 
2007a; Sexton et 
al., 2005; Weiss et 
al., 2001)
Commercial sex parameters 
54. Proportion of male population having sex 
with prostitutes per month 
0.0066 (8% 
in a year) (Ferry et al., 2001; 
Morison et al., 
2001; Nzila et al., 
1991)
55. Gonorrhea prevalence in prostitutes 23% (Morison et al., 
2001; Nzila et al., 
1991)
56. Syphilis prevalence in prostitutes 16%  (Morison et al., 
2001; Nzila et al., 
1991)
57. HSV prevalence in prostitutes 90% (Ferry et al., 2001; 
Morison et al., 
2001; Nzila et al., 
1991)
58. Percentage of circumcised males 31% Derived from 
(National Statistical 
Office)
59. HIV reduction in probability of transmission 
in circumcised males 
2 times (Auvert et al., 2001; 
Baeten et al., 2005)
60. Number of sexual contacts a male individual 
has with a prostitute in a month 
6 Derived from 
(Morison et al., 
2001)
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Table A.3 Parameters sampled and their range for the uncertainty analysis for 
behavioral module 
 
Parameter Range of uniform pdf Reference 
Minimum age [14-18]
Derived from (National 
Statistical Office)
Maximum age [55-62]
Derived from (National 
Statistical Office)
Number of sexual contacts per 
month [6-14]
Representative 
assumption
Duration of casual relationship 
(months) [3-9]
Representative 
assumption
Proportion of married population [0.5-0.7]
Derived from (National 
Statistical Office)
Proportion of male population 
having sex with prostitutes per 
month [0.005-0.01]
Representative 
assumption
Number of sexual contacts a male 
individual has with a prostitute in 
a month [1-20]
Representative 
assumption
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Table A.4 Descriptive statistics from the uncertainty analysis for the behavioral 
module in the absence of co-infections 
 
Descriptive Statistics HIV prevalence 
Mean 0.87 
Median 0 
Standard Deviation 2.07 
25th percentile 0 
95th percentile 4.95 
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Table A.5 Partial rank correlation coefficients of the parameters sampled from the 
behavioral module 
 
Parameter PRCC 
Minimum age 0.02 
Maximum age 0.07 
Number of sexual contacts per month 0.49*** 
Duration of casual relationship 0.53*** 
Proportion of married population 0.04 
Proportion of male population having sex with prostitutes per month 0.01 
Number of sexual contacts a male individual has with a prostitute in a month 0.04 
The results are significant at the 0.05 level (*), the 0.01 level (**) or the 0.001 level (***). 
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Table A.6 Parameters sampled and their range for the uncertainty analysis for the 
epidemiological module 
 
Parameter Range of 
uniform pdf 
Reference 
Amplificatory factor in HIV transmission   
  Gonorrhea [1.1-9] (Celentano et al., 1996; 
Galvin and Cohen, 2004; 
Kapiga and Lugalla, 1998; 
Kassler et al., 1994; Laga et 
al., 1993)
Syphilis [1.4-10] (Deschamps et al., 1996; 
Otten et al., 1994; Rakwar et 
al., 1999)
Malaria [1.1-1.6] Derived from (Kublin et al., 
2005; Quinn et al., 2000)
Enhanced transmission to HIV in HSV-2  
co-infected individual 
[2-5] (Abu-Raddad et al., 2008; 
Blower and Ma., 2004; 
Celum et al., 2004; Corey et 
al., 2004; Freeman et al., 
2007a; Weiss et al., 2001)
Enhanced susceptibility to HIV in HSV-
2 infected individual 
[2-10] (Abu-Raddad et al., 2008; 
Blower et al., 2004; Celum et 
al., 2004; Corey et al., 2004; 
Freeman et al., 2007a; Weiss 
et al., 2001)
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Table A.7 Descriptive statistics from the uncertainty analysis for the epidemiological 
module 
 
Descriptive Statistics HIV prevalence 
Mean 23.44 
Median 22.83 
Standard Deviation 7.35 
25th percentile 17.02 
95th percentile 32.80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
133 
 
Table A.8 First Table in Chapter 1 
 
Parameter PRCC 
Amplificatory factor in HIV transmission  
Gonorrhea 0.42** 
Syphilis 0.46** 
Malaria 0.75***
Enhanced transmission to HIV in HSV-2 co-infected individual 0.04 
Enhanced susceptibility to HIV in HSV-2 infected individual 0.29 
The results are significant at the 0.05 level (*), the 0.01 level (**) or the 0.001 level (***). 
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Table A.9 Descriptive statistics from the uncertainty analysis for the complete 
module 
 
Descriptive Statistics HIV prevalence 
Mean 14.03 
Median 7.12 
Standard Deviation 16.02 
25th percentile 0.23 
95th percentile 45.06 
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Table A.10 Partial rank correlation coefficients of the parameters sampled from the 
complete module 
 
Parameter PRCC 
Minimum age -0.04 
Maximum age 0.09 
Number of sexual contacts per month 0.45*** 
Duration of casual relationship 0.79*** 
Proportion of married population -0.10 
Proportion of male population having sex with prostitutes per month 0.068 
Circumcision -0.17 
Amplificatory factor in HIV transmission  
Gonorrhea -0.03 
Syphilis -0.31 
Malaria 0.23** 
Enhanced transmission to HIV in HSV-2 co-infected individual 0.31** 
Enhanced susceptibility to HIV in HSV-2 infected individual 0.10 
The results are significant at the 0.05 level (*), the 0.01 level (**) or the 0.001 level (***). 
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Figure A.1 Annual degree distribution of the number of sexual partners per year 
Males: (A) Estimated for Malawi (University of Pennsylvania, 2003) (B) resulting from 
the simulations; and for females: (C) Estimated for Malawi (University of Pennsylvania, 
2003) (D) resulted from the simulations. Red lines represent the fitted gamma 
distribution. The histograms represent the distribution of the data. 
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Figure A.2 Age distribution of males and females combined 
(A) Age distribution of sexual active population estimated for Malawi in 2003 (National 
Statistical Office) and (B) Age distribution of sexual active population resulting from the 
simulation for 2003. Red lines represent the fitted gamma distribution. The histograms 
represent the distribution of the data. 
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Figure A.3 Marriage distribution according to age 
(A) Female age distribution estimated from Malawi in 2003 (National Statistical Office) 
and (B) the age distribution from the simulation estimated for 2003. (C) Male age 
distribution estimated from Malawi in 2003 (National Statistical Office) and (D) the age 
distribution from the simulation estimated for 2003. Red lines represent the fitted gamma 
distribution. The histograms represent the distribution of the data. 
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Figure A.4 Number of long-term relationship (marriages) during the entire sexual 
life an individual male or female 
(A) Derived from Malawi in 2003 (National Statistical Office) and (B) derivate from the 
simulations.  
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Figure A.5 Age-distribution of the HIV prevalence 
(A) the observed data from Malawi in 2004 (Glynn, 2008), (B) the resulting HIV 
prevalence distribution from Simulation 2 for the same year. (C) The observed age-
distribution data from Malawi for HSV-2 in 2004 (Glynn, 2008), and (D) the HSV-2 age-
distribution prevalence from Simulation 2 for the same year. 
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Appendix B - Supplementary methods Chapter 5 
 
Mathematical Approach of the Spread of HIV at Population Level 
To evaluate the effect of co-infection at population level, I used a standard deterministic 
population model constructed by Abu-Raddad and coworkers (Abu-Raddad et al., 2008; 
Abu-Raddad et al., 2006). The model is a deterministic compartment model, which 
stratifies the population into compartments according to HIV sero-status and stage of 
HIV infection, and sexual-risk activity group, 
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The index i  stands for an i -sexual risk population where  represent 
the low, low to intermediate, intermediate to high, and high risk groups, respectively. 
 is the susceptible population, and 
1, 2, 3, 4i =
( )S i ( )I iα is the HIV infected populations. The index 
α  indicates the stage of HIV pathogenesis, where 1, 2, 3α =  stand for acute, chronic, and 
late stages respectively.  is the initial population size, of each -risk group.  0 ( )N i i
The progression of HIV is described by 1ω , the rate of progression from acute to 
chronic stage, 2ω , the rate from chronic to late stage, and 3ω , the rate of HIV/AIDS 
disease mortality. pμ is the death rate. The rates iΛ  are the HIV forces of infection 
(hazard rates of infection) experienced by the susceptible populations given by: 
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 Here, ( )X iρ  describes the new sexual partner acquisition rate for each 
population . The expression ( )X i ( , )i jΨ  represents the mixing among the four risk 
groups. It estimates the probability that an individual in risk group i  would choose a 
partner in risk group j  (Garnett and Anderson, 1993) and is described by: 
( ) ( )
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. 
Here, ,i jδ  is the identity matrix and the parameter [ ]0,1e∈
0e
 measures the degree of 
assortativeness in the mixing. For example, at the extreme = , the mixing in the 
population is fully proportional, while at the other extreme 1e = , individuals mix in 
assortative fashion exclusively.  
The parameter It α  represents the HIV transmission probability per partnership in a 
partnership between a member of the susceptible population  and a member of the 
HIV infected population
( )S j
( )I iα . This value is calculated using the binomial model 
( ) ( ) ( ) ( )
( ) ( )1 (1 )
I i S j I i S jnH IV
I I i S jt p α αα α
τ↔ ↔
→= − − , 
which includes the HIV transmission probability per sexual contact per HIV stage 
( ( ) ( )
HIV
I i S jp α →
( ) ( )
), the frequency of sexual contacts per HIV stage in this partnership 
( I i S jn α ↔ ), and the duration of the partnership ( ( ) ( )I i S jατ ↔ ). Assumptions for parameter 
values are summarized on Table B.1. 
 I focused on the study of the endemic equilibrium solutions of the system, which 
yields the following expressions for the population variables in terms of the force of 
infection and other parameters: 
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The equilibrium solution was found through convergent successive 
approximations. Once the force of infection per risk group was determined, I calculated 
the total prevalence and incidence using the different values for the with and 
without co-infection. 
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HIV
I i S jp →
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Diego Fernando Cuadros 2011 
144 
 
Table B.1 Co-infection between-host parameter values 
 
Parameter       Value Reference 
HIV transmission probability per coital act per 
stage of infection ( HIVip ) 
 
Acute stage 0.036 (Hollingsworth et al., 
2008; Pinkerton, 2008; 
Wawer et al., 2005)
Chronic stage 0.0008 (Wawer et al., 2005)
Late stage 0.0042 (Wawer et al., 2005)
Duration of each HIV stage (1/ iω )  
Acute stage 49 days (Pinkerton, 2008; 
Wawer et al., 2005)
Chronic stage 9.0 years (Morgan and 
Whitworth, 2001; 
UNAIDS, 2007; 
UNAIDS/WHO)
Late stage 2.0 years (Wawer et al., 2005)
Frequency of coital acts per HIV stage ( ( ) ( )I i S jn α → )  
Acute stage 10.6/month (Wawer et al., 2005)
Chronic stage 11.0/month (Wawer et al., 2005)
Late stage 7.1/month (Wawer et al., 2005)
Fraction of the initial population size in each risk 
group  
 
Low risk 65% (Ferry et al., 2001)
Low to intermediate risk 23% (Ferry et al., 2001)
Low to high risk 9.5% (Ferry et al., 2001)
High risk 2.5% (Morison et al., 2001a)
Net sexual partner acquisition rate ( ( )X iρ )  
Low risk  0.095 
partners/year 
(Abu-Raddad et al., 
2008)
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Low to intermediate risk 1.30 
partners/year 
(Abu-Raddad et al., 
2008)
Low to high risk 5.46 
partners/year 
(Abu-Raddad et al., 
2008)
High risk 35.78 
partners/year 
(Abu-Raddad et al., 
2008)
Duration of sexual partnership ( ( ) ( )Y i S jατ ↔ )  
            Low risk with low risk         48 months  (Abu-Raddad et al., 
2008)
            Low risk with low to intermediate risk        36 months  (Abu-Raddad et al., 
2008)
            Low risk with intermediate to high risk        24 months  (Abu-Raddad et al., 
2008)
            Low risk with high risk         12 months  (Abu-Raddad et al., 
2008)
            Low to intermediate risk with low to 
intermediate risk           
24 months  (Abu-Raddad et al., 
2008)
            Low to intermediate risk with intermediate 
to high risk           
12 months  (Abu-Raddad et al., 
2008)
            Low to intermediate risk with high risk        6  months  (Abu-Raddad et al., 
2008)
            Intermediate to high risk with intermediate 
to high risk           
6  months  (Abu-Raddad et al., 
2008)
            Intermediate to high risk with high risk        1  months  (Abu-Raddad et al., 
2008)
            High risk with high risk           1  week  (Abu-Raddad et al., 
2008)
Duration of sexual lifespan (1 μ ) 35 years (Abu-Raddad et al., 
2008)
Degree of assortativenes ( ) e 0.224 (Abu-Raddad et al., 
2006; Buve, 2001a)
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